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1 Abstract 
Evolution of the mammalian brain encompassed a remarkable increase in size of the 
cerebral cortex. One key question is how cortical expansion is regulated and what 
mechanisms distinguish larger brains from smaller ones. During brain development radial 
glial cells (RG) are stem cells that give rise to neurons and later also to glial cells that then 
together populate the adult brain. In order to increase the future brain size, initially the 
stem cell pool needs to be expanded leading to a lateral (also called tangential) expansion 
of the cerebral cortex. Later, cortical neurogenesis occurs in different modes: first, RGs can 
give rise to neurons directly by asymmetric cell division thereby re-generating one radial 
glial cell and producing one neuron at the same time. Second, RGs can give rise to basal 
progenitor cells (BP) that typically divide once more to give rise to two differentiating 
neurons. Thereby the neuronal output is increased which then leads to a radial expansion of 
the cerebral cortex increasing its thickness. At mid-neurogenic stages the pool of RGs is 
heterogeneous with subpopulations mainly regenerating themselves and giving rise to 
neurons directly, and others mainly generating BPs. However, the factors determining 
these different subsets of radial glial cells are mostly unknown. Trnp1, a nuclear protein 
with previously undescribed in vivo function, was recently identified in such RG cells that 
do not produce BPs (Pinto et al., 2008). 
The major aim of my work was to investigate Trnp1 function during cortical neurogenesis. 
I found Trnp1 protein to be expressed in a subset of radial glial cells at midneurogenesis in 
the murine cerebral cortex. Trnp1 is absent in BPs but re-expressed in all newborn neurons 
of the cerebral cortex that then loose Trnp1 expression within the first postnatal week. 
Expression of Trnp1 in RGs faded at later developmental stages correlating with a more 
gliogenic potential of the remaining radial glial cells. Additionally, in the adult murine 
brain Trnp1 is only expressed in the neurogenic subependymal zone, the rostral migratory 
stream and the olfactory bulb. Therefore, Trnp1 expression is restricted to neurogenic 
niches of the developing and the adult brain. 
Gain- and loss-of-function experiments in vitro and in vivo identified Trnp1 as a crucial 
regulator of neural stem cell fate. Trnp1 is important to expand the pool of neural stem 
cells through self-renewal. Loss of Trnp1 in vivo provoked a strong radial expansion of the 
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developing cerebral cortex by increasing the number of basal progenitors and the recently 
identified so-called outer radial glial cells (which are normally only sparsely found in the 
murine brain). Remarkably, loss of Trnp1 was even able to induce gyrification of the 
otherwise smooth murine brain. Molecularly, Trnp1 is tightly associated with DNA and is 
involved in gene regulation acting in transcriptional activation.  
These data suggest that Trnp1 acts as a molecular switch in neural stem cells with high 
levels provoking self-renewal and tangential expansion of stem cells whereas low levels of 
Trnp1 lead to radial expansion and folding of the murine cerebral cortex reminiscent of 
larger gyrencephalic brains. Remarkably, Trnp1 is also expressed in the human developing 
brain with regional difference, suggesting that control of Trnp1 expression is crucial for 
proper cortical development and folding in gyrencephalic brains. Furthermore, these data 
implicated Trnp1 in evolutionary processes of brain size expansion.  
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Zusammenfassung 
Die Evolution des Säugetiergehirns umfasst eine bemerkenswerte Vergrößerung der 
Großhirnrinde. Eine wichtige Frage in diesem Zusammenhang lautet: wie wird die 
Größenzunahme der Großhirnrinde geregelt und welche Mechanismen unterscheiden sich 
in der Entstehung von größeren im Vergleich zu kleineren Gehirnen? Während der 
Entwicklung des Gehirns werden Nervenzellen aus Radialen Gliazellen (RG) – den 
neuronalen Stammzellen – gebildet. Des Weiteren gehen später in der Entwicklung auch 
Gliazellen (wie Atrozyten und Oligodendrozyten) aus RG hervor, welche zusammen mit 
den gebildeten Nervenzellen das erwachsene Gehirn besiedeln. Um das Zukünftige Gehirn 
während der Entwicklung zu vergrößern, muss zunächst die Stammzellpopulation 
vergrößert werden. Dies führt zu einem lateralen (auch als tangential bezeichneten) Ausbau 
der Großhirnrinde. Etwas später in der Entwicklung findet dann die Neurogenese der 
Großhirnrinde in zwei unterschiedlichen Modi statt: erstens können Radiale Gliazellen 
direkt Neurone durch asymmetrische Zellteilung bilden, dadurch wird eine Radiale 
Gliazelle erneuert und ein Neuron gebildet. Zweitens können Radiale Gliazellen basale 
Vorläuferzellen (auch Basale Progenitoren oder einfach BP genannt) bilden, die sich 
typischerweise ein weiteres Mal teilen und dadurch jeweils zwei Neuronen generieren. Auf 
diese Art wird die Anzahl der gebildeten Neuronen erhöht, was dann zu einer radialen 
Ausdehnung der Großhirnrinde führt und somit die Dicke der Großhirnrinde vergrößert. In 
der zeitlichen Mitte der Neurogenese, ist die Population der neuronalen Stammzellen 
heterogen. Sie besteht aus solchen Subpopulationen, welche sich vor allem selbst 
regenerieren und direkt Neurone bilden und jenen Subpopulationen welche vornehmlich 
basale Vorläuferzellen bilden. Jedoch sind die Faktoren, die diese unterschiedlichen 
Subpopulationen von Radialen Gliazellen bestimmen weitgehend unbekannt. Trnp1, ein 
Zellkernprotein mit bisher unbekannter in vivo Funktion, wurde vor kurzem in denjenigen 
neuronalen Stammzellen, die keine BPs bilden identifiziert (Pinto et al., 2008). 
Das Hauptziel meiner Arbeit war es die Funktion von Trnp1 während der kortikalen 
Neurogenese zu untersuchen. Ich konnte zeigen, dass das Protein Trnp1 von einer 
Subpopulation von Radialen Gliazellen in der sich-entwickelnden Großhirnrinde der Maus 
exprimiert wird. Zudem konnte ich zeigen, das Trnp1 nicht mehr in BPs exprimiert wird, 
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aber dafür in allen neugeborenen Neuronen der Großhirnrinde wieder gebildet wird. 
Jedoch klingt die Expression von Trnp1 in Neuronen innerhalb der ersten Lebenswoche 
auf undetektierbare Spiegel ab. Die Expression von Trnp1 in Radialen Gliazellen lässt in 
späteren Entwicklungsstadien nach, was mit dem gliogenen Potenzial der verbleibenden 
Radialen Gliazellen korreliert. Des Weiteren ist Trnp1 im erwachsenen Mäusegehirn nur in 
der neurogenen Subependymalzone entlang des lateralen Ventrikels, dem rostralen 
Migrationsstrom und im olfaktorischen Bulbus zu finden. Dies bedeutet, dass sich die 
Expression von Trnp1 während der Gehirnentwicklung und im erwachsenen Gehirn auf die 
neurogenen Zonen beschränkt. 
In vitro und in vivo Experimente bei denen das Trnp1 Protein über-exprimiert oder aber 
herunterreguliert wurde konnten zeigen, dass Trnp1 einen entscheidenden Regulator von 
neuronalen Stammzellen darstellt. Trnp1 ist wichtig, um die Population von neuronalen 
Stammzellen durch Selbsterneuerung zu vergrößern. Verlust von Trnp1 in vivo, führte zu 
einer starken radialen Ausdehnung der sich-entwickelnden Großhirnrinde durch 
Vermehrung von basalen Vorläuferzellen und den kürzlich identifizierten sogenannten 
äußeren Radialen Gliazellen (oRG) (die normalerweise nur spärlich im Mäusegehirn 
vorhanden sind). Bemerkenswerterweise war der Verlust von Trnp1 sogar in der Lage 
Gyrierungen (Faltungen) im normalerweise glatten Mäusegehirn zu induzieren. Auf 
molekularer Ebene ist Trnp1 stark an DNA gebunden und ist an 
Genregulationsmechanismen durch Transkriptionsaktivierung beteiligt. 
Diese Daten legen nahe, dass Trnp1 wie ein molekularer Schalter in neuronalen 
Stammzellen wirkt, wobei hohe Trnp1 Spiegel Selbsterneuerung und tangentiale 
Expansion von Stammzellen hervorrufen, während niedrige Trnp1 Spiegel zu einer 
radialen Ausdehnung und Faltung der Großhirnrinde der Maus führen, welche an größere, 
gyrierte Gehirne erinnert. Bemerkenswerterweise ist Trnp1 auch im sich-entwickelnden 
menschlichen Gehirn exprimiert und weist dabei regionale Unterschiede des 
Expressionsspiegels auf. Dies lässt vermuten, dass die Kontrolle der Trnp1 Expression 
entscheidend für die korrekte Entwicklung und Faltung in gyrierten Gehirnen ist und 
impliziert, dass Trnp1 eine Rolle in der evolutionären Vergrößerung der Großhirnrinde 
spielt. 
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2 Introduction  
The central nervous system (CNS), which includes the spinal cord and the brain, represents 
the biggest part of the nervous system. The CNS consists of two major cell types: nerve 
cells (neurons) and supporting and protecting elements named after the Greek word for 
glue (“glia”), so called glial cells. Recent studies have shown that during CNS 
development radial glial cells (belonging to the glial class of cells) are actually stem cells 
that give rise to both differentiated glial cells, but also to neurons. Therefore the neural 
stem cells during development are actually a class of glial cells. For decades it has been a 
dogma that all neurons in an adult brain are developmentally born and that there is no 
replacement or addition of neurons (neurogenesis) occurring in the adult brain. The famous 
Spanish pathologist, histologist and neuroscientist Ramón y Cajal proclaimed in 1928: 
"once development was ended, the founts of growth and regeneration of the axons and 
dendrites dried up irrevocably. In the adult centers the nerve paths are something fixed, 
ended and immutable. Everything must die, nothing may be regenerated. It is for the 
science of the future to change, if possible, this harsh decree." (Cajal, 1928). This dogma 
was later revised and Cajal’s „science of the future“ indeed unraveled proceeding 
neurogenesis in the adult brain in specialized niches. However, it also became clear that 
regeneration of neurons upon neuronal loss is not a ubiquitous, very efficient process. 
Neuroscientists tried to elucidate the mystery of neurogenesis ever since. The aim persists 
to understand the molecular and cellular mechanisms of neurogenesis and to make use of 
the knowledge generated by basic neuroscience to cure neuronal loss resulting from 
neurodegenerative diseases or CNS injuries such as stroke in the (far) future. Therefore, 
understanding the factors and temporal happenings involved in neurogenesis is crucial. 
One way to elucidate these mechanisms is to analyze neurogenesis in its natural course, i.e. 
during embryogenesis when neurons are born for the first time. Knowledge from the field 
of developmental neuroscience may then ultimately be applied for approaches aiming to 
compensate for neuronal loss. 
Introduction 
 
 6 
2.1 Cerebral cortical development - neurogenesis in its natural course 
For a long time, neurons and glial cells of the CNS have been thought to developmentally 
originate from different pools of progenitors. In 1846 Rudolf Virchow first suggested the 
presence of supporting cells within the CNS and called them glia. Virchow believed that 
glial cells were originating from meschenymal progenitors as other support cells found 
within the CNS. The CNS itself however originates from a specific region of the ectoderm 
(the outer of the three germ layers endo-, meso- and ectoderm), i.e. the neural plate. Later, 
Wilhelm His demonstrated that glial cells also had an ectodermal origin actually 
developing within the CNS itself but he still concluded that neurons and glia are derived 
from different progenitors (for reviews see Rao and Jacobson, 2005; Kriegstein and 
Alvarez-Buylla, 2009). From observations of the developing human neocortex Wilhelm 
His defined several key principles: first, germinal cells divide rapidly in the ventricular 
zone; second, immature neuroblasts migrate from inner to outer zones; and that third, so 
called spongioblasts form a syncytium through which the neuroblasts migrate (Bentivoglio 
and Mazzarello, 1999; Lui et al., 2011). For the past century neurons were believed to be 
derived from specialized neurogenic progenitors (neuroblasts) whereas glia were believed 
to be derived from spongioblasts that are now called radial glial cells (Rakic, 1971). Radial 
glial cells have a radial morphology and are attached both to the apical and the basal 
surface of the developing cortex (see Figure 1). The scaffold generated by radial glial cells 
was believed to have mainly a guiding function for migrating neurons which are found 
closely attached to radial glial cells in the developing cortex (Rakic, 1971; 1972). Studies 
in primates led to the so called “radial unit” hypothesis (Rakic, 1988) claiming, that the 
neuronal output at the ventricular surface is guided by radial fibers towards the cortical 
plate and that neurons of the same ontogeny tend to migrate along the same radial columns 
thereby projecting a ventricular proto-map onto the developing cortex (Rakic, 1988; 2009; 
Lui et al., 2011) (Figure 2). Therefore, neurons of the same cortical column share their site 
of origin but have been generated at different time points. However, the radial unit 
hypothesis did not identify the lineage relationship of radial glial cells and neuronal 
progenitors in the ventricular zone (VZ) (Lui et al., 2011). First hints towards a neurogenic 
role of radial glial cells were obtained by analysis in songbirds some twenty years ago 
(Alvarez-Buylla et al., 1988; 1990). However, this concept was not fully appreciated until 
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one decade ago, when cell fate analysis in the developing brain proved that RG cells give 
rise to neurons (Malatesta et al., 2000; Miyata et al., 2001; Noctor et al., 2001). These 
studies finally showed, that neurons and glia developmentally share a glial origin and that 
radial glia are the progenitors of nearly all glial cells and neurons in the mammalian cortex 
(Malatesta et al., 2000; Noctor et al., 2001; Campbell and Götz, 2002; Götz et al., 2002; 
Kriegstein and G tz, 2003; Pinto and Götz, 2007; Johansson et al., 2010).  
 
 
Figure 1: Radial glial cells during brain development 
(A) Coronal section of a developing murine brain (embryonic day 16). Cell nuclei are labeled with DAPI, 
one hemisphere is shown. (B) Simplified Illustration of the region marked with a square in (A). Radial glial 
cells span from the apical to the basal surface. Cells undergo proliferation at the ventricular surface. Newborn 
neuroblasts migrate along radial glia fibers towards the cortical plate. V: Ventricle; VZ: ventricular zone; CP: 
cortical plate. 
 
 
Figure 2: Radial unit lineage model of cortical neurogenesis  
Cartoon illustrating the mode of neuron migration in the 
developing cerebral cortex. Newborn, migrating neurons (MN) are 
generated in the ventricular zone (VZ) and migrate along RG 
fibers through the intermediate zone (IZ), the subplate (SP) and 
the earlier born deep layer neurons to settle at the top of the 
cortical plate (CP) at the interface of the CP and the marginal zone 
(MZ). Newborn neurons form a radial stack of cells in a columnar 
organization. Cells in one column in the CP share the same site of 
origin, but are born at different time points. For example neurons 
born in radial unit 1 in the VZ, will all form the ontogenetic 
column 1. Neurons then are able to interact with afferents from 
different sites of the brain. Radial unit hypothesis illustration 
modified from Rakic (2009). 
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2.1.1 Neural stem and progenitor cells during forebrain development 
Radial glial cells have a bipolar morphology spanning from the ventricle to the pial surface 
of the developing cerebral cortex. Similar to their ancestors during development - the 
neuroepithelial cells - their cell bodies reside in the ventricular zone (see Figure 1B). 
During the cell cycle their somas undergo apical to basal to apical nuclear translocation 
within the VZ. This somal translocation is called internuclear migration (INM) (in contrast 
to RGs, internuclear migration of neuroepithelial cells covers the entire distance from the 
ventricular surface to the pial surface (Götz and Huttner, 2005)). In the course of INM, 
radial glial cells undergo S-phase and DNA replication at basal positions several cell 
diameters away from the ventricular surface, and M-Phase at apical positions directly at the 
ventricle (Sauer and Walker, 1959; Sidman et al., 1959; Fujita, 1962; Hayes and 
Nowakowski, 2000; Frank and Tsai, 2009; Fietz and Huttner, 2010). Similar to 
neuroepithelial cells radial glia are able to give rise to neurons directly. However, besides 
RG so-called basal progenitors (BP also called neurogenic intermediate progenitors or 
nIPCs) residing more basally are believed to be the major source of amplification and 
neuronal output in the developing cerebral cortex (Haubensak et al., 2004; Miyata et al., 
2004; Götz and Barde, 2005; Malatesta et al., 2007; Sessa et al., 2008; Fietz and Huttner, 
2010; Sessa et al., 2010; Borrell and Reillo, 2012) (see Figure 3). Basal progenitors 
originate from radial glia but retract their apical and basal processes to form a second 
germinal layer, the so-called subventricular zone (SVZ). BPs usually divide once more to 
give rise to two postmitotic neurons thereby increasing the neuron number at least two fold 
(Haubensak et al., 2004; Noctor et al., 2004; Götz and Huttner, 2005; Noctor et al., 2008; 
Kriegstein and Alvarez-Buylla, 2009). In species with increased brain size, the number of 
BPs is increased as well, suggesting that the number of this progenitor subtype is crucial 
for the increase in cortical brain size (Molnár and Kennedy, 2007; Pontious et al., 2008; 
Cheung et al., 2010; Lui et al., 2011; Molnár, 2011; Borrell and Reillo, 2012).  
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Figure 3: Different modes of neurogenesis during cortical development 
Representative drawing of cortical neurogenesis at cellular level during brain development. Radial glia can 
generate neurons in three different modes: first, RG are able to generate neurons directly, through 
asymmetric divisions (generating one neuron and regenerating a RG cell at the same time). Second, RG can 
generate neurons indirectly by generating so-called basal progenitors (BPs) (also called neurogenic 
intermediate progenitors (nIPC)), which then generate two neurons in the next cell division. Alternatively, 
RG generate nIPCs but this nIPCs undergo a second round of amplification (regenerating themselves) before 
they produce neuronal output, thereby increasing the number of neurons. Amplification of the number of 
BPs/nIPCs is crucial for radial expansion of the cerebral cortex during development. At later stages of 
development, RG give rise to glial cells such as astrocytes and oligodendrocytic progenitors. BP, basal 
progenitors (also called nIPCs); CP, cortical plate; IZ, intermediate zone; MZ, marginal zone; nIPC, 
neurogenic intermediate progenitor cell (also called BP); oIPC, oligodendrocytic progenitor cell; RG, radial 
glia; SVZ, subventricular zone; VZ, ventricular zone. The time course of brain development is represented 
from left to right. Figure adapted from Kriegstein and Alvarez Buylla (2009). 
 
Two additional types of neural progenitors, the so called outer radial glial cells (oRGs) and 
short neural progenitors (SNPs) have recently been described in the developing 
mammalian cerebral cortex. SNPs have been suggested to be derived from RG (Gal et al., 
2006) and imaging studies were able to show that oRGs are directly derived from RGs 
(Shitamukai et al., 2011; Wang et al., 2011). SNPs lack a basal process and do therefore 
not contact the pial surface but they still possess apical polarity (Gal et al., 2006). Genetic 
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fate mapping revealed, that SNPs produce rather neurons directly instead of producing BPs 
(Gal et al., 2006; Stancik et al., 2010). In contrast to SNPs, oRGs lack their apical process, 
but still possess a basal process. SNPs and oRGs share expression of the transcription 
factor Pax6 with radial glial cells. Imaging studies were able to show that oRGs undergo 
asymmetric self-renewing divisions producing neurons and replicating themselves 
(Shitamukai et al., 2011; Wang et al., 2011). In contrast to humans and primates that are 
populated by a large number of oRGs, oRGs are only sparsely present in the murine brain 
(~5% at E14). In this context, oRGs have been suggested to contribute to cortical 
expansion in higher mammalian species by representing another type of proliferating 
progenitors (Fietz et al., 2010; Hansen et al., 2010; Reillo and Borrell, 2011; Reillo et al., 
2011; Shitamukai et al., 2011; Wang et al., 2011; Kelava et al., 2012). In summary, BPs 
and oRGs represent intermediate cell types that are believed to be responsible for the 
increase in cortical size.  
 
2.1.2 Heterogeneity amongst neurogenic stem cells 
Throughout the course of development cellular heterogeneity is crucial for proper 
formation of the cellular diversity found in an adult organism. In the context of direct 
versus indirect neurogenesis (via the generation of BPs) from radial glial cells, 
heterogeneity of the radial glial population has recently been suggested (Sommer et al., 
1996; Yaworsky and Kappen, 1999; Malatesta et al., 2003; Gal et al., 2006; Molyneaux et 
al., 2007; Pinto and Götz, 2007; Pinto et al., 2008; Franco et al., 2012). In contrast to 
neuroepithelial cells radial glial cells show expression of astrocytic markers such as BLBP, 
GLAST, GFAP or S100 but similar to NE cells also specific transcription factors such as 
Pax6. However, although radial glia share their common morphology and specific marker 
expression (Götz and Barde, 2005; Götz and Huttner, 2005; Pinto and Götz, 2007), 
heterogeneity amongst them ensures the proper balance between neuronal output and self-
renewal of the stem cell pool. To generate such heterogeneity, cell-internal (intrinsic) as 
well as environmental (extrinsic) cues play a central role (see also 2.1.4). It has for 
example been shown, that asymmetric segregation of intrinsic factors during cell division 
can determine differential cell fate of the daughter cells (Götz and Huttner, 2005; Morin et 
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al., 2007; Bultje et al., 2009). The existence of cellular heterogeneity is a consequence of 
the interplay of intrinsic and extrinsic cues together forming individual cellular characters. 
Encountering different environmental cues can therefore guide initially identical cells into 
different subpopulations. In the course of development, initially multipotent progenitors 
become more and more restricted and different subsets of progenitor cells specialize 
progressively to produce one of the three major cell types: neurons, astrocytes and 
oligodendrocytes. In this context stem cells produce neurons first before different subsets 
of them produce astrocytes and oligodendrocytes later. This sequential progression and 
heterogeneity seems to represent another crucial intrinsic program ensuring the proper 
organization of the resulting neuron-glia circuitry in the adult brain. However, the factors 
involved in regulation of radial glial heterogeneity still remain poorly understood.  
 
2.1.3 Cellular diversity forming the six-layered mammalian cerebral cortex 
In mammals the dorsal forebrain or pallium gives rise to the neocortex (the biggest part of 
the cerebral cortex), a highly complex structure that contains a plethora of different 
neurons and glial cells. A hallmark of the neocortex is the appearance of a six-layered 
structure (Molyneaux et al., 2007). The generation of this organized structure includes the 
timed genesis of particular neuronal subtypes. The first neurons arriving in the prospective 
neocortex around embryonic day (E) 11 are directly generated from neuroepithelial cells 
and settle in the so-called preplate (Casanova and Trippe, 2006; Pinto and Götz, 2007). 
With the replacement of neuroepithelial cells by RG, neurons are generated in different 
modes: either directly by RG or through BPs serving as intermediate progenitors. Newborn 
neurons settle in the cortical plate in an “inside-out” manner with the latest generated 
neurons forming the most superficial layers (Rakic, 1988; Bayer et al., 1991; Casanova and 
Trippe, 2006; Nóbrega-Pereira and Marín, 2009; Rakic, 2009; Marín et al., 2010). In the 
laminar architecture of the mature neocortex distinct populations of projection neurons are 
located in different cortical layers and areas, have unique morphological features, express 
different complements of transcription factors, and ultimately serve different functions 
(Molyneaux et al., 2007). The different cortical layers are distinguishable by their 
individual cytoarchitecture and by specific gene expression patterns of their neurons 
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(Molyneaux et al., 2007). Neurons generated from dorsal progenitors are excitatory cortical 
projection neurons whereas inhibitory neurons are generated from ventral telencephalic 
progenitors. Molecularly, dorsal RGs and BPs as well as ventral progenitors are 
characterized by their specific transcription factor expressions. Radial glial cells in the 
dorsal telencephalon express the homeobox transcription factor Pax6, whereas BPs can be 
distinguished from RGs by their expression of Tbr2 (Englund, 2005). Dorsal telencephalic 
excitatory neurons generated from these progenitors express the transcription factor Tbr1 
that can be used as a marker for glutamatergic, pyramidal neurons. On the other hand 
GABAergic (inhibitory) interneurons of the future neocortex are born in the ganglionic 
eminence within the ventral forebrain and migrate towards the neocortex (Marín and 
Rubenstein, 2001; 2003; Marín et al., 2010). The progenitors in these ventral regions 
express distinct transcription factors such as Dlx1/2, Gsx2 (formerly also called Gsh2), 
Ascl1 (also called Mash1), Nkx2.1 or Olig2. In this context, transcription factors have been 
shown to control neural development and subtype specification of these cells. For example, 
loss of Pax6 leads to a ventralization of the dorsal cerebral cortex (Stoykova et al., 1996; 
1997; Chapouton et al., 1999; Yun et al., 2001; Haubst et al., 2004).  
Altogether this suggests, that progenitors at any time are restricted to produce layer and 
subtype specific neurons to constitute the typical six-layered neocortex. Diverse molecular 
determinants are important for such specification and identification of so far unknown 
factors is crucial towards a better understanding of brain development.  
 
2.1.4 Control of stem cell proliferation and differentiation by intrinsic and 
extrinsic factors 
Controlling stem cell fate and proliferation versus differentiation is one of the most critical 
steps during development. First, the stem cell pool needs to be expanded before giving rise 
to differentiated, specialized cells. Therefore, during brain development a tangential 
expansion of stem cells is observed first before a radial expansion takes place due to 
increased neuronal output and differentiation. Tight regulation of such processes is 
accomplished by cell intrinsic and extrinsic signaling factors. As already mentioned, 
intrinsic factors play a central role in control of stem cell proliferation, differentiation and 
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fate specification. Intrinsic regulation of the cell cycle and fate for example comprises the 
regulation of cell polarity. In this context, knock down of Par3 (which plays a role in apical 
positioning of the Par complex) leads to premature differentiation of cortical progenitor 
cells showing, that apico-basal polarity is crucial during development (Costa et al., 2007). 
It was also reported, that Par3 regulates asymmetric cell division of radial glial cells in a 
Notch signaling dependent manner (Bultje et al., 2009). Additionally, the small GTPase 
cdc42 participates in activation of the Par complex and was shown to be required for RG 
self-renewal (Cappello et al., 2006). Loss of cdc42 function induced RG cells to detach 
from their apical surface and increased the number of Tbr2 positive progenitors (Cappello 
et al., 2006).  
Transcriptional regulators of cell proliferation and fate comprise members of the basic 
helix loop helix (bHLH) transcription factor (TF) family such as Ngn1/2, Mash1(Ascl1) or 
Olig1/2 (Fode et al., 2000; Nieto et al., 2001; Lu et al., 2002; Zhou and Anderson, 2002; 
Schuurmans et al., 2004; Heng et al., 2008; Pacary et al., 2011) and the homeobox TFs 
Pax6 and Dlx1/2 (Götz et al., 1998; Heins et al., 2002; Petryniak et al., 2007). For example 
Pax6 was shown to have a regulatory role on cell proliferation but also to influence the 
identity of progenitor cells (Götz et al., 1998; Warren et al., 1999; Haubst et al., 2004; 
Quinn et al., 2007; Tuoc et al., 2009) and its deletion in the dorsal telencephalon resulted in 
severely defective neurogenesis. Additionally, Tbr2 was also reported to be involved in 
control of progenitor proliferation (Arnold et al., 2008; Sessa et al., 2008). Moreover, 
recent studies demonstrated, that such transcription factors are also able to redirect cells 
with astrocytic characteristics postnatally into the neurogenic lineage (Berninger et al., 
2007; Heinrich et al., 2010; Blum et al., 2011). Clonal analysis in vitro demonstrated that 
intrinsic molecular differences are able to govern fate decision, independent of 
extracellular signals (Williams and Price, 1995; Qian et al., 1998; Malatesta et al., 2000; 
Heins, 2001; Heins et al., 2002; Shen et al., 2006). 
On the other hand, extrinsic signals known to be involved in regulation of cortical 
development include the Notch and Wnt signaling pathways (Johansson et al., 2010). 
Notch is a receptor expressed on radial glia cells and activation through its ligands 
(Delta/DLL) expressed on newborn neurons inhibits neuronal differentiation and leads to 
self renewal of RGs (Lui et al., 2011). In this context it has been reported, that deletion of 
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the downstream effectors Hes1, 3 and 5 resulted in extensive cell cycle exit and accelerated 
differentiation of former stem cells (Hatakeyama et al., 2004; Lui et al., 2011). In addition 
to the short-range signaling of Notch between adjacent cells, Wnt signaling is considered 
to be a long-range, diffusive signal that can act in a canonical and a non-canonical way 
(Michaelidis and Lie, 2008). The canonical Wnt signaling cascade involves -catenin as an 
effector (Galceran et al., 2001; Wang et al., 2005; Cho and Cepko, 2006; Gulacsi and 
Anderson, 2008). Wnt inhibits GSK3 dependent -catenin phosphorylation and thereby 
releases -catenin that is then able to translocate to the nucleus and act as a transcriptional 
activator (Behrens et al., 1998; Huelsken et al., 2001; Cadigan and Liu, 2006). In this 
context, overexpression of a constitutively active form of -catenin blocked cell cycle exit 
and led to significantly increased cortical size (Chenn and Walsh, 2002; 2003). Differences 
in cell cycle length of RG versus BP have been shown and the length of the cell cycle may 
also affect the cellular identity of stem/progenitor cells (Calegari and Huttner, 2003; 
Calegari et al., 2005). In this context shortening of cell cycle length through 
overexpression of Cdk4/CyclinD1 was able to delay neurogenesis and cause the expansion 
of the basal progenitor pool (Lange et al., 2009). 
In summary, during brain development a multitude of extrinsic and intrinsic factors 
interplay together to result in proper cell proliferation, differentiation and fate 
determination (Farkas and Huttner, 2008; Lui et al., 2011; Tiberi et al., 2012). Such 
regulation is crucial for the formation of the most complex structure in mammals – the 
brain. 
As all the so far known molecular regulators have not been able to regulate RG versus BP 
and oRG generation at the same time, it has recently been suggested that there may be 
novel, so far unknown fate regulators of radial glial cells (Lui et al., 2011). Moreover, 
understanding the factors involved in different subtypes of radial glial cells may help to 
understand the regulatory mechanisms that ultimately lead to proper formation of the 
cerebral cortex. In addition, such factors may also be directly or indirectly involved in 
regulating cortical expansion and creating differences amongst different species and during 
evolution. One approach to identify proteins that are specifically up-regulated in RG 
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subpopulations was performed by Pinto et al and will be discussed specifically in the next 
section. 
 
2.1.5 Identification of factors involved in direct and indirect neurogenesis 
The adult brain is populated by different neuronal and glial cell types that have been 
generated from heterogeneous progenitor populations during development (Pinto, 2008). In 
order to identify the molecular differences of such progenitor subpopulations and to find 
new factors determining heterogeneity during development, Pinto et al. previously 
performed a transcriptome analysis of different radial glial subsets (Pinto et al., 2008). For 
this purpose, Pinto et al. used a mouse line expressing GFP under the human version of the 
GFAP promoter (hGFAP). In order to exclusively isolate radial glia and not their progeny 
that delaminated from the ventricular surface, the apical membrane protein CD133 
(prominin) was additionally used for FACS purification. Cells were sorted for GFP- and 
prominin expression and pooled as GFPhigh/prom+ and GFPlow/prom+. Remarkably, 
GFP expression levels of RGs correlated with their prospective fate (Pinto et al., 2008) and 
a clear heterogeneity of radial glial cells was observed. Radial glial cells with high level 
GFP expression mainly formed neurons indirectly through the production of BPs, whereas 
almost no BPs were detectable from GFP low expressing RG cells that produced neurons 
directly. This observation is in agreement with the hypothesis that neurogenic radial glial 
cells down regulate glial markers such as GFAP when they undergo transition to neurons 
directly (Pinto et al., 2008). Therefore, directly neurogenic RG showed lower GFP 
expression under the hGFAP promoter at E14 and produced very few BPs as compared to 
RG that showed high GFP expression and where the main source of BPs (Pinto et al., 
2008). In order to identify fate determinants of these two RG subpopulations, 
transcriptome analysis was performed and revealed strong differences in gene expression 
(Pinto et al., 2008). One factor that was found in this screen in the indirectly neurogenic 
lineage generating BPs is AP2 (Pinto et al., 2008; 2009). Indeed it was recently shown 
that AP2 is expressed in a subpopulation of RG and is involved in BP cell fate (Pinto et 
al., 2009). In order to find possible regulators of directly neurogenic radial glial cells, 
another gene expressed at higher levels in the other, directly neurogenic subset of radial 
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glial cells was chosen for further investigation. This factor has recently been described as 
Trnp1 (previously called 2300002d11Rik) and was shown to play a role in proliferation in 
vitro (Volpe et al., 2006 see also 2.4). Analysis of Trnp1 expression and function during 
forebrain development and its role in neurogenesis was the topic of my work presented in 
this thesis.  
 
2.2 Cortical Expansion and brain Evolution  
In the 17
th
 century, Thomas Willis first proposed that higher cognitive functions originate 
from the sheer size of the brain (Molnár, 2011). The increase of intellectual capacity during 
mammalian evolution is believed to highly correlate with the increase in brain size. In this 
context, the cerebral cortex has undergone an impressive expansion including profound 
gyrification to accommodate an enormous increase in neuron numbers (Kriegstein et al., 
2006; Rakic, 2009; Cheung et al., 2010; Lui et al., 2011; Borrell and Reillo, 2012). In 1664 
Willis already realized, that the gyrifications of the human cerebral cortex are larger and 
more numerous as compared to other species (Willis, 1664). 
The evolutionary increase in cortical size correlates with the appearance of the so-called 
outer subventricular zone in larger brains. Hereby, the subventricular zone is divided into 
inner (iSVZ) and outer (oSVZ) areas separated by a layer of fibers. The strong expansion 
of larger brains is believed to be due to an increase in the number of basal progenitors, 
which subsequently increase the number of neurons. In this context, the strong 
proliferation of cells residing in the SVZ of primates correlates with the main wave of 
corticogenesis (Rakic, 1974; Lukaszewicz et al., 2005; Lui et al., 2011). Basal progenitors 
have been suggested to be the main source of cortical expansion. Indeed, genetic studies in 
humans showed that the cause of congenital microcephaly was silencing of the 
transcription factor TBR2 (EOMES) (Baala et al., 2007), a protein shown to be 
functionally required for SVZ neurogenesis (Arnold et al., 2008; Sessa et al., 2008; 2010) 
and  also used as a marker for basal progenitors (Bulfone et al., 1999; Faedo et al., 2002; 
Englund, 2005). 
Recently, another type of progenitors has been described and implicated in cortical 
expansion and folding (see also 2.1.1). This type of cell shares several characteristics such 
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as Pax6 expression with radial glial cells, but in contrast to those has only a basal process 
lacking the apical contact to the ventricular surface and their cell body resides in the oSVZ. 
This cell type is called outer radial glial cell (oRG) or basal radial glial cell (bRG). Outer 
radial glial cells contribute to cortical expansion by representing another type of 
proliferating progenitor (Fietz et al., 2010; Hansen et al., 2010; Reillo and Borrell, 2011; 
Reillo et al., 2011; Shitamukai et al., 2011; Wang et al., 2011; Kelava et al., 2012). 
Expanding the population of radial glia in a distinct germinal zone is a mechanism for 
increased neuron production that is highly relevant for building a larger brain (Lui et al., 
2011). Despite their role in proliferation and expansion of neuron numbers, oRGs are also 
a crucial part of the migratory scaffold in the developing brain. As expanded, folded brains 
have a strong increase in basal surface with only slightly increased ventricular surface 
oRGs are needed to keep the fiber density constant throughout the process of radial 
expansion (Lui et al., 2011; Reillo and Borrell, 2011; Reillo et al., 2011; Martínez-Cerdeño 
et al., 2012) (see Figure 4). This interpretation is strongly supported by the appearance of 
larger numbers of oRGs in brains with a high degree of gyrification (Fietz and Huttner, 
2010; Borrell and Reillo, 2012; Martínez-Cerdeño et al., 2012). In contrast, the little and 
lissencephalic mouse brain has only small numbers of oRGs (Shitamukai et al., 2011; 
Wang et al., 2011). In human cortical development the number of neurons in the cortical 
plate increases by about 5 billion new neurons between the 13
th
 and the 20
th
 gestation 
week. In this context it has been suggested, that on average there must be 1000 neurons 
arriving every second in the CP during that period indicating that there may be 500-1000 
progenitors dividing every second to produce this enormous output (Martínez-Cerdeño et 
al., 2012). Therefore, tight control of neuronal production and guidance through RGs, BPs 
and oRGs is crucial for proper brain development. 
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Figure 4: Differences in neocortical development of the rodent and human brain 
(A) Model of the current view of rodent corticogenesis. Radial glia (RG) mostly generate intermediate 
progenitors (IP also called basal progenitors (BP)) that divide again to produce neurons. Newborn neurons 
migrate along RG fibers towards the cortical plate. Small numbers of outer radial glial cells (oRG) exist in 
the murine brain. (B) Simplified Model of the human developing neocortex. The increase of the 
subventricular zone (SVZ) divided into inner- and outer SVZ is illustrated. The number of radial fibers that 
neurons can use to migrate along is increased due to the abundance of oRGs. Additionally, the number of 
ontogenetic “units” is significantly increased through the addition of oRG cells to ventricular radial glial cells 
(vRG). Integrin and Notch signaling are involved in maintenance of oRGs. Additionally, short neuron 
precursors (SNPs) are depicted in (A) and (B). Transcription factor combinations expressed by the different 
progenitor types is indicated. Illustration from Lui et al (2011)  
 
In summary, a diversity of progenitors exists in the developing cerebral cortex. Amongst 
them neuroepithelial cells (that mainly self replicate to initially increase the pool of stem 
cells), RG cells, SNPs, BPs and oRGs. All of them contribute to the formation and 
expansion of the cerebral cortex. A general concept of forebrain development indicates that 
the progenitor pool initially needs to be expanded leading to a tangential expansion at first 
place. In order to incorporate a large number of neurons, radial expansion takes place later 
eventually leading to cortical folding and gyrification in higher species (Smart and 
McSherry, 1986a; 1986b; Rakic, 2009; Lui et al., 2011; Molnár, 2011; Borrell and Reillo, 
2012). 
 
Introduction 
 
 19 
2.3 Neurogenesis in the adult brain 
Although neurogenesis was initially believed to be restricted to the prenatal phase of 
development, first studies in the 1960s already indicated the persistence of neurogenesis in 
the adult brain (Altman, 1963; Altman and Das, 1965; 1966; Altman, 1969). These studies 
utilized [H
3
]-thymidine to label dividing cells by incorporation into DNA during S-phase 
of the cell cycle. This technique was first described in the 1950s (Sidman et al., 1959). 
However, little attention was given to these studies, perhaps because they were considered 
to lack functional relevance (for a review see Ming and Song, 2005). Later studies showed 
that adult neurogenesis is relevant and that newborn neurons survive for a long period, 
therefore revealing the significance of neurogenesis in the adult rodent brain (Kaplan and 
Hinds, 1977; Bayer et al., 1982; Kaplan and Bell, 1983; 1984; Cameron et al., 1993; Seki 
and Arai, 1995; Kuhn et al., 1996). The synthetic thymidine analogue Bromodeoxyuridine 
(BrdU) revolutionized the field because (just like [H
3
]-thymidine) it incorporates into 
dividing cells during S-phase but in contrast can easily be detected by immunological 
approaches (Gratzner, 1982). Before the end of the 20
th
 century adult neurogenesis was 
observed with BrdU analysis in all mammalian species examined including primates and 
human patients  (BrdU was used in human cancer diagnostics therefore analysis of human 
neurogenesis post mortem was possible). It has recently become generally accepted that 
adult neurogenesis occurs in discrete regions of the mammalian CNS (Kempermann and 
Gage, 1999; Gross, 2000; Rossi and Cattaneo, 2002; Goh et al., 2003; Parent, 2003; 
Alvarez-Buylla and Lim, 2004; Lie et al., 2004; Lindvall et al., 2004; Ming and Song, 
2005). Two main neurogenic regions in the adult mammalian brain have been well 
described, the subependymal zone (SEZ) of the lateral ventricle (from where newborn 
neurons migrate through the rostral migratory stream (RMS) to the olfactory bulb (OB)) 
and the subgranular zone (SGZ) of the dentate gyrus (Kriegstein and Alvarez Buylla, 2009) 
(see Figure 5). However, neurogenesis outside such specific neurogenic niches seems to be 
extremely limited, or non-existent, in the intact adult mammalian brain (Ming and Song, 
2005). The adult SEZ is related to the embryonic SVZ and contains relatively quiescent 
neural stem cells called type B cells. These type B cells give then rise to so-called type C 
cells that are highly proliferative generating immature neuroblasts (also called type A cells) 
Introduction 
 
 20 
(see Figure 6), which migrate in chains through the rostral migratory stream to the 
olfactory bulb. Type B cells of the SEZ as well as the stem cells in the SGZ of the 
hippocampus show characteristics of astrocytes and have also been frequently called SEZ 
or SGZ astrocytes (Doetsch et al., 1999; Kriegstein and Alvarez-Buylla, 2009). For type B 
cells of the adult SEZ it has been shown that they are derived from RG cells during 
development (Merkle et al., 2004) and the same has been suggested for stem cells of the 
SGZ (Eckenhoff and Rakic, 1984; Altman and Bayer, 1990; Kriegstein and Alvarez-
Buylla, 2009). Moreover, recent studies indicate that NSCs in the adult brain share several 
important properties with RG (such as an apical contact to the ventricle with a single 
primary cilium) and a link between embryonic and adult neural stem cells has been 
suggested (Mirzadeh et al., 2008; for detailed reviews see Ming and Song, 2005; 
Kriegstein and Alvarez-Buylla, 2009). One major question is what factors distinguish such 
specialized cells in neurogenic niches of the adult brain from regular, non-neurogenic 
astrocytes and why neurogenesis in the adult brain is limited to very few restricted regions.  
 
 
Figure 5: Regions of adult neurogenesis in the rodent brain 
Schematic Illustration of the adult rodent brain and its neurogenic niches. Saggital section of the adult murine 
brain highlighting the SEZ of the lateral ventricle and the SGZ of the hippocampal dentate gyrus as the two 
well described regions with proceeding neurogenesis. Note also the rostral migratory stream (RMS) along 
which newborn neurons migrate towards the olfactory bulb. Modified model from Ma et al. (2009). 
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Figure 6: Illustration of progenitor types and lineages in the adult SEZ 
Neural stem cells (NSCs) correspond to type B cells and retain epithelial properties, including the extension 
of a thin apical process contacting the ventricle and a basal process that ends on blood vessels. Type B cells 
give rise to highly proliferative type C cells (also called intermediate progenitor cell or IPC). These IPCs then 
give rise to mainly neurons but alternatively also oligodendrocytes. Blue lines represent asymmetric, red lines 
symmetric cell divisions. oIPC: oligodenrocytic intermediate progenitor cells, nIPC: neuronal intermediate 
progenitor cells, SEZ: Subependymal zone. (Kriegstein and Alvarez-Buylla, 2009). 
 
2.4 Trnp1 – a nuclear protein highly conserved within the mammalian 
lineage 
Trnp1 has recently been found in a yeast two hybrid screen searching for interacting 
partners of the TATA Element Modulatory Factor (TMF/ARA160) (Volpe et al., 2006). 
Trnp1 has been described to be localized to the nucleus and to interact with TMF which 
leads to proteasomal degradation of Trnp1 in C2C12 cells (Volpe et al., 2006). The gene 
previously known as 2300002D11Rik was thus named Trnp1 (for TMF Regulated Nuclear 
Protein 1). Trnp1 has a single, highly conserved ortholog for each sequenced mammalian 
genome. A 1607bp cDNA encodes for a 223aa protein in the mouse and a 1745bp cDNA 
encodes for a 227aa protein in humans with about 90% homology between the human and 
the murine protein (see Figure 7A). The gene resides at chromosome 1p36.11 in the human 
genome and at chromosome 4D3 in the murine genome each producing an invariantly 
spliced, two exon mRNA from an approximately 7,5kb nascent messenger (see Figure 7B). 
The coding region is entirely located within the first exon and the second exon represents 
the 3’-UTR of the mRNA (see Figure 7B). 
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Phylogenic tree analysis supports the existence of a single (never duplicated) mammalian 
ancestral gene for all Trnp1 orthologs (Volpe et al., 2006). Volpe et al performed extensive 
search for Trnp1 homologues in other sequenced vertebrate genomes and claimed that they 
did not reveal any homolog, thus the Trnp1 gene seemed to have arisen exclusively in the 
mammalian lineage (Volpe et al., 2006). Moreover, protein sequence analysis did not 
convincingly reveal any known protein motif or domain. However, two regions of low 
structural complexity can be identified and are present in all mammalian orthologs: a 
proline rich region (P
20
-P
54
 in the murine protein) and a glycine/alanine rich region (G
72
-
G
94
 in the murine protein) (Volpe et al., 2006). 
Western blot analysis of HEK cells overexpressing a Trnp1-HA or Trnp1-Myc fusion 
protein revealed multiple heterogeneous bands extending from about 30 to 36 kDa that 
were suggested to be due to extensive posttranslational modification (Volpe et al., 2006). 
Immunocytochemical analysis of ectopically expressed Trnp1-Myc in C2C12 cells showed 
an exclusively nuclear localization of Trnp1 being excluded from defined nuclear spots 
strongly labeled by propidium iodide. This indicated that Trnp1 is not localizing to highly 
condensed chromatin. Nevertheless, Trnp1 was detectable in a highly insoluble nuclear 
fraction that also contained histones. The inclusion of the protein in a nuclear precipitate 
was suggested to reflect the association of Trnp1 with chromatin (Volpe et al., 2006). 
Treatment of nuclei with micrococcal endonuclease led to the release of histones to the 
nucleoplasm but did not affect the association of Trnp1 with the insoluble nuclear fraction 
(Volpe et al., 2006). However, combination of nuclease treatment with a 0.5M NaCl wash 
led to a partial release of Trnp1 from the insoluble fraction.  
In order to functionally assess the role of Trnp1, Volpe et al. ectopically overexpressed the 
protein in MCF-7 cells (a breast carcinoma cell line that does not express Trnp1 
endogenously). Trnp1 overexpression accelerated the cell cycle with significantly more 
cells residing in S-phase five days after transient transfection in vitro suggesting, that 
Trnp1 may be involved in cell proliferation. However, an endogenous role of Trnp1 in vivo 
remained elusive. 
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Figure 7: Trnp1 is a highly conserved mammalian gene with a single protein coding exon  
(A) Multialignment of five mammalian Trnp1 protein sequences: human protein gi: 61966741; mouse protein 
gi: 38078875; and chimpanzee, dog and cow protein models derived through sequence similarities to genome 
and expressed sequences of these three organisms. Amino acid identities are shown in black boxes, 
similarities in shades of gray. (B) Human and mouse Trnp1 genes each produce an invariantly spliced 
approximately 1.7-kb two exon message from an approximately 7-kb nascent message. The entire coding 
region resides within the first exon of each message. Exons, introns and coding regions are diagrammed 
according to the provided key. Genome position is indicated by cytogenetic locus (4D3 for mouse and 
1p36.11 for human) and by position of the chromosome’s sequence axes (with provided scales). Illustration 
modified from Volpe et al. (2006). 
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3 Aim of this study 
Heterogeneity amongst stem cells is crucial for developmental processes. In search of 
factors specifically expressed in subpopulations of radial glial cells during forebrain 
development of the murine brain, Pinto et al previously described a molecular screen of 
radial glial subsets (see Introduction 2.1.5). Amongst the factors highly expressed in 
directly neurogenic radial glial cells several genes with so far unknown in vivo function 
were identified. Trnp1 was chosen for further analysis, as the protein is highly conserved 
within the mammalian lineage and its nuclear localization in vitro (described by Volpe et 
al, 2006) proposed a possible function in stem cell regulation. As Trnp1 had so far not been 
described in vivo I set out to investigate the expression of Trnp1 during cerebral cortical 
development. Using gain- and los-of-function experiments in vitro and in vivo I then aimed 
at analyzing the role of Trnp1 in neurogenesis and its molecular mode of action. 
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4 Results 
In order to search for regulators of radial glial fate in an unbiased manner, a gene 
expression analysis of apical progenitor cells has previously been performed (Pinto et al., 
2008) (see Introduction 2.1.5). In this context, microarray data of radial glial cells with 
direct neurogenic potential were compared to such with indirect neurogenic potential 
(including the generation of basal, Tbr2-expressing progenitors). In order to identify 
molecular regulators promoting the generation of apical progenitors, candidate genes from 
the lineage of direct neurogenesis were selected. So far not a single molecular mechanism 
has been described to affect the formation of both outer radial glial cells (oRGs) and basal 
progenitors (BPs) at the same time; therefore another aim was to determine whether one 
may find co-regulators of basal progenitors and oRGs. One candidate for such a function 
was Trnp1, a nuclear protein previously described as TMF Regulated Nuclear Protein 1 
(Volpe et al 2006 see 2.4) with unknown in vivo function. Trnp1 was chosen for further 
investigation, because the search for Trnp1 homologs in other species revealed its high 
degree of sequence conservation (with 90% sequence homology of the murine and the 
human protein) (Volpe et al., 2006). Trnp1 therefore represented an intriguing novel 
candidate for cerebral cortex evolution. Remarkably, the Trnp1 protein sequence does not 
carry any known motif or domain (Volpe et al., 2006) thereby possibly opening an avenue 
for a new class of proteins. 
Trnp1 was first described in 2006 as TMF-regulated nuclear protein in vitro upon 
overexpression (Volpe et al., 2006). However, the existence of the endogenous protein at 
cellular level has never been shown before in vivo.  
  
4.1 Generation of an antibody raised against Trnp1 
Antibodies directed against Trnp1 are currently not commercially available. In order to be 
able to analyze the expression of endogenous Trnp1 an antibody had to be generated first.  
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4.1.1 Antibody recognition site  
To raise an antibody specifically detecting Trnp1 protein, a unique region of the protein 
needed to be identified. To exclude possible reactions of the antibody with other proteins a 
region of the protein was choosen that carries no overlap with other proteins (with the help 
of Dr. Robert Blum). For this purpose Blastp database search was performed together with 
an accessibility prediction by Peptide Specialty Labs GmbH Heidelberg. Two possible 
protein regions were identified: Peptide 1 with the length of 19 amino acids 
(AETPVEGQELQRWRQGASG) and Peptide 2 with the length of 20 amino acids 
(PEPDSPFRRSPPRGPASPQR) (underlined sequences in Figure 8). Antibodies raised in 
guinea pig were ordered from Peptide Specialty Labs GmbH Heidelberg. For each peptide 
serum of the animal was collected after 3 and after 4 immunizations. Specificity and 
affinity for Trnp1 protein was subsequently tested (see 4.1.2). As the antibody raised 
against Peptide 1 turned out to be more specific and had a higher affinity for Trnp1 as 
compared to the antibody raised against Peptide 2 (data not shown) all the studies 
presented in this work are based on the antibody raised against Epitope1. 
 
 
Figure 8: Antibody Epitopes 
Sequence Homology of the human, murine and rat version of Trnp1. Regions being conserved in all of the 
three species are indicated in turquoise, regions conserved in two of the three species are indicated in yellow. 
The two protein regions of the murine protein against which the different antibodies were raised are 
underlined in red. Peptide 1: aa 57 – aa 75. Peptide 2: aa204 - aa223 of the murine sequence. Note the 
differences in the protein sequence of human and mouse Trnp1 within the region of Peptide 1 – suggesting 
that this antibody may not be able to detect the human version of Trnp1. 
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4.1.2 Test of antibody specificity 
To test the specificity of the generated antibody, a vector for the expression of a Trnp1-
GFP fusion protein was cloned (encoding for the murine version of Trnp1). Through GFP-
fusion and transient expression of Trnp1-GFP in HEK293 cells by transfection, the 
localization of the Protein was readily visible in living cell cultures. In agreement with 
previous analysis by Volpe and colleagues (Volpe et al., 2006), Trnp1 was found to be 
localized exclusively to the nucleus. Immunocytochemistry with the generated antibody 
confirmed the nuclear localization of Trnp1 and showed a co-localization with the GFP 
signal in all cases (Figure 9A to D). In addition, Trnp1 was only detectable in transfected 
cells, suggesting that the Trnp1 antibody does either not detect the endogenous version of 
Trnp1 (as HEK cells are human and the antibody recognition site carries strong differences 
in the human and murine version of Trnp1 – see Figure 8 Peptide 1) or that Trnp1 is not 
expressed in HEK cells. This observation confirmed the specificity of the antibody for the 
overexpressed murine protein. Western blotting further confirmed the specific recognition 
of Trnp1 with three to four distinct bands with a size ranging from 24kDa to 32kDa and no 
detectable signal in untransfected HEK cells (Figure 9E). Compared to the theoretically 
expected molecular weight of Trnp1 of 23,09kDa, the molecular weight of Trnp1 
expressed in HEK cells is larger - possibly due to posttranslational modifications. This 
observation is supported by the work of Volpe et al. that also proposed Trnp1 to be 
posttranslationally modified. In addition, the serum of the pre-immunized guinea pig was 
used for immunohistochemistry and for western blotting as a control. In both cases no 
signal was detectable in Trnp1 transfected HEK cells (data not shown).  
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Figure 9: Analysis of Trnp1 localization and antibody specificity 
(A-D) Immunocytochemistry of HEK293 cells transiently transfected with peGFP-Trnp1-N3 to express a 
Trnp1-GFP fusion protein. Cells were fixed 48h post transfection. Localization of the fusion protein was 
visualized by GFP staining (A). To visualize the cytoplasm of the cells staining for -tubulin was performed 
(B). Trnp1 expression was directly visualized with the antibody generated against Trnp1 (Peptide 1) (C). 
Merge confirmed the specificity of the Trnp1 antibody and showed that the protein is exclusively expressed 
in the nucleus (D). Note that only transfected cells showed Trnp1 expression three days after transfection. 
Single optical sections are shown. (E) Western blot of HEK cells transfected with pCMV-Trnp1 for 
overexpression of Trnp1. Note that no signal can be detected in untransfected HEK cells. 
 
To further test possible non-specific signals in immunostaining, an antibody-antigen 
competition experiment was performed. For this purpose different concentrations of the 
19-amino acid (epitope) peptide against which the antibody was raised were incubated 
together with the antibody. This antibody-peptide mixture was then used (Figure 10) for 
staining of HEK cells transfected with pCMV-Trnp1. The peptide was able to compete 
with the detected signal in a concentration dependent manner, thereby further showing that 
the antibody successfully recognizes Trnp1.  
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After characterization of the in vivo expression of Trnp1, the same experiment was later on 
also carried out on brain sections with a similar reduction of the signal upon antibody-
antigen competition (data not shown).  
 
 
Figure 10: Test of antibody specificity – antibody antigen competition experiment 
(A-D’) Immunocytochemistry of HEK cells transfected with pCMV-Trnp1. Cells were fixed three days after 
transfection and stained with Trnp1 antibody pre-incubated with different concentrations (as indicated) of the 
peptide the antibody was raised against. Note that higher concentrations of the peptide were able to compete 
with the signal of immunocytochemistry. 
 
4.2 Expression analysis of Trnp1 during murine telencephalic development 
4.2.1 Analysis of Trnp1 expression during forebrain development 
In order to get insights into the possible role of Trnp1 during brain development, 
expression of Trnp1 protein needed to be determined at the cellular level.  
For this purpose, a detailed expression analysis was carried out at different developmental 
stages of the murine forebrain. Trnp1 was exclusively localized to the nucleus at all 
developmental stages analyzed confirming the localization of the protein found upon 
overexpression in vitro. Specifically, at embryonic day 12 (E12) Trnp1 was expressed in 
virtually all apical progenitors (Figure 11A and A’). At mid neurogenesis, Trnp1 was 
expressed in a subpopulation of apical progenitors lining the ventricle and in newborn 
neurons (Figure 11B and B’). Interestingly, Trnp1 immunoreactivity in the progenitor layer 
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at the ventricle underwent a significant decline during forebrain development with virtually 
all progenitors being Trnp1 positive at E12 to no detectable immunoreactivity at E18, the 
end of neurogenesis (Figure 11A to D’). This indicates that gliogenic radial glia lining the 
ventricle at later stages of telencephalic development (i.e. E18) do not express Trnp1. 
Conversely, the signal in neurons of the cortical plate persisted a little longer and faded 
within the first postnatal week (Figure 11E to F’), suggesting another role of Trnp1 in 
newborn neurons. 
 
 
Figure 11: Expression analysis of Trnp1 protein at different stages of forebrain development 
(A-D’) Micrographs of coronal sections of the developing cerebral cortex at different developmental stages 
(E12-E18) labeled for Trnp1 and DAPI. Note that Trnp1 is expressed in apical progenitors close to the 
ventricle and in the cortical plate. (E-F’) Coronal sections of postnatal stages of murine development 
(Postnatal day 2 and 6 (P2 and P6)) were labeled for Trnp1 and DAPI. Note that Trnp1 expression in the 
postnatal cerebral cortex declines at postnatal stages. Single optical sections are shown. Ctx, cortex; V: 
ventricle. 
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4.2.2 Detailed expression analysis at mid-neurogenesis 
To determine the identity of the progenitor subtype expressing Trnp1 at mid-neurogenesis 
(E14), immunohistochemical staining for the progenitor specific markers RC2, Pax6 (both 
labeling apical neural stem cells) and Tbr2 (expressed in basal neural progenitors) was 
performed. Double staining with anti-Trnp1 antibody revealed that Trnp1 is expressed in a 
subpopulation of Pax6 positive apical progenitors (radial glial cells) while hardly any Tbr2 
positive basal progenitor showed Trnp1 expression (Figure 12A to C’). Double staining 
with the neuronal transcription factor Tbr1 confirmed the neuronal identity of Trnp1 
positive cells within the cortical plate (Figure 12D and D’). Taken together, its expression 
pattern suggested a role of Trnp1 in the regulation of different subsets of radial glial cells 
during cortical neurogenesis.  
As Trnp1 was not only found to be expressed in the dorsal but also in the ventral part of 
the telencephalon (Figure 12E and E’) the ventral progenitor specific transcription factor 
(TF) Mash1 (also called Ascl1) was utilized for further analysis. A mouse line expressing 
nuclear GFP under the Mash1 promoter (Leung et al., 2007) was used to stain for GFP 
(labeling Mash1 expressing progenitor cells in the ventral telencephalon) and Trnp1. Trnp1 
was expressed in all Mash1-driven, GFP expressing cells. However, Trnp1 is also 
expressed in apical, Mash1 negative progenitors lining the ventricle of the ganglionic 
eminence (GE) - indicating that Trnp1 expression precedes the expression of Mash1 in 
ventral neuronal development (Figure 12F and F’).  
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Figure 12: Trnp1 is expressed in a subset of radial glial cells and in newborn neurons 
(A-F’) Micrographs depicting immunolabeled coronal sections of the developing cerebral cortex at E14 
(confocal, single optical sections are depicted). Co-expression analysis of Trnp1 together with the radial glial 
specific antibody RC2 (A-A’), the radial glial transcription factor (TF) Pax6 (B and B’), the basal progenitor 
TF Tbr2 (C and C’) and the neuronal TF Tbr1 (D and D’). Note that Trnp1 is expressed in a subpopulation of 
Pax6 positive apical progenitors and that most of the Tbr2 positive basal progenitors do not express Trnp1. 
Arrows indicate double positive cells, arrowheads indicate Pax6+ or Tbr2+ cells that do not express Trnp1. 
(E-E’) Overview of Trnp1 expression at E14. Note that Trnp1 is also expressed in ventral regions of the 
developing forebrain including the ganglionic eminence. (F-F’) Coronal section of a transgenic embryo 
expressing GFP under the Mash1 promoter. Labeling for GFP and Trnp1 shows that virtually all Mash1 
positive cells co-express Trnp1. Note that Trnp1 is also expressed in apical progenitors in the GE that are 
negative for Mash1. VZ: ventricular zone; SVZ: subventricular zone; IZ: intermediate zone; CP: cortical 
plate; LGE, lateral ganglionic eminence; V, ventricle; Scale bars as indicated. 
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4.2.3 Expression analysis of Trnp1 in the adult murine brain 
Neurogenesis is known to persist in the adult brain in two neurogenic niches – the 
subependymal zone (SEZ) of the lateral ventricle (from where newborn neurons migrate 
via the rostral migratory stream (RMS) to the olfactory bulb (OB)) and the subgranular 
zone of the dentate gyrus (Kriegstein and Alvarez-Buylla, 2009; see also Introduction 2.3). 
Given that expression of Trnp1 was also observed in progenitors of the GE during 
development (see 4.2.2) together with the fact that adult neural stem cells of the SEZ 
originate from these progenitors, the next question was whether Trnp1 protein might 
persist in regions of adult neurogenesis. Indeed, immunohistochemistry revealed that 
Trnp1 is not expressed ubiquitously in the adult brain but rather specifically in the 
neurogenic SEZ, the RMS and the OB (Figure 13 and Figure 14). 
 
 
Figure 13: Overview of Trnp1 expression in the adult murine brain  
(A-B) Trnp1 expression analyzed on sagittal sections of the adult murine brain. (A) Overview of Trnp1 
expression in the adult brain. Reconstruction of a sagittal section using Zeiss LSM710 “ZEN-tilescan”. Note 
that Trnp1 is expressed selectively in the SEZ lining the LV, in the RMS and in the OB. (B) Higher 
Magnification of the SEZ/RMS labeled for Trnp1 and doublecortin (Dcx). Confocal single optical section is 
shown. Note that Dcx positive neuroblasts do express Trnp1. OB, olfactory bulb; SEZ, subependymal zone; 
LV, lateral ventricle. Scale bars: 1mm (A) and 100µm (B). 
Intriguingly, cells in the subgranular zone of the dentate gyrus (the other well known 
neurogenic niche in the adult brain) did not express Trnp1 (Figure 14B). Double staining 
for the pyrimidine analogue Bromodeoxyuridine (BrdU) (applied one hour before sacrifice, 
thereby labeling fast proliferating cells) or doublecortin (Dcx) (labeling neuroblasts) 
together with Trnp1 revealed its expression in all BrdU positive, fast proliferating cells 
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within the SEZ and in virtually all neuroblasts of the SEZ, RMS and OB (Figure 14C and 
D). Taken together, the expression pattern of Trnp1 during development and in the adult 
brain suggested a functional role of Trnp1 in neurogenesis.  
 
 
Figure 14: Trnp1 expression in adult neurogenic niches of the mouse brain 
(A-D) Sagittal sections of the adult murine brain were labeled for Trnp1, DAPI and Dcx or BrdU (single 
optical sections are shown). (A) Trnp1 expression in the SEZ, RMS and OB. (B) Trnp1 expression in the 
dentate gyrus. Note that Trnp1 is not expressed in progenitors of the subgranular zone. (C) Trnp1 and Dcx 
co-labeling in the SEZ. Note that Dcx positive neuroblasts do express Trnp1. (D) Trnp1 and BrdU (BrdU 
treatment 1h prior to sacrifice) co-labeling in the SEZ. Note that all transit amplifying (BrdU positive) 
progenitors do express Trnp1. LV: lateral ventricle; scale bars as indicated. 
Results 
 
 35 
4.3 Investigating the functional role of Trnp1 in vitro 
The above described expression pattern suggested a potential role of Trnp1 in the 
regulation of neurogenic stem or progenitor cells. Therefore, the aim of this study was to 
determine the function of Trnp1 in neurogenesis by gain and loss of function approaches.  
4.3.1 Generation of a retroviral construct for forced expression of Trnp1 
In order to overexpress Trnp1, its cDNA was cloned into a retroviral vector containing the 
chicken beta actin (CAG) promoter driving Trnp1 expression together with GFP as a 
reporter linked by an internal ribosomal entry site (IRES) (Heinrich et al., 2011; see Figure 
15A). Co-expression of GFP and Trnp1 was confirmed by immunostaining of transfected 
HEK cells (data not shown). Furthermore, a retrovirus for overexpression of Trnp1 was 
produced and tested for expression of Trnp1 and GFP in HEK293 cells (Figure 15B and 
B’) and dissociated cells from the cerebral cortex of E14 embryos (Figure 15C to C’’) 
seven days post transduction. All infected cells showed co-expression of Trnp1 and GFP.  
 
Figure 15: Generation 
of a retroviral vector 
for forced expression 
of Trnp1 
(A) Trnp1 cDNA 
lacking the 3’-UTR 
was cloned into a 
retroviral expression 
vector with the CAG 
promoter driving the 
transcription of Trnp1-
IRES-GFP mRNA. 
GFP and Trnp1 are 
thus translated from the 
same mRNA produced 
from pCAG-Trnp1-
GFP. (B) HEK cells 
were transduced with 
viral particles 
containing pCAG-
Trnp1-GFP and tested 
for Trnp1 expression seven days post infection. Labeling for Trnp1 and GFP is shown. Note that each cell 
expressing GFP also expresses Trnp1. (C) Dissociated cells from the cerebral cortex of E14 mouse embryos 
were infected with the same virus for overexpression of Trnp1. Reliable co-expression of Trnp1 and GFP in 
infected cells was tested by immunostaining seven days post infection. CAG, chicken beta actin promoter; 
IRES, internal ribosomal entry site; DPI, days post infection. 
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4.3.2 Overexpression of Trnp1 increases proliferation of neurogenic 
progenitors in vitro  
The above-described viral vector was utilized to overexpress Trnp1. By using less than 25 
viral particles per well (in a 24 well plate) a clear separation of single clones was ensured. 
Each clone represents the progeny of initially one single infected cell (note that 
retroviruses do not integrate into non-dividing cells) (Williams et al., 1991; Haubst et al., 
2004; Costa et al., 2008). Interestingly, overexpression of Trnp1 led to a dramatic increase 
in clone size seven days post transduction at clonal density. Clones transduced with Trnp1 
virus contained more than double the number of cells compared to such infected with the 
control virus (Figure 16).  
 
 
Figure 16: Forced expression of Trnp1 in dissociated cells from the embryonic cerebral cortex 
dramatically increases clone size  
Representative images of dissociated cell cultures of the embryonic cerebral cortex at E14 infected with 
either CAG-GFP control (A-A’) or CAG-Trnp1-GFP virus (B-B’). Cells were infected with a low number of 
viral particles and analyzed seven days post infection. Note that the clones transduced with CAG-Trnp1-GFP 
virus are bigger than clones transduced with control virus. (C) Quantification of the average size of clones 
expressing either GFP control or Trnp1. Data are shown as mean +/- SEM, n=4 (independent experiments); 
***p<0.001. Blue bars: control virus, red bars: Trnp1 virus. Statistical significance tested using students t-
test.  
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The observed strong increase in clone size suggested a profound increase in proliferation, 
reduced cell death or alterations in the mode of cell division as possible effects of Trnp1 
overexpression. To elucidate these possibilities, live imaging of transduced cells was 
performed. For that purpose dissociated cell cultures of the embryonic cerebral cortex at 
E14 were transduced with Trnp1 or control virus respectively. Imaging was started one day 
post transduction and cells were imaged for the next six days. Remarkably, Trnp1 
overexpression led to a strong increase of proliferation rate and promoted self renewal of 
stem cells (see Figure 17). Sepecifically, Trnp1 increased cell cycle reentry and led to 
sustained self renewal of proliferating stem cells (Figure 17D and E). However, it is 
important to mention, that the effect of Trnp1 overexpression was so strong, that tracking 
of cell divisions and following single cells turned out to be impossible in most of the cases 
some days after transduction (see Figure 17B first lineage tree). Therefore Figure 17 
represents only the “trackable” proportion of clones. Nevertheless, the strong increase of 
proliferation and continued self-renewal of proliferating cells was clearly shown by this 
experiment. 
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Figure 17: Live imaging of dissociated cells from the developing cerebral cortex overexpressing Trnp1 
Dissociated cells from the developing cerebral cortex at E14 were transduced either with CAG control virus 
or with Trnp1 virus. (A and B) Lineage tree analysis of single cells infected with either control (A) or Trnp1 
virus (B) - representative trees are depicted (time lapse images for analysis were taken every five minutes 
over a period of six days). Horizontal lines represent cell divisions; vertical lines represent single cells over 
time. Red cross indicates cell death. Time axis in days is shown on the left side. Note that in many cases of 
Trnp1 overexpression tracking of single cells was impossible after several days. (C) Time lapse analysis of 
representative clones for control and Trnp1 transduced cells. Images over time of one single clone derived 
from initially one single cell are shown for both control and Trnp1 transduced cells. Note the persistent self 
renewal of progenitors through symmetric progenitor divisions upon Trnp1 transduction. (D and E) 
Quantification of the mode of cell division of control (D) and Trnp1 (E) transduced cells. ST symmetric 
terminal divisions (none of the daughter cells divided anymore); AS: asymmetric divisions (one daughter cell 
divided further, the other did not proliferate anymore) SP: symmetric progenitor divisions (both daughter 
cells underwent another round of proliferation). n = 14 clones each, from two independent experiments. 
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As during cortical neurogenesis Trnp1 was expressed in only a subset of radial glial cells 
(Figure 12) the next question addressed was whether neurogenic progenitors are affected 
by sustained Trnp1 expression. To determine possible changes in cell fate, the different 
types of generated clones were examined. Dissociated cells from the mouse embryonic 
cerebral cortex typically form three different types of clones seven days post infection with 
a control virus:  
1. Purely non-neuronal clones (consisting only of glia or undifferentiated progenitors) 
2. Purely neuronal clones (consisting only of neurons) 
3. Mixed, neural stem cell clones (generating a mixed neuronal and glial / progenitor 
progeny).  
Immunostaining for the neuron specific protein III-tubulin and progenitor and glia 
antigens such as Nestin and GFAP allowed the classification accordingly as mixed (stem 
cell) clones (comprising both III-tubulin positive (+) cells and III-tubulin negative (-) 
cells), purely neuronal clones (all GFP+ cells were also III-tubulin+) and purely non-
neuronal clones (no GFP+ cell was III-tubulin+). 
Forced Trnp1 expression significantly increased the percentage of mixed (stem cell) clones 
at the expense of purely neuronal clones (Figure 18A to C). Interestingly, the proportion of 
non-neuronal clones was not affected. This suggests that high levels of Trnp1 do not 
simply suppress the generation of neurons per se (otherwise one would expect more purely 
non-neuronal clones). High levels of Trnp1 rather increase the self-renewal of neural stem 
cells still allowing neurogenesis to occur at the same time (leading to more mixed clones, 
some of which would otherwise terminally differentiate into neurons generating a purely 
neuronal clone). This interpretation was further corroborated by analysis of the size of the 
different clone types. Quantification revealed a selective size increase of mixed clones 
while the clone size of restricted, purely glial and purely neuronal clones was not affected 
(Figure 18D). Furthermore, co-immunolabeling for GFAP or PDGFR (labeling 
oligodendrocytes) showed that Trnp1 overexpression still allowed the generation of 
different cell lineages (Figure 18E and F). Taken together this analysis suggested an effect 
of Trnp1 levels on cell fate. Forced Trnp1 expression promoted neural stem cell self-
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renewal and inhibited symmetric terminal divisions that would give rise to neurons only 
(as described previously: Costa et al., 2008; Asami et al., 2011).  
 
 
Figure 18: Forced expression of Trnp1 increases self renewal of neurogenic progenitors 
(A and B) Representative micrographs of dissociated cell cultures of the embryonic cerebral cortex at E14 
transduced with a low titer of either CAG-IRES-GFP control virus (A) or CAG-Trnp1-IRES-GFP virus (B) 
immunostained for GFP and III-tubulin seven days post transduction. Arrows indicate examples of double 
positive cells. (C) Quantification of the percentage of purely non-neuronal, purely neuronal or mixed clones 
seven days post transduction. Note that Trnp1 overexpression specifically increases the self-renewal of 
neurogenic progenitors thereby increasing the percentage of mixed clones. (D) Quantifications of the number 
of cells per clone within the different clone types. Trnp1 overexpression specifically affects the clone size of 
mixed clones. (E-F) Infected clones were immunostained for Trnp1 and GFAP (E) or PDGFR (F). Note that 
overexpression of Trnp1 still allowed production of different cell lineages such as glial (GFAP) and 
oligodendrocytic cells (PDGFR). Data are shown as mean +/- SEM, n=4 (independent experiments); 
*p<0.05, **p<0.01, ***p<0.001. Blue bars: control virus, red bars: Trnp1 virus. Statistical significance was 
tested using students t-test. 
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4.4 Functional analysis of Trnp1 in vivo 
Analysis of Trnp1 overexpression in vitro raised the question to which extent forced Trnp1 
expression may also promote proliferation or expansion of radial glial cells in vivo. On the 
other hand, another question was how knock down of the endogenous protein would affect 
neurogenesis. In utero electroporation at mid neurogenesis has previously been shown to 
specifically target radial glial cells and not basal progenitors (Stancik et al., 2010). 
Therefore, utilizing this technique allowed analyzing the function of Trnp1 on radial glial 
cells and their fate during forebrain development in vivo.  
4.4.1 Forced expression of Trnp1 in vivo by in utero electroporation 
4.4.1.1 Forced expression of Trnp1 in vivo increases the number of apical 
progenitors and causes tangential expansion 
To study the effect of forced Trnp1 expression in vivo, pCAG-Trnp1-IRES-GFP or pCAG-
IRES-GFP as a control were electroporated into the cerebral cortex of embryos at E13.5. 
The brains of electroporated embryos were examined 3 days later at E16.5. Trnp1 
overexpression led to a clear overall increase in the number of GFP immunoreactive cells 
with many cells still residing below the cortical plate in progenitor layers (Figure 19A to 
B’). Quantification of the distribution of electroporated cells – discriminating between cells 
still residing in the ventricular/subventricular zone (VZ/SVZ - harboring proliferative 
progenitors), cells found in the intermediate zone (IZ - mainly consisting of migrating 
neurons) and the cortical plate (CP) (consisting of newborn neurons) – confirmed a 
remarkably different distribution as compared to control electroporations. Upon forced 
Trnp1 expression the majority of cells (56.6%)  was found in the VZ/SVZ at the expense 
of migrating/newborn neurons in the IZ and CP (Figure 19C). Notably, in each experiment 
large numbers of weakly GFP positive cells were found in the VZ. The weak GFP 
expression is indicative of strong proliferation through which the cells typically dilute the 
protein and the GFP encoding plasmid (Figure 19B, note the number of weakly GFP 
positive cells close to the ventricular surface). Accordingly, a strong tangential expansion 
of GFP positive cells was observed upon overexpression of Trnp1 as compared to control 
electroporated cells (Figure 18E-F’). Such tangential expansion is indicative of 
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proliferating apical progenitors that expand laterally, whereas basal progenitor proliferation 
is believed to lead to radial expansion. 
To ensure, that Trnp1 is indeed overexpressed upon electroporation, immunostaining for 
Trnp1 was performed. A clear increase of Trnp1 immunostaining was detectable upon 
overexpression through in utero electroporation (Figure 19D and D’). In this context it 
should be mentioned that, upon overexpression, Trnp1 was detectable without any 
pretreatment of brain sections whereas endogenous protein levels were only detectable 
after pretreatment with hydrochloric acid. This suggests a strong interaction of the 
endogenous protein with an acidic partner (such as DNA) whereas binding partners may be 
saturated upon protein overexpression above a critical level, making Trnp1 detection 
easier. 
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Figure 19: Forced expression of Trnp1 in vivo increases cells residing within the progenitor area and 
causes tangential expansion 
Embryonic cortices were electroporated at E13.5 with either pCAG-IRES-GFP control plasmid or pCAG-
Trnp1-IRES-GFP plasmid and analyzed three days later. (A-B’) DAPI and GFP labeling of coronal sections 
of embryonic brains electroporated with either control (A and A’) or Trnp1 (B and B’) encoding plasmid. (C) 
Quantification of the cellular distribution of electroporated cells revealed a significant increase of cells 
residing in the proliferative VZ/SVZ with significantly less cells in the IZ and CP. (D-D’) Analysis of Trnp1 
expression upon Trnp1 overexpression by in utero electroporation. Note that the Trnp1 immunostaining was 
carried out without HCl pre-treatment and the endogenous Trnp1 protein is not detectable without pre-
treatment. (E-F’) Overview of the distribution of transfected cells three days after in utero electroporation of 
either pCAG-GFP control plasmid (E-E’) or Trnp1 expression plasmid (F-F’). Note the strong tangential 
expansion upon Trnp1 overexpression. Data are shown as mean +/- SEM, n=5 embryos; *p<0.05, **p<0.01, 
statistical significance calculated using Mann Whitney U-Test. White bars represent control electroporated 
cells, black bars represent Trnp1 overexpressing cells.Single optical sections are shown in (A-B’ and D-D’). 
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4.4.1.2 Forced expression of Trnp1 in vivo increases self renewal of Pax6+ radial 
glial cells 
The accumulation of cells residing in the VZ/SVZ and the observed tangential expansion 
raised the question to which extent this observation was due to postmitotic neurons that 
failed to migrate towards the cortical plate or whether these cells remained in the 
progenitor state and continued to proliferate. To address this issue, BrdU was injected 
intraperitoneally into electroporated animals one hour before sacrifice. As an analogue of 
the nucleoside thymidine, BrdU is being incorporated into newly synthesized DNA thereby 
labeling cells in S-phase when applied for one hour only. The proportion of proliferating 
cells of Trnp1 or GFP electroporated embryos was analyzed based on their incorporation 
of BrdU. Trnp1 overexpression led to a highly significant increase of cell proliferation by 
about threefold compared to control electroporated animals (Figure 20A, A’ and C). Given 
the endogenous expression of Trnp1 in only a subset of radial glial cells and its increase of 
progenitor clones in vitro, Trnp1 might have an effect on apical versus basal progenitor 
equilibrium. Therefore, the number of apical (Pax6+) and basal (Tbr2+) progenitors was 
quantified three days after Trnp1 electroporation. Trnp1 overexpression provoked a strong 
increase in Pax6+ radial glial cells as compared to control electroporated embryos (Figure 
20B, B’ and D). These results showed that Trnp1 expression leads to the maintenance of 
proliferating radial glial cells and thereby significantly amplifies the pool of apical 
progenitors. Interestingly, conversely to the increase in apical progenitor cells high levels 
of Trnp1 significantly inhibited the generation of Tbr2+ basal progenitors to less than 50% 
of the control (Figure 20E). The reduced proportion of basal progenitors may also explain 
the decrease in neurons found within the intermediate zone and the cortical plate. Thus, 
high levels of Trnp1 increase the maintenance and proliferation of Pax6+ apical 
progenitors and reduce the generation of Tbr2+ basal progenitors in vivo. This finding is 
consistent with the higher expression levels of Trnp1 in radial glia that do not generate 
Tbr2+ basal progenitors (Pinto et al., 2008) and with the above described results in vitro of 
Trnp1 promoting self-renewal of neural stem cells (see 4.3.2). 
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Figure 20: Proliferation analysis and characterization of radial glial fate upon forced Trnp1 expression 
Embryonic cortices were electroporated at E13.5 with either pCAG-IRES-GFP control plasmid or pCAG-
Trnp1-IRES-GFP plasmid for the overexpression of Trnp1 and analyzed three days later. (A-B’) Co-
Immunostaining of GFP together with BrdU (A and A’) or Pax6 (B’ and B’) of electroporated cortices.Single 
optical sections are shown. (C) Quantification of proliferating cells (BrdU+/GFP+) revealed a strong increase 
in proliferation (BrdU treatment one hour prior to sacrifice). (D and E) Analysis of the number of Pax6 (D) 
and Tbr2 (E) positive cells within the proliferative VZ/SVZ. Note that the proportion of Pax6 positive apical 
progenitors is significantly increased upon Trnp1 overexpression, whereas the proportion of Tbr2 positive 
basal progenitors is decreased. Data are shown as mean +/- SEM, n=4; *p<0.05, **p<0.01, Mann Whitney 
U-Test. White bars represent control electroporated cells, black bars represent Trnp1 overexpressing cells. 
 
4.4.2 Knock down of Trnp1 in vivo by in utero electroporation 
As forced expression of Trnp1 resulted in an increase of apical progenitors, the next 
question was whether Trnp1 is not only sufficient for the increase of radial glia 
proliferation but is also necessary for the self-renewal of these neural stem cells. In order to 
determine to which extent loss of Trnp1 may result in an opposing effect as compared to 
overexpression, short hairpin RNAs were created targeting Trnp1 mRNA.  
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4.4.2.1 Generation of short hairpin RNAs for the knock down of Trnp1 
Three of initially five designed short hairpin RNAs (shRNAs) targeting the 3’-UTR of 
Trnp1 mRNA were generated. In order to reduce possible off-target effects, the shRNA 
target sequences were designed with the help of BlockIT (Invitrogen) and Oligoengine 
software. In addition, Blast search was used to confirm specificity of the sequences. 
ShRNAs were cloned into pSUPER.GFP vector (Figure 21A) as this vector has the 
advantage of expressing the shRNA (controlled by the H1 promoter) and GFP (controlled 
by the PGK promoter) from the same plasmid. The knock down efficiency of the different 
shRNAs was tested using western blotting (Figure 21B) and immunostaining (Figure 21C). 
To test the efficiency of RNA interference, HEK cells were co-transfected with a plasmid 
encoding full length Trnp1 mRNA (pCMV-Trnp1) plus the pSUPER.GFP-shRNA vector 
or the empty pSUPER.GFP vector as a control. Cells were collected 48 hours later and 
western blotting was performed. Two out of three generated shRNAs showed significant 
reduction of protein signal in western blot analysis. ShRNA#4 had only marginal effects on 
Trnp1 protein expression, whereas shRNA#1 resulted in a strong knock down of the 
protein and shRNA#5 was able to reduce the protein to almost un-detectable levels (see 
Figure 21B). These results were confirmed in three independent experiments. In order to 
exclude off-target effects of the shRNAs, one approach is to rescue the knock down effect 
of the gene of interest by simultaneously re-expressing a resistant form of it. Thereby off-
targets of the used shRNA can be excluded, as only the gene of interest is re-expressed. 
Towards this end, the shRNA was tested with an shRNA resistant form of the Trnp1 
sequence (i.e. Trnp1 coding sequence lacking the 3’-UTR which is the target of all the 
shRNAs). The shRNAs described above were not able to reduce the signal of the shRNA 
resistant form of Trnp1 (Figure 21B’). Thus the Trnp1 version lacking its 3’-UTR could be 
subsequently used for rescue experiments (see 4.4.2.5. “Rescue of Trnp1 knock down”). 
To further test the efficiency of the generated shRNAs to reduce endogenous Trnp1 levels, 
immunocytochemistry was performed. In this context, dissociated cells from the cerebral 
cortex of E12 embryos were infected with a lentivirus encoding for the shRNA plus GFP 
or GFP only as a control. A strong reduction of Trnp1 protein levels was observed five 
days post infection (Figure 21C). 
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In summary, two of three generated shRNAs were very effective in reducing Trnp1 protein 
levels.  Both shRNAs (shRNA#1 and shRNA#5) were therefore subsequently used for in 
utero electroporation and analysis of the effect of Trnp1 knock down in vivo. 
 
Figure 21: Generation 
and test of shRNAs 
targeting Trnp1 
(A) Three different 
shRNAs (each targeting 
the 3’-UTR of Trnp1) 
were cloned into 
pSUPER.GFP. ShRNA 
expression is driven by H1 
promoter, GFP expression 
is driven by the PGK 
promoter from the same 
plasmid. (B) Test of knock 
down efficiency of these 
shRNAs. HEK293 cells 
were co-transfected with 
pCMV-Trnp1 and 
pSUPER.GFP-shRNA 
plasmids or the empty 
pSUPER.GFP as a vector 
control. Note that 
shRNA#1 and #5 led to 
significant knock down of 
Trnp1, whereas #4 was not 
effective in reducing 
Trnp1 levels. (B’) Test of 
a resistant version of 
Trnp1 lacking the shRNA 
targeted 3’-UTR. HEK 
293 cells were co-
transfected with pCAG-
Trnp1-GFP (Trnp13’-
UTR) and pSUPER.GFP 
shRNA plasmids or the empty pSUPER.GFP as a vector control. Note that neither shRNA#1 nor #5 were 
able to down regulate the resistant (3’-UTR ) Trnp1 version. (C) ShRNAs were also sub-cloned into a 
lentiviral vector (pLVTHM) and viral particles were used to transduce dissociated cells from the embryonic 
cerebral cortex (at day 12) in order to test successful down regulation of endogenous Trnp1. As a control the 
same GFP-only expressing lentivirus was used. Five days post transduction immunostaining for Trnp1 and 
GFP was performed. Note that the shRNA#1 was able to significantly down regulate endogenous Trnp1 
levels. Arrows indicate GFP positive, Trnp1 positive cells, arrowheads indicate GFP positive cells with 
down-regulated Trnp1 expression. 
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4.4.2.2 Knock down of Trnp1 in vivo leads to radial expansion of the developing 
forebrain 
In order to test the effects of down regulation of Trnp1 in vivo, embryos were 
electroporated at E13.5 and analyzed three days later at E16.5. Knock down of Trnp1 
consistently led to a very strong and obvious radial expansion of the developing cortex in 
the electroporated region compared to the non-electroporated hemisphere and to control 
electroporations (Figure 22A to B’; compare A’ with B’ – note the white bar indicating the 
radial length of the control cortex and compare it to the radial expansion of the cortex upon 
knockdown). Surprisingly, the proportion of cells residing in the VZ/SVZ was not altered. 
However, knock down of Trnp1 by electroporation of pSUPER.GFP-shRNA#5 at E13.5 
resulted in a consistently altered distribution of GFP+ cells at E16.5. In pronounced 
contrast to the overexpression of Trnp1, knock down of the protein resulted in a significant 
increase in the proportion of cells within the cortical plate three days after electroporation 
(Figure 22C). 
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Figure 22 Knock down of Trnp1 in vivo results in strong radial expansion of the developing cortex 
Embryonic cortices were electroporated at E13.5 with either pSUPER.GFP control (A-A’) or pSUPER.GFP-
shRNA (B-B’) plasmid for the knock down of Trnp1 and analyzed three days later. (A-B’) Images of GFP 
and DAPI labeled coronal sections of electroporated brains. Note the strong radial expansion of shRNA 
electroporated cortices. The white bar (in A’ and B’) represents the radial length of the control electroporated 
cortex. (C) Quantification of the localization of GFP+ cells in shRNA electroporated brains (black bars) 
compared to control electroporated brains (white bars). Data are shown as mean +/- SEM; n=5 embryos; 
*p<0.05, Mann Whitney U-Test.  
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4.4.2.3 Knock down of Trnp1 increases the number of basal progenitors 
As down regulation of Trnp1 did not alter the proportion of cells residing within the 
proliferative VZ/SVZ, overall proliferation was analyzed next. For this purpose, BrdU was 
injected intraperitoneally into electroporated animals one hour before sacrifice. 
Surprisingly, co-immunostaining for BrdU and GFP revealed, that the overall proportion of 
proliferating BrdU+/GFP+ cells was not altered as compared to control electroporations 
(Figure 23E). Thus Trnp1 is able to increase proliferation but it is not necessary to 
maintain proliferation overall. However, quantification of the proportion of basal 
progenitors revealed that the number of Tbr2+ basal progenitors was significantly 
increased when levels of Trnp1 were reduced in radial glia (Figure 23A to D). Remarkably, 
immunostaining for Tbr2 clearly showed an atypically increased band of basal progenitors 
within the shRNA electroporated region (Figure 23C). A diffuse expansion of Tbr2+ cells 
towards very basal regions of the SVZ with concomitant expansion of the SVZ was 
observed (see Figure 22C) resembling the situation observed in larger brains where an 
expanded diffuse Tbr2+ band has recently been described (Martínez-Cerdeño et al., 2012).  
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Figure 23: Loss of Trnp1 provokes generation of Tbr2+ basal progenitors 
Coronal section of embryonic brains electroporated at E13.5 with either pSUPER.GFP control plasmid or 
pSUPER.GFP-shRNA#5 plasmid and analyzed three days post electroporation. (A-B’) Images of control or 
shRNA electroporated cortices immunostained with GFP and Tbr2. Single optical sections are depicted. (C) 
Reconstruction of a coronal section of an shRNA electroporated cerebral cortex immunolabeled for Tbr2. 
Note that the knock down of Trnp1 led to a strong increase of Tbr2 positive basal progenitors at the 
electroporation site (indicated by an arrow) with a resulting diffuse band of Tbr2+ cells that is usually not 
seen in control electroporated sections or in the non-electroporated hemisphere. (D-E) Quantifications of the 
number of basal progenitors (D) and cell proliferation (E) in shRNA electroporated brains (black bars) 
compared to control electroporated brains (white bars). Data are shown as mean +/- SEM; n=4 for basal 
progenitor and n=3 for cell proliferation analysis; *p<0.05, Mann Whitney U-Test.  
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4.4.2.4 Knock down of Trnp1 at mid neurogenesis induces an increase of oRGs and 
folding of the cortical plate  
Previous studies of neocortical development showed that besides radial glia and basal 
progenitors another subtype of progenitor exists in the developing brain. This type of cells, 
the so-called basal- or outer radial glial cells (bRGs or oRGs) are implicated in expansion 
of the cerebral cortex (Fietz et al., 2010; Hansen et al., 2010; Reillo et al., 2011; 
Shitamukai et al., 2011; Wang et al., 2011). While basal progenitors lack Pax6 expression, 
oRGs are characterized by the expression of Pax6, the location of their nucleus in the outer 
(basal) area of the SVZ and the presence of a basally anchoring process with the absence of 
an apical process. Given the strong radial expansion of the region electroporated with 
shRNA against Trnp1 it was conceivable that Trnp1 knock down not only leads to 
increased abundance of basal progenitors but may also increase the number of outer radial 
glial cells. 
To address this possibility, sections of shRNA electroporated brains and control brains 
were immunostained with Pax6 and GFP antibodies. Remarkably, after knocking down 
Trnp1 many Pax6+ cells were found to be located in the outer area of the SVZ (Figure 24A 
to A’’). These cells were clearly separated from the VZ where Pax6+ cells are normally 
located. Consistent with an oRG identity, these cells lacked an apical process but still 
possessed a long basal process (Figure 24C to C’) thereby clearly distinguishing them from 
VZ radial glia and SVZ basal progenitors. Quantification further confirmed the significant 
increase of Pax6+ cells within the outer SVZ by more than threefold in the electroporated 
regions as compared to the unelectroporated hemisphere of the same embryo (Figure 24D). 
Remarkably, only one third of these cells are Tbr2 negative in control conditions, whereas 
about two third were Pax6+ but Tbr2 negative upon Trnp1 knock down (Figure 24E) 
resembling a drastic increase of oRGs upon down regulation of Trnp1.  
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Figure 24: Loss of Trnp1 increases the number of outer radial glial cells 
Knock down of Trnp1 through shRNA electroporation at E13.5 and analysis at E16.5 not only increased the 
number of Tbr2+ basal progenitors, but also lead to an increase of Pax6 positive outer radial glial cells. (A-
A’’) Coronal section of an shRNA electroporated cortex labeled with Pax6, GFP and DAPI. Note the number 
of Pax6 positive cells residing far outside the ventricular zone indicated by an arrowhead in A. (B) Higher 
magnification of the area indicated by a square in A’’. (C and C’) Example of a Pax6+ cell residing in a very 
basal region of the SVZ (square in B) possessing only a basal but no apical process. (D) Quantification of the 
number of Pax6+ cells at the site of electroporation residing in basal SVZ areas. (E) Quantification of the 
percentage of Pax6+/Tbr2- cells amongst basal Pax6+ cells counted in (D). Note that upon loss of Trnp1 
significantly more Pax6+ cells in basal SVZ regions were detected (D), with two third of them being Tbr2 
negative (E). Data are shown as mean +/- SEM; n=3 embryos; *p<0.05, Mann Whitney U-Test.  
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One very interesting feature observed upon loss of Trnp1 was the either simple outward 
directed radial expansion of the neocortex (see Figure 22A to B’) or alternatively an 
expansion that resulted in folding of the neocortex (Figure 25A to B’). In this context, in 4 
out of 10 shRNA electroporated embryos not only expansion but also folding of the 
neocortex was observed (Figure 25A to B’). This observation together with the increase in 
oRGs is consistent with previous reports on oRGs implicated in expansion and folding of 
the cortex (Lui et al., 2011 for review; Reillo et al., 2011). To examine the morphology of 
radial glia in these folded regions, shRNA electroporated brains were examined by staining 
with the radial glia specific antibody RC2 (Figure 25C). Interestingly, radial fibers 
diverged as they entered the cortical plate resembling a fanned array that has been 
described in larger brains (see Lui et al., 2011). Figure 26 shows more examples of 
different expanded brains upon Trnp1 shRNA electroporation and compares non-
electroporated hemispheres to electroporated hemispheres of the same section.  
Altogether, down regulation of Trnp1 leads to cortical expansion in a dual mode. First, low 
levels of Trnp1 induce the generation of basal progenitors thereby increasing the total 
number of neurons. Second, radial glia with low levels of Trnp1 are also capable of 
generating outer radial glial cells lacking a ventricular apical process thereby leading to 
regional expansion in another way resembling cortical folding of gyrencephalic brains (see 
Model Figure 38).  
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Figure 25: Loss of Trnp1 induces folding of the murine developing neocortex 
(A-A’’) Series of rostral to caudal images of an example of a Trnp1 shRNA electroporated brain. Note the 
folds that developed at the site of electroporation and how the folding develops from two independent folds 
rostrally (A) to one big fold caudally (A’-A’’). (B-B’) DAPI and GFP labeling of a different brain 
electroporated with shRNA targeting Trnp1. Note the radial expansion and folding of the cortex in a more 
lateral region (indicated by two arrows). (C) Staining of radial glial fibers (RC2) in an shRNA electroporated, 
radially expanded brain (image is a reconstruction out of 2 single confocal images ). Note the divergence of 
radial fibers as they enter the cortical plate forming a fanned array. (A-B’ are reconstructions of a coronal 
section using Zeiss or Nikon fluorescence imaging software) 
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Figure 26: Different Examples of radially expanded /folded forebrains 
(A-C’) DAPI labeled examples of coronal sections of embryonic brains electroporated with pSUPER.GFP-
shRNA to down regulate Trnp1. A, B and C show the electroporated hemispheres, A’, B’ and C’ show the 
non-electroporated hemispheres of the same (!) sections. Red bars indicate the radial length and blue bars the 
ventricular zone size of the non-electroporated side. Bars are shown to compare with the size-increase of the 
electroporated side. Note the dramatic radial expansion in examples with strong expansion (A-B’) and the 
milder expansion as seen in some examples (C, C’), which still show a strong increase of the DAPI dense 
ventricular zone (blue bars).  
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4.4.2.5 Rescue of Trnp1 knock down 
Utilizing one particular shRNA may additionally result in down regulation of genes other 
than the one targeted (such side actions are called off-target effects). However, use of 
another, second shRNA reduces the likelihood that both result in down regulation of the 
same off-targets. Therefore, to exclude possible off-target effects of the used shRNA#5, 
the second shRNA (shRNA#1) targeting a different region within the 3’-UTR of Trnp1 
mRNA was used for in utero electroporation. Knock down of Trnp1 with this second 
shRNA resulted in similar effects as observed with shRNA#5 ultimately leading to cortical 
expansion. Comparable to shRNA#5 knock down of Trnp1 through shRNA#1 increased 
the number of Tbr2+ basal progenitors and provoked folding of the cerebral cortex (see 
Figure 27A-D). However, despite an increase of the number of cells residing in the cortical 
plate, shRNA#1 did not reach the significance level as obtained by shRNA#5 (Figure 
27C). This may possibly be due to the slightly lower knock down efficiency of shRNA#1 
as compared to shRNA#5 (see Figure 21B). However, as both shRNAs led to radial 
expansion and increase in Tbr2+ basal progenitors, the next question was whether this 
effect can be rescued through expression of a knock down resistant form of Trnp1. As a 
further test of specificity, the shRNA-resistant form of Trnp1 (lacking the targeted 3’-UTR 
of Trnp1, which was tested before for shRNA resistance – see Figure 21B’) was 
simultaneously expressed to test its ability to preclude the increased generation of Tbr2+ 
basal progenitors observed upon down regulation of Trnp1. Consistent with a key role of 
Trnp1 in regulating basal progenitor generation, co-electroporation of shRNA against 
endogenous Trnp1 mRNA together with the shRNA resistant Trnp1 cDNA was able to 
rescue the effect on basal progenitors to a level comparable to the control situation (Figure 
27E to F). In addition, radial expansion of the cortex was precluded by simultaneous 
expression of the shRNA and the resistant Trnp1 in the rescue experiment. Altogether, 
these data showed, that the effects of Trnp1 knock down described in this work are 
specifically due to a loss of Trnp1 function and are not a result of secondary, off target 
effects. Thus these results further support the previously described impact of basal 
progenitors and oRGs on expansion of the neocortex. Furthermore, these data suggest that 
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Trnp1 expression levels play a pivotal role in regulating the generation of these progenitor 
types.  
 
Figure 27: Confirming the specificity- and rescue of Trnp1 knock down 
(A-B’). Coronal sections of embryonic cortices labeled with GFP and DAPI. Embryos were electroporated 
either with pSUPER.GFP control plasmid (A-A’) or pSUPER.GFP-shRNA#1 (B-B’) at E13.5 and analyzed 
at E16.5. Distribution of cells was analyzed (C) and the number of basal progenitors was characterized using 
Tbr2 immunolabeling (D). Note that use of shRNA#1 - a second, independent shRNA against Trnp1 - 
resulted in a similar effect on basal progenitors with significantly more basal progenitors upon knock down 
of Trnp1 in radial glia. (E-E’) Rescue experiment of Trnp1 knock down by simultaneously expressing the 
shRNA directed against endogenous Trnp1 together with an shRNA resistant version of Trnp1. Coronal 
sections of embryonic cerebral cortices co-electroporated with pSUPER.GFP-shRNA#5 and pCAG-
Trnp1(3’-UTR)-dsRed labeled for GFP, dsRed and DAPI. (F) Quantification of the number of basal 
progenitors upon rescue as compared to control- and the knock down situation. Data are shown as mean +/- 
SEM; n=3 embryos for shRNA#1 and n=5 embryos for rescue experiments; *p<0.05, Mann Whitney U-Test.  
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4.5 Molecular analysis of Trnp1 
Given the functional importance of Trnp1 during brain development described above, 
unraveling its molecular function is of major interest. Trnp1 localizes to the nucleus and 
has been proposed by Volpe et al. (2006) to bind DNA. Its highly basic biochemical 
characteristics with a very high (calculated) isoelectric point of 11.43 (with 32 out of 223 
amino acids being positively charged – arginines (29) and lysines (3)) suggests that Trnp1 
may bind to DNA due to electrostatic interactions (see Introduction: 2.4). However, Trnp1 
sequence analysis did not reveal any homology to known protein motifs or domains. 
Therefore predictions of its molecular function were primarily not possible. In addition, its 
highly basic characteristics make biochemical analysis very difficult as electrostatic 
interactions during the experimental procedure may lead to false-positive results.  
 
4.5.1 Trnp1 is tightly associated with DNA 
Trnp1 was found in a highly insoluble nuclear fraction upon overexpression in vitro (Volpe 
et al., 2006) and it was suggested that Trnp1 is bound to DNA (Volpe et al., 2006).  
However, in vivo DNA binding has never been shown before. As shown in Figure 28 (A 
and B) endogenous Trnp1 is distributed throughout the nucleus rather homogenously in 
euchromatin but not detectable in heterochromatin. To analyze the localization of Trnp1 
during M-phase, sections of the mouse brain at embryonic day 12 (a highly proliferative 
stage during brain development) were immunolabeled with Trnp1 antibody and co-labeled 
with DAPI. Investigation of the ventricular surface allowed analyzing the localization of 
the protein during chromatin condensation as radial glial cells undergo M-phase including 
cytokinesis at the apical surface. Remarkably, Trnp1 was tightly associated with chromatin 
during mitosis, co-localizing with condensed chromosomes (see Figure 28C and D). Taken 
together these data suggest, that during G1, G2 and S-phase Trnp1 is localized to DNA 
regions of active transcription but not to highly compact, silenced regions of the genome, 
whereas Trnp1 is associated with condensed chromosomes during M-phase. However, 
further investigation of the molecular function of the protein needs to be done in order to 
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identify the reason for this characteristic behavior. Accordingly, its exact interaction 
partners remained to be identified. 
 
 
Figure 28: Trnp1 co-localizes with condensed chromatin during mitosis 
(A-B) Dissociated cells from the embryonic cerebral cortex at E14 transduced with CAG-Trnp1 virus. 
Immunostaining for Trnp1 and labeling for DAPI shows overexpressed Trnp1 localized in the nucleus but 
excluded in highly dense chromatin areas (areas of strong DAPI signal) - arrows indicate examples and one 
cell is shown as an example in a higher magnification. (C-D) Coronal sections of wild type E12 mouse 
embryos were labeled for Trnp1 and DAPI. Note the clear association of Trnp1 with condensed chromatin as 
seen in anaphase chromosomes indicated by arrows. Single optical confocal images are shown. 
To determine possible interaction partners, first Trnp1 was examined using western blot 
analysis. In the adult olfactory bulb Trnp1 protein was clearly detectable and resembled the 
pattern seen in lysates of Trnp1 overexpressing HEK cells (Figure 29A). As 
immunohistochemical-staining did not reveal any Trnp1 expression in the cerebral cortex 
of the adult murine brain (see Figure 13), tissue from the adult cerebral cortex was used as 
a control. In agreement with these data, a specific Trnp1 band was only detectable in the 
OB but not in the cortex (Figure 29A). Surprisingly, tissue lysates from the developing 
cerebral cortex revealed multiple bands ranging from about 20kDa to more than 100kDa 
(when using regular RIPA buffer for tissue lysis) (see Figure 29B). Use of very high salt 
concentrations (1M NaCl) or DNase treatment improved the signal of Trnp1 from the E14 
cerebral cortex (see Figure 29B). However, a clear identification of Trnp1 bands without 
background signals as compared to overexpression in HEK cells or compared to the adult 
OB was not possible using regular RIPA, high salt or DNase treatments. A characteristic 
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and highly reproducible pattern of bands with a wide range of molecular weight was 
detectable with all these lysis protocols. These bands may represent very strong complexes 
of Trnp1 with other proteins or may be due to protein-DNA interactions. In order to access 
the association of Trnp1 with DNA in a different way, E14 embryonic cortices were lysed 
with a different protocol to detect the endogenous protein upon acidic lysis - which is 
usually used for detection of very strong DNA binding proteins such as for example 
Histones or MeCP2 (protocol kindly provided by Dr. Raymond Poot, Erasmus MC, 
Rotterdam – see 6.2.3.1). Use of this acidic lysis protocol revealed Trnp1 in a highly 
insoluble pellet (Figure 29C). Histones released from DNA were detectable (strong 
background signal of the secondary antibody at 15kDa) in the soluble fraction 
(supernatant) upon acidic lysis showing that the lysis worked per se but was not able to 
solubilize Trnp1. Interestingly, Trnp1 was highly enriched in the insoluble fraction using 
this procedure. This shows that Trnp1 is tightly associated with DNA but is less soluble 
than Histones. Taken together, Trnp1 is tightly associated to DNA in stem cells during 
cortical development and release of the protein from an insoluble complex was very 
difficult. However, in the adult olfactory bulb (lacking progenitor or stem cells) release of 
the protein is easier and clear Trnp1 bands were observed with tissue lysis using RIPA 
buffer containing 0.5M NaCl. The characteristic pattern of signals seen in E14 lysates 
(similar to a ladder, see Figure 29B) was not visible in lysates from the OB. These data 
suggest a different way of association of Trnp1 with DNA and/or protein complexes in the 
adult OB (Trnp1 is expressed in neurons in the OB see Figure 14) as compared to the 
developing cortex (Trnp1 expressed in stem cells and newborn neurons see Figure 12). 
 
Results 
 
 62 
 
Figure 29: Endogenous Trnp1 in Western blot analysis  
Tissue from the adult cerebral cortex and adult OB (A) or from the E14 cerebral cortex (B and C) was lysed 
using different lysis buffers and protocols. Protein lysates were subjected to SDS-PAGE and analyzed by 
western blotting using Trnp1 antibody. (A) Adult cerebral cortical tissue (Ctx) and adult OBs were lysed 
using RIPA buffer containing 0.5M NaCl. Note the clear Trnp1 signal in OB lysates but not from cortical 
lysates. As a positive control, lysates from HEK cells overexpressing Trnp1 was used (o.E. in HEK); (B) 
Cortices from E14 mouse embryos were lysed with RIPA buffer (R.) containing either 150mM NaCl, 
0.5M NaCl or 1M NaCl respectively. Alternatively tissue was lysed with RIPA buffer and treated with 
Benzonase DNase (Bz.) for 20 or 60 minutes. (C) Nuclei from E14 cortices were isolated using HRSB buffer 
and acidic protein extraction. Nuclei, wash, pellet and supernatant of acidic extraction were subjected to 
western blot analysis using anti-Trnp1 antibody. Note that Trnp1 is mainly detectable in the insoluble 
fraction upon acidic treatment and that histones are detectable as a background signal of the secondary 
antibody in the acidic soluble fraction (SN). SN: supernatant. 
4.5.2 Bioinformatic analysis of Trnp1 structure 
Search for homology revealed no similarity of Trnp1 with any known motif or domain. 
The only distinguishable features are a proline rich region (P
20
-P
54
) and a glycine alanine 
rich region (G
72
-G
94
) (see also Introduction - 2.4). As endogenous Trnp1 was found to bind 
to DNA, crystallography of the protein would give further insights into its mode of 
interaction with DNA. For this purpose, in collaboration with the group of Prof. Dr. Patrick 
Cramer a first bioinformatical analysis of Trnp1 was carried out. In this context the 
Bioinformatic toolkit available online (http://toolkit.tuebingen.mpg.de) was used to further 
analyze the probability of characteristic secondary structure of the protein. The murine 
protein sequence of Trnp1 was used for bioinformatical analysis of native disordered 
regions (Figure 30A and B), analysis of regions of coiled coil structures (Figure 30C) and 
for PSIPRED analysis (a structure prediction method that incorporates two feed-forward 
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neural networks to perform an analysis of results obtained by the PSI-Blast homology 
search algorithm) (Figure 30D). Predictions of the secondary structure of Trnp1 revealed 
highly unstructured N- and C-terminal regions whereas the central part of the protein has a 
very high probability to form either one large helix stretch or multiple shorter helices that 
may then form a coiled coil structure (see Figure 30). These results finally dismissed 
seeking for crystallography of Trnp1 as it is impossible to analyze unstructured regions 
using this method. However, this analysis revealed characteristics of the Trnp1 protein 
structure: highly unstructured N- and C-terminal ends with a very structured central part. 
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Figure 30: Bioinformatic analysis of the Trnp1 protein structure 
(A-B) Disorder analysis of the Trnp1 protein structure. Values range from 0 to 1, 1 represents the highest 
value of disorder, 0 stands for highly ordered protein regions. (A) DisEMBL analysis of Trnp1 - protein 
disorder prediction based on neural networks. DisEMBL Predicts propensity for loops, hot loops and 
disordered regions. (B) DISOPRED analysis for protein disorder prediction. (C) PCoils analysis of the 
probability to adopt a coiled-coil structure. 1 represents the highest likelihood, 0 the lowermost likelihood to 
adopt a coiled coil structure. (D) PSIPRED analysis of the secondary structure of Trnp1. Analysis was carried 
out using “Bioinformatics toolkit” from the Max Planck Institute of Developmental Biology Tübingen. For 
details see: http://toolkit.tuebingen.mpg.de 
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4.5.3 Mass Spectrometry analysis to uncover direct binding partners of 
Trnp1 
To find direct interaction partners of one protein of interest co-immunoprecipitation with 
subsequent mass spectrometry is a commonly used approach. For this purpose, the 
molecule of interest needs to be precipitated under mild conditions using an antibody 
raised against it. Every protein that is bound to the protein of interest will be co-
immunoprecipitated and can be subsequently analyzed and identified through mass 
spectrometry. 
In general to test for successful immunoprecipitation of a given protein two antibodies that 
were raised in different species against the same protein are used. With the first antibody 
the protein is being precipitated, the second antibody is then used for western blotting to 
test for enrichment of the protein. Unfortunately in the case of Trnp1 both generated 
antibodies were raised in guinea pig. As Trnp1 has a molecular weight of about 30kDa 
(correlating with the size of the light chains of immunoglobulins) test of successful 
immunoprecipitation was difficult. The light chain of the antibody used for 
immunoprecipitation would always be detected by the secondary (anti guinea pig) antibody 
used to detect Trnp1 in western blot analysis. In addition, the pattern observed in western 
blotting revealed several additional bands for Trnp1 – either due to strong complexes of 
Trnp1 or simply due to unspecific reactions of the antibody. Altogether these observations 
triggered the aim of a clean immunoprecipitation using a fusion protein of Trnp1 with 
commercially available antibodies. In this context the previously used Trnp1-GFP fusion 
construct was utilized to overexpress Trnp1 in vitro and precipitate the fusion construct 
together with its interaction partners.  
Therefore, Trnp1-GFP was expressed in HEK cells, cells were lysed and pull down was 
performed using GFP-Trap®_A (ChromoTek) according to the manufacturer’s protocol. 
Efficiency of the pull down was tested using western blotting (Figure 31). Co-precipitated 
samples were separated on coomassie gels and the different bands were excised and 
submitted for mass spectrometry analysis. However, using three independent biological 
replicates no protein was found to reproducibly interact with the Trnp1-GFP fusion 
construct (see Appendix 7.1). This may be due to the use of HEK cells, which do not 
express Trnp1 endogenously. Therefore, endogenous interaction partners may simply be 
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not expressed in HEK cells. Or, alternatively due to the use of a fusion protein of Trnp1 
that may represent a non-functional version of Trnp1. To test this possibility I later 
transfected HEK cells with the Trnp1-GFP fusion construct and examined its ability to still 
interact with DNA (see 4.5.5). 
 
 
Figure 31: Pull down of Trnp1-GFP using GFP-Trap®_A 
In order to test for specificity and efficiency of the pull down of Trnp1-GFP fusion construct by GFP-
Trap®_A (Chromotek) the input (IN), supernatant (SN), wash and pull down (IP) was tested by western 
blotting using the anti-Trnp1 antibody. Note the high efficiency of the pull down with almost no residual 
protein left in the supernatant and wash after pull down. Using beads only (without the GFP trap coupled to 
them) as a control tested the specificity of the GFP-trap_A pull down.  
 
4.5.4 FRAP experiment for Trnp1  
Trnp1 was found to be tightly associated with condensed chromosomes during mitosis. 
One possibility to test the immobility of the protein due to its association to DNA was the 
use of Fluorescence Recovery After Photo bleaching (FRAP). FRAP is used to measure the 
speed of diffusion of a protein of interest which correlates with its mobility. The protein is 
fused to a fluorescent protein such as GFP. The fusion protein is then expressed in vitro 
and the fluorescing signal is being bleached using a short laser pulse. The time of recovery 
is then recorded and a correlation between the speed of signal recovery and 
immobility/mobility of the protein can be visualized. Fast recovery kinetics upon bleaching 
correlate with a high mobility of the protein. In case of a tightly associated protein lateral 
diffusion and fluorescence recovery is very difficult, as only few free molecules are 
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available to replace the bleached ones. Proteins tightly bound to cell compartments are 
therefore immobile and the signal will recover slowly as compared to such that are freely 
available or loosely attached and mobile (Schermelleh et al., 2005). All FRAP experiments 
in this study were carried out in the laboratory of Professor Dr. Heinrich Leonhardt with 
the help of Katrin Schneider. C2C12 or HeLa cells and alternatively also murine primary 
cortical cultures of embryonic day 14 were transfected with peGFP-Trnp1. FRAP 
experiments were then performed 48h later. Trnp1-GFP molecules were bleached in a 
small strip spanning half of the nucleus with 100% laser intensity and recovery was 
recorded with 20% laser intensity. Nuclei were imaged for 5 seconds before and 60 
seconds after bleaching. Trnp1-GFP showed fast recovery of fluorescence with about 80% 
of signal recovery within 10 seconds after bleaching (Figure 32A). Compared to that, the 
vast majority of tightly DNA associated molecules such as Histones, DNA methyl 
transferases or other known DNA binding molecules is long term immobilized and exhibits 
little recovery after bleaching (Kanda et al., 1998; Kimura and Cook, 2001; Schermelleh et 
al., 2005; van den Boom et al., 2007). However, Trnp1-GFP showed slower recovery as 
compared to the GFP control. This may be due to the size differences in GFP only versus 
Trnp1-GFP (about twice as big as GFP) that also influence the speed of diffusion. As 
Trnp1-GFP showed such fast kinetics, the association of Trnp1-GFP with DNA was tested 
in time-lapse analysis. Live, time lapse analysis of Trnp1-GFP fusion protein showed a 
clear localization of Trnp1-GFP to the nucleus but surprisingly did not show Trnp1 
localized to condensed chromosomes during M-phase (Figure 32B) as seen before in vivo 
(see Figure 28). Taken together, these data suggested that the fusion of Trnp1 with GFP 
may lead to conformational changes ultimately abolishing the endogenous function of the 
protein. Trnp1-GFP fusion protein therefore needed to be further tested for its DNA 
binding ability compared to full length Trnp1. 
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Figure 32: FRAP analysis of Trnp1-GFP fusion protein 
(A) Fluorescence recovery after photo bleaching with either GFP as a control or Trnp1-GFP in C2C12 and 
HeLa cells. Relative intensity is shown depending on the time after bleaching. (B) Time-lapse analysis of 
Trnp1-GFP in C2C12 cells during the cell cycle. 1-6: subsequent time points of the same cell undergoing 
mitosis. Dashed lines indicate either nuclei (1 and 6) or cell bodies during mitosis. Note, that Trnp1-GFP is 
localized exclusively in the nucleus and dissolves completely in the whole cell body during M-phase (note 
that not clear association of Trnp1-GFP with DNA is visible). 
 
4.5.5 C-terminal fusion of GFP to Trnp1 inhibits its DNA binding ability 
Both the FRAP experiment and the Mass Spectrometry experiments revealed very 
unexpected results and time lapse imaging indicated that Trnp1-GFP fusion protein did not 
localize to chromosomes during M-phase anymore. Therefore, the next question was 
whether this was due to a non-functional GFP-Trnp1 fusion protein. In this context the C-
terminal fusion of GFP to Trnp1 might inhibit its interaction with DNA or Trnp1-GFP was 
not able to bind its regular partners anymore (and one may be the consequence of the 
other). For a protein that is co-localizing with condensed chromosomes in anaphase one 
would expect very slow recovery kinetics in FRAP experiments. However the experiments 
with the Trnp1 fusion construct revealed fast kinetics indicating, that the fusion construct 
did not interact with the DNA in the same way as the endogenous protein did. To test this 
possibility with a higher sensitivity as compared to the previously performed live imaging 
immunocytochemistry was used. The co-localization of the fusion protein with DNA was 
compared to that of the endogenous, full-length protein (Figure 33A to A’’ and B to B’’). 
Consistent with the live imaging data, Trnp1-GFP fusion protein did not co-localize with 
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condensed chromosomes during M-phase anymore. The fusion protein clearly detached 
from DNA and was separated from condensed chromosomes identified by PH3 
immunostaining and DAPI labeling (Figure 33C to C’’). This result shows that Trnp1 
association with DNA is abolished by C-terminal fusion of GFP and explains the fast 
kinetics found in FRAP experiments but may also be an explanation why no consistent 
interaction partners were found in mass spectrometry analysis. It is conceivable that Trnp1-
GFP shows conformational changes and therefore does also no longer interact with the 
regular partners of Trnp1.  
 
Figure 33: Trnp1-GFP fusion protein behaves differently as compared to the full-length protein  
(A-A’’) Example of endogenous Trnp1 expression and localization in the GE of an E14 murine brain. 
Coronal sections of a Mash1-GFP E14 brain (expressing a nuclear GFP version in Mash1 positive cells in the 
GE) were immunostained for Trnp1, GFP and labeled with DAPI. Arrows indicate condensed chromosomes 
of a cell during M-Phase. Note the clear association of Trnp1 with condensed chromosomes during anaphase. 
(B-C’’) E14 primary culture either stained for endogenous Trnp1 and phosphohistone 3 (PH3) (B-B’’) or 
transfected with a construct to express the Trnp1-GFP fusion protein stained for GFP and PH3 (C-C’’). Cells 
were fixed three days post transfection, stained and co-labeled with DAPI. Arrows indicate an example of a 
cell during mitosis and intersects show a higher magnification of the same cell. Single optical sections are 
shown. Note the clear dissociation of Trnp1-GFP from condensed chromatin during M-Phase. 
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4.5.6 Analysis of direct regulation of gene expression through Trnp1 
The tight association of Trnp1 with DNA implicated a possible role in gene regulation. 
Furthermore, Trnp1 overexpression and down regulation showed a strong effect on radial 
glial cell fate as analyzed by the radial glia and basal progenitor specific transcription 
factors Pax6 and Tbr2. One possible explanation would be that Trnp1 may directly regulate 
expression of genes such as Pax6 target genes or of the basal progenitor TF Tbr2. 
Overexpression of Trnp1 increased the number of Pax6 positive radial glia in the 
developing cortex. To elucidate a possible direct transcriptional activation of Pax6 target 
genes through Trnp1, a luciferase reporter assay in P19 cells was utilized. The pGL3-based 
promoter plasmids containing the Pax6 consensus binding site P6CON (binding site of the 
Pax6 paired domain) together with the retroviral Trnp1 expression plasmid pCAG-Trnp1-
IRES-GFP were used either alone or in combination with Pax6 to elucidate a possible 
activating function of Trnp1 (i.e. a function as co-factor) on Pax6 target gene regulation. 
As a positive control Pax6 alone was used (Figure 34). However, no effect of Trnp1 on 
activation of the P6CON promoter was observed, neither alone, nor in combination with 
Pax6. 
On the other hand, Trnp1 overexpression reduced the number of Tbr2+ basal progenitors, 
hence another possible scenario was that Trnp1 acts as a transcriptional repressor of Tbr2. 
Therefore, the effect of Trnp1 on Tbr2 expression activated through Pax6 (a known Tbr2 
transcriptional activator (Sansom et al., 2009)) was tested in P19 cells. Cells were co 
transfected with the pGL3-based promoter plasmid containing the Tbr2 promoter and the 
retroviral Trnp1 expression construct pCAG-Trnp1-IRES-GFP in combination with a Pax6 
expression construct. As a positive control Pax6 expression alone was used (Figure 34). 
While Pax6 alone activated the Tbr2 promoter as previously described (Pinto et al., 2009), 
no repression of Tbr2 activation was observed after co-expression of Trnp1. Taken 
together these data could not show any direct gene regulatory function of Trnp1 on these 
promoters. However, the luciferase reporter assay may not contain the Trnp1 binding sites 
and hence direct gene regulation through Trnp1 may still occur for these or other target 
genes in vivo. 
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Figure 34: Luciferase Assays of Trnp1 on P6CON and Tbr2 promoter 
(A-B) Histograms depicting the transcriptional activation of the Pax6 consensus site P6CON (A) and the 
Tbr2 promoter (B) through Pax6 alone, Trnp1 alone or both Pax6 and Trnp1 together. Transactivation was 
measured by reporter gene activation in luciferase assay in P19 cells. Absolute values were normalized to 
vector controls. Data are shown as mean values of different wells of one experiment. 
4.5.7 Gene Expression analysis of gain and loss of Trnp1 
In order to analyze the genes that are directly or indirectly regulated by overexpression or 
knock down of Trnp1, gene expression analysis after in utero electroporation was 
performed. For this purpose, embryos were electroporated at E13 with either pCAG-
Trnp1-GFP (for forced expression of Trnp1), pSUPER.GFP-shRNA (for knock down of 
endogenous Trnp1) or pCAG-GFP control plasmid. Cerebral cortices were then dissected 
22-24 hours post electroporation and GFP positive cells were separated from non-
electroporated cells through fluorescence activated cell sorting (FACS) (Figure 35). As a 
control non-electroporated cortices were used to set the gates for forward- and sideward 
scatter (to select relevant and living cells and exclude debris), the gates for FSC-A and 
FSC-W (to exclude cellular aggregates such as doublets) and to set the gates for GFP 
sorting. RNA was immediately extracted from sorted cells and cDNA was produced for 
Microarray analysis. cDNA was hybridized on Affymetrix Gene ST 1.0 arrays (containing 
about 28.000 probe sets) and gene expression differences between GFP control, Trnp1 
overexpression and knock down electroporated cells were determined. Genewise testing 
for differential expression was done employing the limma t-test and Benjamini-Hochberg 
multiple testing correction. Datasets were filtered for average expression levels > 50 in at 
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least one group (overexpression, knock down or control) and for a linear ratio difference of 
> 1.5-fold between control and overexpression or control and knock down. To verify 
successful overexpression and knock down of Trnp1 and as a first test of the performed 
microarray, the expression levels of Trnp1 in the different probes were analyzed. Exon 
level analysis with two different probe sets (one in the non-coding exon 2 and one in the 
protein coding exon 1) were used and showed differences in Trnp1 levels for control 
versus overexpression or knock down probes.  
 
 
Figure 35: Sorting of GFP positive cells after in utero electroporation  
Cortices electroporated at E13 with either pCAG-GFP control plasmid (B-B’’’), pSUPER.GFP/Neo-
shRNA#5 for knock down of Trnp1 (C-C’’’) or pCAG-Trnp1-GFP for Trnp1 overexpression (D-D’’’) were 
dissected one day later at E14 and FACS sorted. As a control and to set the gates, dissociated cells from non-
electroporated cortices were used (A-A’’’). (A, B, C and D) Relevant and living cells were selected by setting 
forward (FSC-A) and sideward scatter (SSC-A). (A’, B’, C’ and D’) Cellular aggregates were excluded based 
on FSC-A and FSC-W. (A’’, B’’, C’’ and D’’) Gates for GFP sorting. (A’’’, B’’’, C’’’ and D’’’) Analysis of 
cell numbers and percentage of the sorted cells in the different gates. Graphs represent 100.000 (A and D) or 
300.000 sorted cells (B and C). Red dots indicate GFP positive cells. 
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As overexpression was performed with a plasmid lacking the non-coding 3’-UTR of Trnp1 
detected by probe-set#1 (10517054: within the non-coding exon 2) this probe-set showed 
expectedly almost no differences in Trnp1 expression versus control. Probe set#2 
(10517055: within the protein coding exon 1) revealed strong differences in Trnp1 levels 
with strong up-regulation in all four biological replicates of Trnp1 overexpression 
compared to control (Figure 36 A). Additionally, both probe-set#1 and probe-set#2 showed 
successful down regulation of Trnp1 mRNA in three of five biological replicates of 
shRNA electroporated Trnp1 knock down. The other two probes (KD_3 and KD_5) 
showed only slight down regulation as compared to control and were therefore not used for 
subsequent gene expression analysis. Thus, four probes of Trnp1 overexpression, three 
probes of Trnp1 knock down and four probes of control GFP electroporation were used for 
transcriptome analysis. 
In total 152 genes were found differentially expressed upon Trnp1 down-regulation as 
compared to control probes (all meeting the criteria of an average expression > 50, a p-
value <0.01 and fold changes of >1.5) (Figure 36B; for a detailed table of genes and 
expression levels see Appendix 7.2.1). Upon overexpression of Trnp1 31 genes were found 
differentially expressed using the same criteria (p<0.01, average expression > 50 and fold 
changes of >1.5) (Figure 36C; for detailed list of the genes and their expression levels see 
Appendix 7.2.2). The genes with the strongest differences upon Trnp1 overexpression were 
genes that are endogenously only expressed in the ventral part of the developing 
telencephalon such as Dlx1, Dlx2, Dlx5, Dlx6, Gsx2 (5 out of the top 9 genes up regulated 
upon Trnp1 overexpression). As progenitor cells in the ganglionic eminence show a 
stronger proliferative behaviour, the expression of these genes may correlate with the 
increased proliferative activity of radial glial cells observed upon overexpression of Trnp1 
in the cortex. Remarkably, genes differentially regulated upon loss of Trnp1 function 
conprised bHLH transcription factors known to play a role in neural differentiation such as 
Neurod1, -2 and -6 but also several chromatin-remodelling factors such as Chd7, Smarca5, 
Bmi1 and different histone variants. The reliability of the transcriptome analysis was 
confirmed by qPCR (Figure 36D). 
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Genomatix GO term analysis showed that most of the differentially expressed genes upon 
knock down or overexpression of Trnp1 are known to be directly or indirectly involved in 
transcriptional regulation (DNA binding, transcriptional repression or -activation, RNA 
metabolic processes, regulation of gene expression etc.) (Figure 37). Additionally, overall 
expression differences upon knock down contained more down regulated genes than such 
that were up regulated, whereas overexpression of Trnp1 resulted in more up regulated 
genes than such that were down regulated (compare Figure 36B to C). Taken together 
these data suggest, that Trnp1 is involved in gene regulation and, more specifically acts 
directly or indirectly in transcriptional activation. This is in agreement with the co-
localisation of Trnp1 with euchromatin (see Figure 28A and B). 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 36: Microarray Data 
Transcriptome analysis of differentially expressed genes upon knock down and overexpression of Trnp1 in 
the developing telencephalon. (A) Analysis of Trnp1-mRNA levels of knock down (KD), overexpression 
(OE) or control (Ctrl). Two different probe-sets were used for Trnp1 expression analysis (10517054 within 
the 3-‘UTR of Trnp1 and 10517055 within the coding region of Trnp1). Note that as overexpression was 
performed with a construct lacking the 3-‘UTR, only probe-set 10517055 can reliably be used for analysis of 
Trnp1 levels. (B) Heatmap showing 152 genes differentially expressed upon Trnp1 knock down as compared 
to control electroporated cells. Genes have an average expression > 50, p-value <0.01 and fold changes of 
>1.5. (C) Heatmaps showing 31 genes differentially expressed in Trnp1 overexpression versus control. (C) 
Differentially expressed genes of Trnp1 overexpression with p<0.01, average expression > 50 and ratio 
differences >1.5. Red indicates higher expression levels, green indicates lower expression levels. Genes are 
shown from up regulated (up) to down regulated Note that more genes are overall down regulated upon 
Trnp1 knock down and more are up regulated upon Trnp1 overexpression. (D) qPCR analysis of several 
genes confirmed the validity of the shRNA microarray. 
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Figure 37 Genomatix GO term Analysis 
GO term Analysis of genes differentially expressed upon knock down (A) or overexpression of Trnp1 (B) in 
the developing mouse cortex. Note that most of the differentially expressed genes are directly or indirectly 
involved in regulation of gene expression. 
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5 Discussion 
5.1 Expression of Trnp1 in the murine brain 
In this study, the expression pattern of Trnp1 during forebrain development was elucidated. 
For this purpose, two antibodies targeting different regions of the protein (size of each 
epitope 19-20 amino acids) were generated in guinea pig. One of the two generated 
antibodies was able to specifically and efficiently recognize Trnp1 upon overexpression 
and was also able to detect the endogenous protein in the developing murine brain by 
immunohistochemistry. The specificity of the antibody was tested using competition 
experiments in vitro and in vivo. Furthermore, specificity was demonstrated by the use of 
shRNAs for knock down of Trnp1 (see 4.4.2.1). In agreement with the previous description 
of Trnp1 by Volpe et al., Trnp1 protein was detectable as multiple bands upon 
overexpression in HEK293 cells. In this context, Trnp1 may be posttranslationally 
modified such as phosphorylated. Several Bioinformatic predictions of posttranslational 
modifications such as KinasePhos (http://kinasephos.mbc.nctu.edu.tw) or ELM 
(http://elm.eu.org/) suggest that Trnp1 is target of several kinases such as CDK, MAPK, 
PKA, PGC or PKG. Accordingly, endogenous Trnp1 protein was also detectable as 
multiple bands in the developing cortex as well as in the adult olfactory bulb suggesting 
that post translational modifications occur endogenously and may regulate Trnp1 function 
in vivo (see Figure 29).  
In this study, Trnp1 was for the first time identified in brain tissue as a nuclear protein. 
This observation is in agreement with Volpe et al. that showed Trnp1 localizing to the 
nucleus upon overexpression in immortalized cell lines. Characterization of different cell 
types at different developmental stages revealed that Trnp1 is expressed in the developing 
murine forebrain in neural stem cells but also in newborn neurons. However, supporting its 
initial identification in directly neurogenic radial glial cells (Pinto et al., 2008), Trnp1 is 
absent in most basal progenitors and localizes to a subset of radial glial cells at mid 
neurogenesis in the developing cortex. Trnp1 was found in all Tbr1 expressing newborn 
neurons at E14 indicating that Trnp1 is re-expressed in neurons derived from basal 
progenitors. In cortical development Trnp1 is ON (expressed) in a subset of stem cells 
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(radial glial cells) and their direct neuronal progeny while it is OFF (not expressed) in the 
subset of RG generating basal progenitors (being responsible for the expansion of neuronal 
output) and ON again in newborn neurons.  
In contrast to its expression in the developing cortex, Trnp1 was detectable in both apical 
progenitors and in Mash1 positive basal progenitors in the ventral forebrain. Accordingly, 
in the adult SEZ (that is developmentally derived from the ventral part of the forebrain) 
Trnp1 is expressed in GFAP positive stem cells but also in transit amplifying progenitors 
(TAPs) labeled by a short BrdU pulse. Similar to its expression in newborn neurons in the 
developing forebrain, the protein is also detectable in neuroblasts and in neurons in the 
olfactory bulb. However whether its expression in the OB is restricted to newborn neurons 
remains to be elucidated. In contrast to the SEZ, Trnp1 is not detectable in neurons of the 
adult cortex and is also absent in the other well-known neurogenic niche of the adult 
murine brain, the dentate gyrus of the hippocampus. Previous reports showed differences 
of the progenitors in the DG as compared to the ones in the SEZ (see Ming and Song, 2005 
for a review) and such differences may explain why Trnp1 is restricted to the 
SEZ/RMS/OB neurogenic niche in the adult brain. In this context it needs to be mentioned, 
that Volpe et al showed quantitative PCR data of Trnp1 of different adult tissues and 
claimed that Trnp1 is present in adult whole brain extracts. Importantly, the Primers used 
contained a very high content of GC basepairs increasing the possibility of unspecific 
signals. In my work mRNA levels were not analyzed, but Trnp1 protein was not detectable 
utilizing immunohistochemistry or western blotting in the adult murine cortex. However, 
in agreement with the obtained immunohistochemical data, Trnp1 is clearly detectable in 
lysates from the OB as multiple distinct bands (comparable to overexpressed Trnp1 in 
HEK cells). In contrast to that, Volpe et al. provided a western blot that shows one single 
very weak band in whole brain extracts which seems to be likely due to background signal 
of the used primary or secondary antibody, especially since the multiple distinct bands 
observed in the OB but also upon overexpression are lacking. Alternatively Trnp1 may be 
expressed at very low levels in the cortex and the antibody used in this work was not able 
to detect these low levels. If this would be the case, the lack of multiple posttranslational 
modifications in the cortex may represent differently regulated Trnp1 protein in the cortex 
as compared to the OB.  
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The observed expression pattern strongly suggested that Trnp1 is involved in regulation of 
neurogenesis and in early integration of newborn neurons. Supporting this hypothesis 
Trnp1 was found being expressed in neural stem cells at highly neurogenic stages of 
murine cortical development, but at the time of gliogenesis (late embryonic stages such as 
E18) the protein was absent in gliogenic progenitors.  
In his Master thesis that Michael Metzger performed under my supervision in our 
laboratory, he showed that Trnp1 is not restricted to the central nervous system (Metzger, 
2011). Trnp1 was detectable in proliferating cells throughout the developing mouse 
embryo in different tissues such as the developing heart, the eye and the spinal cord and 
was found in proliferating cells labeled by PH3 (Metzger, 2011). However, in strong 
contrast to the previously suggested function in proliferation (Volpe et al., 2006), 
overexpression of Trnp1 was not able to increase the proliferation rate in HEK cells (data 
not shown). Remarkably, Trnp1 protein was not detectable in highly proliferating cells 
such as HEK, NRK and embryonic stem (ES) cell derived neurogenic progenitors (data not 
shown for NRK and ES cells) thereby showing that Trnp1 is not necessary for 
proliferation. Additionally, Trnp1 was absent in gliogenic progenitors at late embryonic 
stages but highly expressed in post-mitotic neurons. Altogether these data questioned the 
exclusive function of Trnp1 in cell proliferation and suggested that it is additionally 
regulating the process of differentiation of newborn neurons.  
In summary, Trnp1 is found in proliferating cells of multiple tissues in the developing 
mouse but strikingly not in all proliferating cells. Therefore, its expression in stem cells 
suggested a role in fate specification. As Trnp1 is additionally also expressed in newborn 
neurons of the developing and adult brain an important role in differentiation seemed also 
likely. 
 
5.2 The function of Trnp1 in the developing forebrain 
During development, radial glia comprise neurogenic, but at later stages also gliogenic 
progenitors (Kriegstein and Alvarez-Buylla, 2009). In addition, some radial glial cells give 
rise to the neural stem cells responsible for adult neurogenesis (Merkle et al., 2004; 
Kriegstein and Alvarez-Buylla, 2009). Yet little is known about the molecular 
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determinants that regulate radial glia self-renewal and expansion of the cortex. Using a 
new antibody raised against Trnp1 I was able to show its expression at protein level in 
neurogenic niches both during development and in the adult murine brain. The expression 
of Trnp1 in only a subpopulation of Pax6-positive radial glial cells at mid neurogenesis 
together with its initial identification in directly neurogenic radial glial cells suggested a 
specific regulatory role of Trnp1 in neurogenesis. Functional analysis presented in this 
work identified Trnp1 as a novel regulator of brain development and neocortical 
expansion. First, to directly examine Trnp1 function a retroviral vector was constructed to 
overexpress Trnp1. Forced expression in dissociated primary cell cultures derived from the 
cerebral cortex of E14 mouse embryos resulted in increased proliferation and self-renewal 
of neural stem cells. This finding was further corroborated with live imaging and single 
cell tracking which showed an impressive increase of symmetric progenitor division and 
sustained neurogenesis over a longer time. In utero electroporation to overexpress Trnp1 in 
the developing cerebral cortex revealed a significant increase of radial glia proliferation in 
vivo supporting the in vitro findings. In contrast, knock down experiments using short 
hairpin RNA strongly increased the number of BPs and neurons after three days in vivo. 
These data show, that high levels of Trnp1 lead to self-renewal of neurogenic radial glial 
cells, whereas low levels promote increased production of basal progenitors and neuronal 
output. This result is consistent with our initial identification of Trnp1 in the radial glial 
subset that does not generate basal progenitors during forebrain development (Pinto et al., 
2008). 
During brain evolution a remarkable increase in size of the cerebral cortex has occurred 
especially amongst mammals. One open key question is how expansion of this brain region 
is regulated at the molecular level and which mechanisms distinguish larger cerebral 
cortices from smaller ones. Gyrification seems to have developed a long time ago as a 
blueprint for today’s mammalian brains (Reillo et al., 2011; Borrell and Reillo, 2012; 
Martínez-Cerdeño et al., 2012). Some species kept the ability to form cortical folds, 
whereas others lost this ability (Kriegstein et al., 2006; Borrell and Reillo, 2012; Kelava et 
al., 2012; Martínez-Cerdeño et al., 2012). This hypothesis provokes the question what 
distinguished that blueprint ancestor from other species, and what factors may have been 
responsible for such an evolution. In this context it is very tempting to think about factors 
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that may have developed such a function in the mammalian lineage and are involved in 
these processes. Trnp1 was initially identified in a screen for directly neurogenic radial 
glial cells. This sub population is suggested to give rise to neurons directly and to self 
renew itself trough asymmetric divisions (Miyata et al., 2001; Noctor et al., 2001; 
Haubensak et al., 2004; Noctor et al., 2004; Pinto and Götz, 2007; Stancik et al., 2010). 
Acute loss of Trnp1 not only increased the number of BPs but also led to a dramatic local 
radial expansion of the cortex. This is consistent with previous studies suggesting basal 
progenitors as the main source of increased neuronal output and expansion (Haubensak et 
al., 2004; Miyata et al., 2004; Noctor et al., 2004; Kriegstein et al., 2006; Pontious et al., 
2008; Sessa et al., 2008; 2010; Hevner and Haydar, 2012). Besides BPs outer radial glial 
cells (oRGs) lacking an apical process have recently been suggested to be a prerequisite of 
brain expansion and folding / gyrification of the cortex (Fietz et al., 2010; Hansen et al., 
2010; Lui et al., 2011; Molnár, 2011; Reillo et al., 2011). Down regulation of Trnp1 was 
able to increase the number of such outer radial glial cells in the murine brain. The striking 
folding of the brain upon Trnp1 knockdown strongly supported this observation and is 
likely a consequence of both the increase in BP and oRG numbers. In summary, loss of 
Trnp1 was able to acutely reproduce several hallmarks of larger brain development: 1) 
strong radial expansion, 2) diverging radial fibers forming a fanned array as has been 
described for gyrencephalic brains (Smart and McSherry, 1986a; 1986b; Lui et al., 2011; 
Reillo et al., 2011), 3) increased numbers of oRGs that have been suggested to be a 
characteristic of larger brains (Fietz et al., 2010; Hansen et al., 2010; Reillo et al., 2011; 
Wang et al., 2011; Borrell and Reillo, 2012; Martínez-Cerdeño et al., 2012), 4) increased 
proportion of Tbr2+ basal progenitors. Additionally, a strong increase of the DAPI dense 
SVZ region in combination with a diffuse Tbr2+ band was found upon down regulation of 
Trnp1. These observations are indicative of an increased SVZ and somewhat reminiscent 
of the diffuse band of BPs present in the oSVZ of higher mammalian brains (Martínez-
Cerdeño et al., 2012). Altogether, these data suggest that Trnp1 represents a molecular 
switch that needs to be expressed or “ON” in progenitors in order to increase the 
progenitor pool and lead to a tangential (lateral) expansion. Accordingly, at the time of 
strong lateral expansion of forebrain development (i.e. in neuroepithelial cells) Trnp1 is 
expressed in virtually all progenitors. Later, when the time for increased neuronal 
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production has come Trnp1 is acutely down regulated in subsets of radial glia to initiate 
abventricular amplification by basal progenitors and oRGs that then together increase the 
number of neurons and their guidance structures resulting in radial expansion (see model 
Figure 38). Therefore, Trnp1 controls progenitor pool expansion and subsequently 
neuronal expansion. In this context, the timing of Trnp1 down regulation may determine 
the extent of radial expansion. Acute loss of Trnp1 immediately increases neuronal output 
at the expense of remaining apical radial glial cells. Hence, acute loss of Trnp1 will 
presumably lead to an acute radial expansion. This suggests, that regulation of Trnp1 
expression may be involved in radial expansion and gyrification to accommodate the 
additional neuron numbers in larger brains. The process of oRG generation in the murine 
brain is endogenously very inefficient and slow as oRGs are found only sparsely 
(Shitamukai et al., 2011; Wang et al., 2011). The level of Trnp1 seems to play a critical 
role in this process and knock down of Trnp1 released the inhibition of oRG production. 
The loss of apical radial glia upon Trnp1 down regulation seems to be compensated by the 
increase in oRG numbers that have been shown to have a higher proliferation coefficient 
than BPs (Lui et al., 2011). 
In summary, using both clonal analysis in vitro and in utero electroporation in vivo Trnp1 
was found to be a master regulator of radial glial fate. So far, Trnp1 represents the first 
factor identified to regulate the generation of both oRGs and BPs at the same time. In 
strong contrast to Volpe et al, Trnp1 was not simply increasing proliferation but it does 
rather represent a crucial regulator of cellular fate and neurogenesis. Additionally, Trnp1 
also represents the first factor capable to generate folding in an otherwise lissencephalic 
brain recapitulating all the hallmarks of higher mammalian gyrencephalic brain 
development. In this context, it should be mentioned that a transgenic mouse line 
expressing a stabilized form of beta catenin has previously been reported to show folding 
of the neocortex (Chenn and Walsh, 2002). However, in strong contrast to the observed 
local expansion and folding upon Trnp1 knock down, the beta catenin induced folding did 
not resemble folding of higher mammalian gyrencephalic brain, but rather represents a 
secondary folding due to lateral expansion of the progenitor pool. Importantly, the folding 
observed by Chenn et al. included folding and expansion of the ventricular surface and did 
not fulfill characteristics of radial expansion. In contrast, down-regulation of Trnp1 
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resulted in a local radial expansion and folding of the cortical plate without increasing the 
ventricular surface therby reflecting the situation in gyrencephalic brains. Together with 
the above mentioned characteristics such as the appearance of oRG cells, timed and local 
manipulation of Trnp1 was able to recapitulate central features of gyrencephalic brains.  
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Figure 38: Model of Trnp1 action during mammalian cortical brain development 
Illustration of the mode of Trnp1 action in neural stem cells during cerebral cortical development. (A) High 
levels of Trnp1 in radial glial cells lead to proliferation and self renewal of radial glia with either symmetric 
divisions to generate two radial glial cells or asymmetric division allowing direct neurogenesis to occur at the 
same time. (A’) High levels of Trnp1 enlarge the pool of stem cells leading to tangential expansion. (B) In 
contrast to that, low levels of Trnp1 lead to the generation of basal progenitor cells that subsequently amplify 
the neuronal output. At the same time, low levels of Trnp1 also provoke generation of outer radial glia (oRG) 
that lost their apical process and serve to amplify the neuronal output but also are essential for folding of an 
expanding cortex. (B’) Both the high number of basal progenitors and the generation of oRGs together lead 
to a radial expansion of the cortex and ultimately result in folding of the brain as naturally occurring in higher 
mammalian species. 
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5.3 The role of Trnp1 in neurogenesis and its potential in reprogramming 
Trnp1 is an important regulator of direct versus indirect neurogenesis and generation of 
different progenitor sub-classes. Regarding the direct role of Trnp1 in neurogenesis, I also 
identified Trnp1 to be expressed at protein level upon reprogramming of postnatal 
astrocytes into neurons (data not shown). It has previously been shown that astrocytes from 
the postnatal cerebral cortex (postnatal day 7) can be directly converted into functional 
neurons by forced expression of Ngn2 or Mash1/Dlx2 (Berninger et al., 2007; Heinrich et 
al., 2010). Trnp1 was induced and detectable in reprogrammed cells generated both from 
Ngn2 and Mash1 transduced astrocytes 14 days after infection only in reprogrammed cells, 
i.e. in neurons (data not shown). Along this line, using chromatin immunoprecipitation our 
collaborator Francois Guillemot was able to detect Ngn2 as well as Mash1 to bind very 
closely to the proposed promoter region of Trnp1. This suggested that Ngn2 and Mash1 
might directly regulate Trnp1 activity. Altogether, Trnp1 seems to have an additional role 
in newborn neurons, which is emphasized by its endogenous expression in newborn 
neurons during cortical development. During his master thesis under my supervision 
Michael Metzger was able to show that Trnp1 is an important survival factor for newborn 
neurons in their early days. In vitro time-lapse analysis of loss of Trnp1 function in 
newborn neurons of dissociated cells from the developing cerebral cortex (at E12) 
identified Trnp1 as a promoter of survival in newborn neurons (Metzger, 2011). Therefore, 
in addition to its role in neural stem cells, Trnp1 may represent a crucial factor for neuronal 
survival in their early days. 
 
5.4 TRNP1 in human brain development 
5.4.1 TRNP1 expression in the developing human brain 
Down regulation of Trnp1 resulted in increased numbers of BPs and oRGs with a “fanned 
array” expansion of the cortex, which ultimately led to folding and pseudo-gyrification of 
the otherwise lissencephalic murine brain. These observations initiated the hypothesis that 
Discussion 
 
 85 
Trnp1 may be an important regulator of higher mammalian brain development. It has been 
suggested, that gyri and sulci in gyrencephalic brains form due to differences in progenitor 
expansions (Smart and McSherry, 1986a; 1986b; Kriegstein et al., 2006). In this scenario 
local differences of Trnp1 expression levels could regulate differential expansion in folded 
brains. To adress this question, our collaborator Victor Borell was investigating TRNP1 
expression in the human developing brain. In situ mRNA analysis demonstrated the 
expression of TRNP1 in the developing human brain. Remarkably, TRNP1 is expressed in 
a similar manner in the human brain as it is in the murine brain with high levels of TRNP1 
in the ventricular zone and in newborn neurons in the cortical plate, but rather low levels in 
the subventricular zone where the basal progenitors and outer radial glial cells are located 
in the human brain. However, in strong contrast to the murine brain local differences of 
TRNP1 expression within the VZ were clearly detectable in the human brain. Supporting 
the role of TRNP1 in cortical expansion, low levels of TRNP1 in the VZ were associated 
with a rather expanded cortical area, whereas high levels of TRNP1 in the VZ correlated 
with less neurons in the CP. This expression pattern is intriguing in regard to my 
observation in the murine brain in vivo where manipulation of the protein resulted in 
differences of radial glial cell fate with high levels of Trnp1 leading to self renewal of RGs 
and tangential expansion, whereas low levels of Trnp1 provoked amplification of neuronal 
output and radial expansion through production of basal progenitors and outer radial glial 
cells. The local differences of TRNP1 expression in the VZ of the human brain may 
therefore be causative for folding and differential expansion of different regions within the 
human brain resulting in its gyrencephaly. This is in agreement with previously suggested 
models in which a locally enlarged oSVZ correlated with increased expansion (Smart and 
McSherry, 1986a; 1986b; Kriegstein et al., 2006; Martínez-Cerdeño et al., 2012). 
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Figure 39: TRNP1 expression in the developing human brain 
In situ analysis of TRNP1 transcript expression in the human brain. Embryonic brain sections of gestation 
week 12 and 21 were hybridized with TRNP1 antisense probe. (A-A’’) In situ hybridization on embryonic 
sections of gestation week 12. (B-B’’) in situ hybridization on embryonic sections of gestation week 21. Note 
the differential expression of TRNP1 in the VZ of different areas with high levels of TRNP1 in the VZ 
correlating with low numbers of neurons in the CP of the same region and low-level expression of TRNP1 in 
the VZ correlating with increased numbers of neurons in the CP. 
5.4.2 Investigation of a possible association of TRNP1 with human diseases 
The presence of TRNP1 in the human brain emphasized the significance of the findings of 
this work and also led to the question whether TRNP1 may also be disease associated. 
Especially diseases with developmental neurogenesis defects such as lissencephaly or 
mental retardations could be possibly caused by genetic mutations of TRNP1. Online 
search using well established databases such as the genetic association database 
(http://geneticassociationdb.nih.gov/) the human gene mutation database 
(http://www.hgmd.cf.ac.uk) for human disease cases associated with deletions or mutations 
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of TRNP1 did not reveal a single case of TRNP1 affected individuals. However, personal 
internet search revealed one case of a genomic duplication including TRNP1. This 
particular case carries a duplication comprising 763 kilobases of chromosome 1p36.11 
including a duplication of TRNP1 (position: chr. 1 26716140 - 27480136; see Figure 40). 
Other than this genetic duplication no genetic abnormalities were found using 244k-
Oligonucleotide Array (Agilent) and the duplication does not represent a known 
Polymorphism. The above female patient is now six years old and was diagnosed with Rett 
syndrome. The typical “washing movements” initially gave a first hint towards the 
syndrome causative for her disability. In contrast to this patient that carries a duplication 
on chromosome 1, Rett syndrome is typically an X-chromosomal dominantly inherited 
disease. Male fetuses with the disorder rarely survive to term. The main genetic 
background of Rett syndrome is mutations in the gene MeCP2 that is encoded on the X-
chromosome. Loss of function mutations in MeCP2 can arise sporadically or within the 
germ line and are associated with 75% of Rett cases (Hoffbuhr et al., 2001; 2002). 
However, in less than 10% of Rett cases, mutations in the genes CDKL5 or FOXG1 
(involved in control of proliferation of apical progenitors in forebrain development 
(Manuel et al., 2011)) have also been found to cause the syndrome (Tao et al., 2004; 
Weaving et al., 2004; 2005; Chen et al., 2010). Today, Rett syndrome is still diagnosed by 
clinical observation, and in some very rare cases, no known mutated gene can be found.  
These clinical observations prompt the hypothesis that Trnp1 might be directly or 
indirectly associated with MeCP2 thereby causing a similar phenotype as MeCP2 
mutations. It is conceivable, that Trnp1 may represent a downstream target, a co-factor or a 
competitor of MeCP2 and further investigations need to be performed in order to elucidate 
this association. The duplicated chromosomal region of course also includes other genes 
and an effect of the combined action of more than only one gene that is duplicated is 
possible. Nevertheless, the importance of Trnp1 during cortical development together with 
the severe syndrome observed in a case of chromosomal duplication in humans indicates, 
that Trnp1 may also play a central role in development of the human brain.  
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Figure 40: Chromosomal duplication of a girl presented with Rett syndrome 
Graphical representation of human chromosome 1 - region 1p36.11. The region between 26 598 139 and 27 
598 138 is depicted. The region duplicated in the female patient with Rett syndrome is marked with a red 
square. Genes are labeled as indicated. The TRNP1 gene is underlined in red. 
Additionally two cases of chromosomal abnormalities in a region similar to the mentioned 
case (also comprising the TRNP1 gene locus) have recently been reported on the 
DECIPHER homepage (https://decipher.sanger.ac.uk). Both patients showed mental 
retardation. One female patient carries a deletion comprising 1.97 megabases (chr. 1 
27237958 - 29205507) with 38 genes affected (including TRNP1). The other diseased case, 
a male patient with unknown age has two chromosomal regions affected: a deletion on 
chromosome 6 comprising 1.11 megabases (chr.6 169786414 - 170892243) with 10 genes 
affected and a duplication on chromosome 1 comprising 580 kilobases (chr. 1 27190888 –
 27773330) with 17 genes (including TRNP1) affected. Remarkably, the overlap of all the 
three cases comprises a very small region of only 242 kilobases on chromosome 1 
including only 6 genes: NUDC, NR0B2, C1orf172, TRNP1, FAM46B and SLC9A1 
(27237958 – 27480136). Additionally, the latter patient also presented with lissencephaly 
(possibly due to increased TRNP1-levels as only timed loss of the protein was able to 
induce radial expansion and folding of the otherwise lissencephalic murine brain). 
However, in the latter case another gene known to play a central role in neurogenesis was 
affected: DLL1 (deletion on chr. 6). 
While some hypotheses emerge in regard to the cellular and possibly disease associated 
function of Trnp1, it is important to also understand how it may exert its fascinating roles 
at the molecular level.  
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5.5 The Molecular function of Trnp1 
5.5.1 Biochemical characteristics of Trnp1 
Trnp1 is a highly basic protein with many positively charged amino acids at physiological 
pH. Extensive posttranslational modifications have been suggested for Trnp1 (Volpe et al., 
2006) and may regulate its endogenous function. Trnp1 has been identified as a chromatin 
component in this work. Given the absolute lack of any known molecular motif within the 
protein sequence, Trnp1 may be part of a new, so far unrecognized class of nuclear 
proteins. Especially its highly basic biochemical character in combination with the high 
abundance of arginine residues within the protein sequence, a proline rich region at the N-
terminus and an alanine/glycine rich region seem to be very special features of Trnp1. In 
addition, as shown in 4.5.2, Trnp1 is highly unstructured at its N- and C-terminal ends, but 
carries a highly structured central part. This structural characteristics together with the 
abundance of many basic amino acids is somewhat similar to the reported structure of 
linker histones such as H1 (Li, 1975; Happel and Doenecke, 2009). A comparison of both 
protein sequences shows that they both concentrate their positive charges at the C-terminal 
half of the protein (see Figure 41). A possible similarity with linker histones was tested by 
use of a typical linker histone lysis protocol (following a suggestion of Prof. Dr. Axel 
Imhof). Cells were lysed with perchloric acid (HClO4) and linker histones and high 
mobility group proteins were specifically released from DNA. However, this method of 
lysis was not able to release Trnp1 from an insoluble fraction. Accordingly, when using 
another protocol for protein extraction typically used for strongly DNA associated proteins, 
Trnp1 was being concentrated but remarkably not in the soluble fraction but rather in the 
insoluble fraction. Indicating that Trnp1 is even more insoluble than for example proteins 
binding methylated DNA such as MeCP2 (Raymond Poot, unpublished data) or even core 
histones which are released into the soluble fraction using this protocol. Further molecular 
analysis will shed light on the way Trnp1 executes its function on the molecular level. The 
tight association of Trnp1 with DNA suggests that Trnp1 may act as chromatin-associated 
factor possibly involved in regulation similar to epigenetic factors or chromatin remodeling 
factors. The functional importance observed in vitro and in vivo suggests that Trnp1 may 
represent a master regulator of diverse cellular activities such as has also been reported for 
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chromatin remodeling or epigenetic factors (Kouzarides, 2007; Li et al., 2007; Ho and 
Crabtree, 2010) 
 
 
Figure 41: Comparison of Trnp1 to linker histone H1.1 
Protein sequence comparison of Trnp1 and linker histone H1.1. Positively charged amino acids are labeled in 
red and underlined. Note the high abundance of positively charged amino acids in both proteins with the 
difference, that Trnp1 carries manly arginines I and H1.1 carries mainly Lysines (K) possibly indicating 
differential regulation through posttranslational processing. Also note that the distribution of positively 
charged amino acids is strongly shifted towards the C-terminal half of both proteins. 
5.5.2 The regulatory function of Trnp1 on gene expression 
The tight association of Trnp1 with DNA (together with the dramatic phenotype observed 
upon loss of Trnp1 function) suggested that Trnp1 may be involved in regulation of gene 
expression during neural development. In order to identify differences of gene expression 
upon gain and loss of Trnp1 function, a transcriptome analysis was performed. To ensure 
identification of early, primary and not secondary responding genes upon gain- and loss of 
function, gene expression analysis of cells electroporated with either overexpression 
plasmid, Trnp1-shRNA plasmid or control GFP was performed one day post 
electroporation. Moreover, analysis of such an early time point after manipulation avoided 
artifacts due to changes in cellular composition (differences of progenitor composition 
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were observed after 3 days with more RG upon forced expression of Trnp1 and more BP 
upon knock down of Trnp1). The observation that more genes were up regulated upon gain 
of Trnp1 function, whereas more genes were down regulated upon loss of Trnp1 function 
led to the conclusion that Trnp1 activates expression of specific genes, which is in 
agreement with its co-localisation with euchromatin. Gene ontology analysis of the 
significantly regulated genes revealed a high proportion of genes involved in direct or 
indirect gene regulation (chromatin remodelling factors, transcription factors, nucleosome 
associated proteins and epigenetic factors). Forced expression revealed interesting 
candidates as Trnp1 targets such as Dlx1, Dlx2, Dlx5, Dlx6 and Gsx2. These genes are 
endogenously expressed in the developing ganglionic eminence but not in the developing 
cortex. In this context ventral forebrain progenitors have been reported to be characterized 
by higher proliferation rates as compared to dorsal progenitors. It is of interest to mention 
that Dlx5 was shown to increase proliferation in tumor cells through activation of Myc (Xu 
and Testa, 2009). Increased self-renewal and proliferation observed upon forced Trnp1 
expression might be explained with an alteration of progenitor characteristics towards 
ventralized gene expression.  
In contrast, knock down of Trnp1 mainly showed down-regulation of genes. Amongst 
them important regulators of chromatin state such as Bmi1, Smarca5, Chd7 or Nuak1 but 
also genes important for neuronal differentiation such as Neurod1, Neurod2, Neurod6 and 
Rnd2. Differences in differentiation-associated genes can be explained by the inhibition of 
direct neurogenesis from radial glial cells upon knock down of Trnp1 with RGs generating 
more BPs and oRGs cells instead of directly generating postmitotic neurons. In summary, 
gene expression analysis showed that Trnp1 has a severe impact on gene expression 
already 24 hours after initiating alterations in its own expression level. These data 
suggested that Trnp1 is involved in regulation of gene expression either directly or 
indirectly (possibly by changing the chromatin state). 
 
5.5.3 Similarities of Trnp1 with other known proteins 
Proteins with sequence characteristics similar to Trnp1 and tight association with DNA 
comprise well-known factors such as UTF1 (Undifferentiated embryonic cell Transcription 
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Factor 1) or MeCP2 (Methyl CpG binding protein 2). UTF1 is expressed in embryonic 
stem cells and has been reported to act as a transcriptional repressor (Okuda et al., 1998; 
Fukushima et al., 1999; van den Boom et al., 2007). Additionally, UTF1 has also been 
shown to act as a co-activator of transcription and to interact with the basal transcription 
factor TFIID (Fukushima et al., 1998; Okuda et al., 1998). UTF1 was also suggested to 
play a role in proliferation and in teratoma formation of ES cells (Nishimoto et al., 1999; 
2005). Similar to the observed characteristics of Trnp1, UTF1 was shown to be tightly 
associated with chromatin (van den Boom et al., 2007). This study also showed by FRAP 
analysis that UTF1 has a dynamic behavior similar to core histones. Remarkably, just like 
Trnp1 UTF1 has a high isoelectric point (10.46) with 34 out 339 amino acids being 
arginines (see Figure 42) and a coiled coil domain (in the case of UTF1 a typical leucine 
zipper motif) (Okuda et al., 1998; van den Boom et al., 2007). Recently, the functional 
importance of UTF1 was shown in direct reprogramming as it highly increased the 
efficiency to generate induced pluripotent cells (iPS) from fibroblasts up to 100-fold (Zhao 
et al., 2008). This suggested that UTF1 facilitates the formation of a chromatin structure, 
which is supporting pluripotency. In this context it has also been shown, that UTF1 directly 
interacts with core histones and leads to chromatin condensation of target regions thereby 
acting as a repressor of gene expression (Kooistra et al., 2009; 2010). However, although 
UTF1 is found globally associated with chromatin during Meta- Ana- and Telophase (van 
den Boom et al., 2007), it was shown that UTF1-bound regions were significantly enriched 
on chromosomes 11, 17 and Y (Kooistra et al., 2010). Additionally, UTF1 is able to alter 
the chromatin state and thereby also influence gene expression indirectly (Kooistra et al., 
2010).  
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Figure 42: Comparison of Trnp1 and UTF1 protein 
Protein sequence comparison of Trnp1 and UTF1. Positively charged amino acids are labeled in red and 
underlined. Note the high abundance of positively charged amino acids in both proteins with the common 
abundance of arginines (R). Also note that the distribution of positively charged amino acids is strongly 
shifted towards one half of both proteins. 
 
Another tightly DNA associated protein with a highly basic pI of 9.5 is MeCP2 which 
binds to methyl-CpG (methylated DNA) base pairs (Lewis et al., 1992; Meehan et al., 
1992). MeCP2 is a well-investigated protein and mutations in MeCP2 are known to cause 
Rett syndrome (Carter and Segal, 2001; Hoffbuhr et al., 2001; 2002; Luikenhuis et al., 
2004; Weaving et al., 2005; Villard, 2007; Marchetto et al., 2010; Lioy et al., 2011; Babbio 
et al., 2012; Goffin et al., 2012) a human neurodevelopmental disorder that can lead to 
cognitive impairment, autistic features, motor disabilities, seizures and anxiety (Chahrour 
and Zoghbi, 2007) as described above (see 5.4.2 - Investigation of a possible association of 
TRNP1 with human diseases). In vertebrates methylated DNA is associated with 
transcriptional repression and inactive chromatin (Meehan et al., 1992). In this context, 
MeCP2 has been shown to inhibit transcription from both methylated and non-methylated 
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DNA and to contribute to the long-term repression and nuclease resistance of methyl-CpG 
(Meehan et al., 1992). MeCP2 has been shown to be essential for embryonic development 
(Tate et al., 1996) and correlates with the function of DNA methyl-transferase (Li et al., 
1992). Additionally, it has been shown that MeCP2 is able to displace Histone H1 from 
preassembled chromatin containing methyl CpG (Nan et al., 1997). However, the exact 
molecular mode of action still remains partially elusive. MeCP2 is regulated through 
phosphorylation (Zhou et al., 2006; Murgatroyd et al., 2009; Deng et al., 2010) and 
recently it has been suggested, that the protein acts as a histone-like factor regulating 
genome-wide response of chromatin to neuronal activity (Cohen et al., 2011) rather than 
being a sequence specific transcriptional repressor of specific genes. 
The presented data in this work showed, that Trnp1 - just like MeCP2 and UTF1 – is 
tightly bound to DNA and regulates expression of specific genes. Therefore it is 
conceivable, that Trnp1 may act as a chromatin remodeler similar to UTF1 or MeCP2 
thereby exerting its functional effects during neural development. However, further 
experiments are necessary to test this possibility. 
 
5.5.4 A possible role of Trnp1 in regulation of chromatin state 
It has been previously shown, that stem cells have a chromatin structure, DNA methylation 
pattern and nuclear organization that is different from differentiated somatic cells (Mayer 
et al., 2005; Boyer et al., 2006a; Kobayakawa et al., 2007; Mikkelsen et al., 2007; Chen 
and Daley, 2008; Meissner et al., 2008; Gaspar-Maia et al., 2009; Lim et al., 2009; Sun et 
al., 2011; Yellajoshyula et al., 2011; Zhou et al., 2011; Armstrong, 2012). Additionally, 
alterations in chromatin structure are able to change cellular fate and to influence 
differentiation of stem cells into different cell types (Lin and Dent, 2006; Graf and 
Stadtfeld, 2008; Lim et al., 2009; Yellajoshyula et al., 2011; Hung et al., 2012). The 
control of such chromatin alterations is important to regulate amplification of stem cells 
versus their differentiation. Furthermore, heterogeneity plays a central role and is a 
hallmark in both embryonic and adult stem cells (Graf and Stadtfeld, 2008). In this context, 
for neural stem cells it has been previously suggested that there are subtypes of radial glia: 
some that mainly regenerate themselves and produce neurons directly and others that 
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generate basal progenitors (which in turn are prone to generate neurons) to amplify the 
neuronal output (Miyata et al., 2001; Noctor et al., 2001; 2004; Pinto and Götz, 2007; 
Stancik et al., 2010). 
Epigenetic processes have previously been suggested to be involved in control of stem cell 
proliferation versus differentiation (Bibikova et al., 2008; Eilertsen et al., 2008; Sasaki and 
Matsui, 2008; Sauvageau and Sauvageau, 2010; Ben-David and Benvenisty, 2011; Cedar 
and Bergman, 2011; Su et al., 2011). In this context, several reports showed that 
differentiation-genes in ES cells are silenced by Polycomb Group (PcG) complexes 
(Azuara et al., 2006; Bernstein et al., 2006; Bracken et al., 2006; Lee et al., 2006; Loh et 
al., 2006; Boyer et al., 2006b). As another example, the NuRD (nucleosome remodeling 
and disruption) complex is necessary for lineage commitment of ES cells showing that 
nucleosome remodeling is crucial in this process (Kaji et al., 2006).  
Analysis of genome-wide association was able to show that transcription factors occupy 
less than a few percent of their consensus target sites (Carr and Biggin, 1999; Iyer et al., 
2001; Yang et al., 2006; Joseph et al., 2010; Kaplan et al., 2011). Recently, it has been 
suggested that there are three different levels of transcription factor dependent gene 
regulation: DNA-binding site recognition, chromatin accessibility (controlled by epigenetic 
modifications) and co-factor availability in different cell-types (Fong et al., 2012). 
Therefore, accessibility of distinct target sites is of key importance for regulation of gene 
expression. So-called pioneer transcription factors are the first ones in a cascade of events 
establishing competence for gene expression ultimately leading to determination of cell 
fate (Zaret and Carroll, 2011). These pioneer transcription factors initiate the sequential 
binding of a series of factors by independently accessing the first target sites and reducing 
the number of co-factors needed (Carroll et al., 2006; Eeckhoute et al., 2006; Zaret and 
Carroll, 2011). In addition these factors can actively open up local chromatin and thus 
make it competent for further transcription factor binding (Xu et al., 2009; Zaret and 
Carroll, 2011).  
Trnp1 may act similar to UTF1 as a chromatin associated protein involved in gene 
expression but also in alteration of chromatin structure at the same time (Okuda et al., 
1998; van den Boom et al., 2007; Kooistra et al., 2009). Upon down regulation of Trnp1 
most regulated genes were down regulated whereas upon forced Trnp1 expression most 
Discussion 
 
 96 
affected genes were up regulated. This suggested an activating rather than a repressing role 
of Trnp1 on gene expression. It is therefore conceivable that Trnp1 represents a pioneer 
factor initiating transcription directly but also concomitantly leading to changes in 
chromatin state (see also the genes affected upon down regulation of Trnp1 7.2.1) thereby 
influencing gene expression indirectly through other factors as well.  
To further investigate the tight association of Trnp1 with chromatin, fluorescence recovery 
after photo bleaching was performed. However, fusion of GFP to the C-terminal end of 
Trnp1 inhibited its association with chromatin. FRAP experiments therefore where not able 
to show the strong interaction of Trnp1 with DNA. Trnp1-GFP exhibited much faster 
recovery rates than reported for core histones that are tightly associated with DNA and 
show slow recovery rates in FRAP experiments (Kanda et al., 1998; Kimura and Cook, 
2001). However, Trnp1-GFP still showed much slower recovery rates as compared to GFP 
only. It has previously been suggested for Oct4-GFP (which recovered still faster as 
compared to Trnp1-GFP) that it is residing in a high molecular weight complex and 
therefore kinetics would be slower than expected for the size of the protein itself (van den 
Boom et al., 2007). The same may apply to Trnp1-GFP (although the protein does not 
interact anymore with DNA) as interactions with other protein complexes cannot be 
excluded (especially as Trnp1 has been reported to be endogenously expressed at low 
levels in the cell line used in this experiment (Volpe et al., 2006)). Additionally, as Trnp1 
shows a highly predictable coiled coil domain, it may also interact with itself to form 
oligomers and therefore exhibit slower kinetics than GFP alone.  
Towards an identification of Trnp1 interacting proteins, mass spectrometry analysis was 
performed. However, use of Trnp1-GFP for pull down in HEK cells showed no 
reproducible binding partner of Trnp1. This fusion construct later turned out to preclude 
chromatin association of Trnp1 during mitosis and it may therefore also inhibit interaction 
with binding partners. However, as HEK cells do not endogenously express Trnp1, it is 
also possible, that the natural binding partners of Trnp1 are not expressed in HEK cells. 
Thus use of a cell line that shows endogenous expression of Trnp1 may help to identify 
naturally Trnp1 associated proteins in the future.  
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The exact molecular mode of Trnp1 action remains partially unidentified and needs further 
investigation. Lacking any known DNA binding domain or protein motif, Trnp1 may 
represent the first member of a new class of molecules.  
In summary, this work showed a key functional role of Trnp1 during mammalian forebrain 
development, which was further emphasized by its intriguing expression pattern in the 
developing human brain. Trnp1 regulates tangential versus radial expansion of the cerebral 
cortex and is able to control folding of the developing brain. Thus this work identified an 
entirely novel, previously unrecognized DNA associated protein as a molecular switch in 
neural stem cells.  
 
Material and Methods 
 
 98 
6 Material and Methods 
6.1 Materials 
6.1.1 Buffers and Solutions 
6.1.1.1 10x PBS 
Material: 1.4 M NaCl 
27 mM KCl 
83 mM Na2HPO4 
15 mM KH2PO4 
pH 6.8 
For 5 l of 10x PBS 400g NaCl, 10g KCl, 73,66g Na2HPO4 x 2H2O and 10g KH2PO4 were 
dissolved in ddH2O and the pH value was adjusted to 6.8. The buffer was autoclaved. After 
dilution of 1:10 this resulted in 1x PBS with a pH-value of 7.4 
6.1.1.2 4 % PFA (from initially a 20% PFA Stock) 
Material for 20% stock (2 l): 400 g PFA 
    134 g Na2HPO4 
1600 ml ddH2O 
add 32% NaOH until PFA was completely dissolved 
The mixture was stirred on a heater at 60 °C under the hood until the solution cleared 
(approximately 30 min). After the solution cooled down on ice the pH-value was adjusted 
with HCl to 7.4. Then the solution was filled up to 2 l with ddH2O. Finally the solution was 
filtered (0.22 µm) and alliquotted in 50 ml falcon tubes. This 20 % stock solution was then 
stored at -20 °C and diluted 1:5 for fixation of tissue or cells with 4 % PFA. 
6.1.1.3 50x TAE-buffer 
Material: 2 M Tris acetate 
   50 mM EDTA 
   Adjust pH 8.0 with HCl 
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For 1l of 50x TAE-buffer 242 g Tris Base, 57.1 ml acetic acid and 37,2 g Na2EDTA x 
2H2O were dissolved in ddH2O, pH 8.0 was adjusted with HCl. 
6.1.1.4 10x SDS running-buffer 
Material: 0.25 M TRIS-base 
1.92 M Glycine  
1 % SDS  
For 1l 10 x Elektrophoresis buffer 30.3 g TRISbase, 144 g Glycine and 10 g SDS were 
dissolved in ddH2O pH was adjusted to 8.45 and finally the volume was adjusted to 1l with 
ddH2O. 
6.1.1.5 Separation Gel buffer for SDS Gels 
1.5 M TRIS 
pH 8.8 
For 500 ml of separation gel buffer 90.86 g of TRIZMA base was dissolved in 300 ml 
ddH2O. pH was adjusted to 8.8 with HCl. Subsequently volume was adjusted to 500 ml 
with ddH2O. 
6.1.1.6 Stacking Gel buffer for SDS Gels 
0.5 M TRIS 
pH 6.8 
For 500 ml of stacking gel buffer 30.29 g of TRIZMA base was dissolved in 300 ml 
ddH2O. pH was adjusted to 6.8 with HCl. Subsequently volume was adjusted to 500 ml 
with ddH2O. 
6.1.1.7 Transfer-buffer (wet blot) 
Material:  0.025 M Tris-base 
0.192 M Glycine 
0.1 % SDS 
20 % v/v Methanol 
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For 1l of transfer-buffer 100 ml of 10x SDS running buffer were mixed with 200 ml 
Methanol and 700 ml ddH2O.  
6.1.1.8 Lysis Buffers for Cell/Tissue Lysis 
RIPA Buffer 
  50 mM Tris-HCl pH 8.0 
  150 mM NaCl 
  1 % DOC (Sodium Deoxycholate) 
  1 % NP-40 
  0.1 % / 1 % SDS (for cells / for tissue) 
 
HRSB-0.5% NP40 buffer: 
20 mM Hepes pH 7.6, 
3 mM MgCl2, 
10 mM NaCl, 
0.5 % NP40 
 
HRSB +1.2M Sucrose:  
HSRSB + 41 gr/100 ml Sucrose 
 
Extraction-EDTA buffer:  
10 mM Hepes pH 7.6,  
150 mM NaCl,  
1 mM  EDTA,  
10 % glycerol,  
add 1 mM DTT  
To each buffer protease inhibitors were added before use (Complete Protease Inhibitor 
cocktail Roche®)  
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6.1.2 Cell lines 
Bacterial strains:  E.coli TOP10 (Invitrogen) 
    E.coli Dh5alpha (Invitrogen)  
    E.coli DB3.1 (ccdB resistant, Invitrogen) 
Eucaryotic cell lines: HEK 293 cells (kind gift of Dr. Alex Lepier) 
 NRK (kind gift of Dr. Robert Blum) 
 P19 carcinoma cells (kind gift of Dr. Francois Guillemot)  
 C2C12 (Dr. Heinrich Leonhard)  
 HeLa (Dr. Heinrich Leonhard)  
6.1.3 Antibodies 
6.1.3.1 Primary antibodies 
 
Antigen Host WB  IC IH Supplier 
RC2 Mouse (IgM) - - 1:200 
Kind gift of P. 
Leprince 
Pax6 rabbit - - 1:500 Millipore 
Pax6 Mouse (IgG1) - - 1:50 
Dev. Hybridoma 
Bank 
Tbr2 rabbit - - 1:500 Abcam 
Tbr1 Rabbit  1:400 1:200 Abcam 
dsRed/RFP Rat - 1:500 1:500 Chromotek 
GFAP Rabbit - 1:2.000 1:500 Dako Cytomation 
III-Tubulin Mouse (IgG2b) - 1:500 - Sigma Aldrich 
Tubulin Mouse (IgG1) 1:5.000 - - Sigma 
Tubulin Mouse (IgG1) 1:5.000 - - Sigma 
Mash1 Mouse (IgG1) - - 1:200 
Dev. Hybridoma 
Bank 
GFP Chicken - 1:1.000 1:500 Aves Labs 
Trnp1 Guinea Pig 1:2.000 1:500 1:100 Self made 
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Nestin Mouse (IgG1) - 1:20 1:10 
Dev Hybridoma 
Bank 
BrdU Rat (IgG2a) - - 1:500 Abcam 
Dcx Rabbit  - 1:2.000 1:1.000 Abcam 
PDGFR Rat - 1:200 1:200 BD Bioscience 
 
WB: dilution used for Western blotting, IC: dilution used for Immunocytochemistry (cells 
in vitro), IH: dilution used for Immunohistochemistry (cells in tissue sections). 
Nuclei were visualized with 4’,6-Diamidino-2-Phenylindole, Dihydrochloride (DAPI) 
(0,02mg/ml inddH2O) 
6.1.3.2 Secondary antibodies 
Immunocytochemistry and Immunohistochemistry was performed with the appropriate 
species- or subclass-specific secondary antibodies conjugated to either AlexaFluor 488 
(1:500 Invitrogen), Cy™2, Cy™3, Cy™5 (1:500, Jackson ImmunoResearch), FITC 
(fluorescence isothiocyanate; 1:500, Jackson ImmunoResearch ) or TRITC (tetramethyl 
rhodamine isothiocyanate; 1:500, Jackson ImmunoResearch). For Enhanced Chemical 
Luminescence (ECL) detection after Western blotting, appropriate Horseradish-Peroxidase 
(HRP) coupled anti-guinea pig (Abcam – ab6771-1), anti-mouse (Dako), anti-rabbit (GE 
Healthcare – Na934VS) or anti-rat (DAKO) antibodies were used in a 1:5.000-10.000 
dilution. 
6.1.4 Oligonucleotides 
Primer name Sequence (5´→3´) Description 
shRNA#1  
Top Strand 
5’-GATCCCCACTCTGCATTGCTTCCCATACACTGT 
TCAAGAGACAGTGTATGGGAAGCAATGCAGAGTT 
TTTTA -3’ shRNA target 
sequence 
(sense/antisense)  
Loop sequence 
Overhangs 
forming  
BglIII / HindIII 
restriction sites 
shRNA#1 
Bottom Strand 
5’-AGCTTAAAAAACTCTGCATTGCTTCCCATACAC 
TGTCTCTTGAACAGTGTATGGGAAGCAATGCAGA
GTGGG-3’ 
shRNA#4  
Top Strand 
5’-GATCCCCGCAGAAAGGCAAGCCACTTCTTTC 
AAGAGAAGAAGTGGCTTGCCTTTCTGCTTTTTA -3’ 
shRNA#4 
Bottom Strand 
5’-AGCTTAAAAAGCAGAAAGGCAAGCCACTTCT 
TCTCTTGAAAGAAGTGGCTTGCCTTTCTGCGGG-3’ 
shRNA#5  
Top Strand 
5’-GATCCCCGATGGACGGCGTCATCTACTTC 
AAGAGAGTAGATGACGCCGTCCATCTTTTTA -3’ 
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shRNA#5 
Bottom Strand 
5’-AGCTTAAAAAGATGGACGGCGTCATCTACTCT 
CTTGAAGTAGATGACGCCGTCCATCGGG-3’ 
Overhangs used for cloning into pSUPER are according to the manufacturer’s protocol. 
6.1.5 Plasmids 
Plasmid Source 
pCMV-Sport6-Trnp1 RZPD 
pCMV-Sport6-Trnp1-poly-A Personally cloned 
pENTR1A Invitrogen/Life Technologies 
pENTR1A-Trnp1 Personally cloned 
pENTR4-Trnp1 Personally cloned (not used in this study) 
pCAG-GFP-DEST/ pCAG-dsRed-DEST 
(with Gateway cassette) 
Kind gift of Dr. Paolo Malatesta 
pCAG-Trnp1-GFP Personally cloned 
pCAG-Trnp1-dsRed Personally cloned 
pSUPER Oligoengine 
pSUPER-shRNA#1 Personally cloned 
pSUPER-shRNA#4 Personally cloned 
pSUPER-shRNA#5 Personally cloned 
pSUPER.GFP/Neo Oligoengine 
pSUPER.GFP/Neo-shRNA#1 Personally cloned 
pSUPER.GFP/Neo-shRNA#4 Personally cloned 
pSUPER.GFP/Neo-shRNA#5 Personally cloned 
pLVTHM King gift of Dr. Alex Lepier 
pLVTHM –shRNA#1 Personally cloned 
pLVTHM –shRNA#4 Personally cloned 
pLVTHM –shRNA#5 Personally cloned 
peGFP-Trnp1-N3 Kind gift of Dr. Robert Blum 
pCAG-GS King gift of Dr. Alex Lepier 
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pMXIG-IRES-GFP (Nosaka et al., 1999) 
pRenilla-TK Promega 
pGL3-P6CON Kind gift of Dr. Anastasia Stoykova 
pGL3-Tbr2 Kind gift of Dr. Jovica Ninkovic 
Personally cloned plasmids: I cloned these plasmids during this study using standard 
molecular biology methods. Detailed Information about cloning procedure is described 
under 6.2.2. Plasmid maps (electronic – VectorNTI / .gb files) with relevant sequence 
information are available electronically in the lab and are also stored by Dr. Alex Lepier. 
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6.2 Methods 
6.2.1 DNA Methods 
6.2.1.1 Ethanol precipitation of DNA 
Solutions: 3 M Sodium acetate pH 5.2 
100 % Ethanol 
70 % Ethanol 
TE-buffer (pH 8.0):  10 mM Tris/Hcl pH 8.0 
1 mM EDTA pH 8.0 
1/10 Vol. of 3 M Sodium acetate, pH 5.2 and 2.5 Vol. 100 % Ethanol (-20 °C) was added 
to the DNA sample, mixed well, and incubated for 30 min at -20 °C. The precipitated DNA 
was centrifuged for 20 min at 4 °C/13.000 rpm, washed with ice cold 70 % Ethanol, and 
centrifuged for 5 min at 4 °C/13.000 rpm. The supernatant was removed, and the 
precipitated DNA was air-dried and diluted in TE-buffer or H2O.  
Regular Plasmid Maxi preparations of DNA were precipitated according to this protocol 
after isopropanol precipitation. 
6.2.1.2 PCR 
DNA was amplified by PCR using Taq, Pfu, or High Fidelity Taq/Pwo (Roche), as 
appropriate. Specific sense and antisense oligonucleotide primers flanking the desired 
target sequence were used. 
A typical PCR reaction was prepared as follows: 
10-100 ng DNA template 
1 µl Polymerase (1 U) 
5 µl 10x reaction buffer 
1 µl 
10 mM dNTP (Desoxy-Nucleotide-Triphosphate)-Mix: (dATP, dTTP, 
dGTP, dCTP) 
2 µl sense-Primer, 10 pM 
2 µl anti-sense-Primer, 10 pM 
ad 50 µl H2O 
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PCR parameters were adjusted to the appropriate conditions. Generally, 25-35 cycles were 
used for amplification. 
6.2.1.3 Colony PCR 
Colony PCR allows screening of a large number of transformed E. coli colonies for 
positive clones before isolation from small-scale cultures of these cells.  
Colonies were picked with a sterile toothpick and dipped three times in 25 μl dd H2O. 
To break the cell walls and release plasmid DNA, the mixture was boiled at 95 °C for 
5 min prior to the PCR. Taq-Polymerase, dNTPs, MgCl2, and buffer were added, together 
with specific primers for the transformed plasmid. The PCR products were analyzed on an 
agarose gel.  
In parallel, small scale liquid cultures were inoculated with the colonies for isolation of 
plasmid DNA, and incubated on a shaker at 37 °C in LB-medium containing the 
appropriate antibiotic for selection.  
6.2.1.4 Restriction digestion of DNA 
A typical reaction was prepared as follows: 
1 µg DNA plasmid 
2 µl 10x reaction buffer (NEB) 
0.5 – 1.0 µl Restriction enzyme (5-10 U) (NEB) 
ad 20 µl H2O 
 
The reaction was incubated at the appropriate temperature (generally 37 °C) for 1-2 h. 
Alternatively, for highly efficient enzymes and for cloning analysis incubation time was 
shortened. Cleavage efficiency was investigated by gel electrophoresis. 
6.2.1.5 Analysis of DNA-fragments on agarose gels (Meyers et al., 1976)  
Solutions : 1x TAE buffer :  40 mM Tris-acetate 
1 mM EDTA pH 8.0 
Ethidiumbromide stock:  10 mg/ml (use 1:10.000)   
6x DNA sample buffer:  0.25 % (w/v) Bromophenol-blue 
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60 % Glycerol (w/v) 
0.1 mM EDTA pH 8.0 
Depending on the size of the DNA fragments of interest, appropriate 0.8-2 % (w/v) 
Agarose gels were used for separation. The Agarose was dissolved in 1x TAE buffer by 
boiling in a microwave oven. Ethidiumbromide was added to a final concentration of 
1 µg/ml, and the solution was poured into a gel chamber. Samples supplemented with 
DNA sample buffer and (for comparison) a 1 kb DNA ladder were loaded, and 
electrophoresis was performed at 100-200 V. After separation, the gels were photographed 
and pictures were printed.  
For gel extraction DNA fragments were cut out under UV light (254 nm) and transferred 
into an Eppendorf tube. To purify DNA fragments from agarose, the QIAquick gel 
extraction kit (Qiagen) was used according to the manufacturer’s protocol. The DNA was 
eluted in 30 μl H2O pH 8.4. 
6.2.1.6 Ligation 
A typical ligation reaction was prepared as follows: 
300 ng DNA insert fragment 
30 ng DNA vector fragment 
2 µl 5x T4-DNA-Ligase buffer (Invitrogen) 
1 µl T4-DNA-Ligase (Invitrogen) 
ad 10 µl H2O 
 
Insert DNA was generally used in a 5-10 fold excess of vector DNA. The ligation reaction 
was incubated for 2-3 h at 25°C or overnight at 16°C. 
Alternatively, the Quick-Ligation-kit (NEB) was used according to the manufacturer’s 
protocol. The ligation reaction was then incubated for 15-30 min at room temperature. 
6.2.1.7 Preparation of bacterial agar plates (Sambrook et al., 1989) 
Solutions: LB-(Luria-Bertani) Medium:  0.5 % (w/v) NaCl 
         1 % (w/v) Bacto-Tryptone 
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        0.5 % (w/v) yeast extract 
        20 mM Tris/HCl pH 7.5 
The pH value was adjusted to 7.0 with NaOH. 
 
2x YT-Medium:   1 % (w/v) NaCl 
        1.6 % (w/v) Bacto-Tryptone 
                1 % (w/v) yeast extract 
        20 mM Tris/HCl pH 7.5  
The pH value was adjusted to 7.0 with NaOH. 
 
Ampicillin stock (100 mg/ml): use 1:1.000 
Kanamycin stock (50 mg/ml): use 1:1.000 
Material: Bacto-agar 
For agar plates, 7.5 g bacto-agar was added to 500 ml LB or 2x YT medium, and 
autoclaved. After cooling to 60 °C, the appropriate antibiotic was added to a final 
concentration of 100 μg/ml for Ampicillin or 50 μg/ml for Kanamycin, respectively. The 
liquid medium was poured into 10 cm culture dishes and allowed to cool to room 
temperature. The agar plates were stored upside down at 4 °C and covered from light.  
6.2.1.8 Generation of chemo-competent E.coli (modified CaCl2-method) 
Solutions:  
TfbI:  30 mM Kac  (1,47 g for 500 ml of TfbI) 
  100 mM RbCl  (6,05 g for 500 ml of TfbI) 
  10 mM CaCl2 x 2H2O (0.74 g for 500 ml of TfbI) 
  15 % Glycerine (75 ml for 500 ml of TfbI) 
  adjust pH to 6 with HCl 
  50 mM MnCl2 x 4H2O(4.95 g for 500 ml of TfbI) 
  adjust pH to 5.8. Solution was sterile filtered. 
TfbII:  10 mM MOPS  (0.21 g for 100 ml of TfbII) 
  75 mM CaCl2 x 2H2O(1.10 g for 100 ml of TfbII) 
  10 mM RbCl  (0.12 g for 100 ml of TfbII) 
Material and Methods 
 
 109 
  15 % Glycerine (15 ml for 100 ml of TfbII) 
  adjust pH to 6.5. Solution was sterile filtered 
 
A single colony (E. coli TOP10) was inoculated into 2 ml LB-medium and incubated for 
6 h at 37 °C under vigorous shaking. Afterwards 500 µl were inoculated into 500 ml LB-
medium and incubated at 37 °C for 90min to 2.5h under vigorous shaking (w/o 
antibiotics). Solutions TfbI and TfbII were pre-cooled on ice. Bacteria were grown at 37 °C 
until an OD600 ~0.3 was reached. Cells were then cooled down for 5 min on ice and 
pelleted at 3000 g for 1min at 4°C. The following steps were carried out at 4 °C with pre-
cooled materials and solutions. Cell pellet was resuspended in 20 ml TfbI and kept on ice 
for 5 min before another centrifugation step for 1 min at 3000 g (4°C). Cells were 
subsequently resuspended in 1 ml TfbII and incubated on ice for 15 min. Chemocompetent 
cells were then transferred as 100µl aliquots in eppendorf tubes (pre-cooled) and shock-
frozen in liquid nitrogen. Competent TOP10 cells were stored at -80 °C.  
Cells were checked for competence by transformation of 100 µl competent cells with 10, 1, 
0.1, 001 or 0.001 ng of pUC-18. Competence was >10
6
 (i.e. colonies per 1 µg of 
transformed vector). 
Alternatively commercially available competent E.coli TOP10 cells (Invitrogen) were used 
for transformation. 
6.2.1.9 Transformation of chemo-competent E.coli 
Material: LB-medium 
Chemo-competent E.coli 
Bacterial agar plates 
Chemo-competent cells were treated according to (Hanahan, 1983). Cells were thawed on 
ice, DNA (5-200 ng) was added to a 100 μl cell aliquot and incubated for 20 min on ice. 
Cells were heat-shocked for 60-120 s at 42 °C, and cooled on ice for 2 min. 900 μl LB 
medium were added and cells were incubated for 30-60 min at 37 °C on a roller shaker. 
Afterwards, different aliquots were plated on bacterial agar plates (50-500 μl) and 
incubated overnight at 37 °C. 
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6.2.1.10 Small scale DNA-preparation (MiniPrep) 
For small scale DNA preparation (1-5 μg DNA), a single colony was inoculated into 2-
3 ml LB medium supplemented with the appropriate antibiotic, and incubated overnight (or 
at least 8hours) at 37 °C under vigorous shaking. The Qiagen MiniPrep Kit was used. 
Small scale liquid cultures (1-2 ml) were transferred into an Eppendorf tube and 
centrifuged at 6.000 rpm for 5 min. Cells were resuspended in 250 μl P1-buffer and further 
processed according to the manufacturer’s protocol. Finally plasmid-identity was 
confirmed by restriction digestion and analysis on agarose gels. 
6.2.1.11 Large scale DNA-preparation (MaxiPrep) 
For large scale DNA preparation (200-500 μg DNA), a 200 µl aliquot of a 2 ml pre-culture 
was inoculated into 200 ml LB-medium supplemented with the appropriate antibiotic, and 
incubated overnight (max. 16 h) at 37 °C under vigorous shaking. The Qiagen MaxiPrep 
kit, or the PureLink HiPure Plasmid MaxiPrep kit (Invitrogen) were used. 
The liquid cell culture was centrifuged for 10 min at 6.000 rpm/4 °C. Cells were further 
processed according to the manufacturer’s protocol. The DNA precipitated with 
isopropanol was dissolved in 500 μl H2O and precipitated again with Ethanol as described 
(see “Ethanol Precipitation of DNA”). After centrifugation, the precipitated DNA was 
washed with 70 % Ethanol once and centrifuged for 5 min at 13.000 rpm. The DNA pellet 
was air-dried and dissolved in TE-buffer or H2O. 
6.2.1.12 Sequencing of DNA 
Cloned plasmids were sequenced by MWG Eurofins, Martinsried, München. 
 
6.2.2 Plasmids and Cloning of Constructs 
6.2.2.1 Cloning of pCAG-Trnp1-GFP/dsRed 
The coding region of Trnp1 was subcloned into Gateway® (Invitrogen/Life Technologies) 
forms of pCAG-GFP or pCAG-dsRed (pCAG Destination vectors were kindly provided by 
Dr. Paolo Malatesta). To do so Trnp1 coding sequence was first subcloned from pCMV-
Sport6-Trnp1 (RZPD) into pENTR1A and then cloned into the corresponding pCAG 
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vectors through Gateway LR-reactions. As in pCAG-GFP/dsRed the coding sequence of 
the gene of interest is connected through an internal ribosomal entry site to the coding 
sequence of GFP/dsRed ultimately generating one single mRNA holding both sequences 
and a poly-A signal at the end of the full mRNA, removal of the intrinsic poly-A signal of 
the gene of interest is necessary. Therefore, the poly-A signal and parts of the 3’-UTR 
were first removed from the initial pCMV-Sport6-Trnp1 expression clone by BamHI/XbaI 
digestion, reblunting and relegation. Subsequently, Trnp1 cDNA was subcloned into 
pENTR1A via EcoRI/XhoI and Trnp1 cDNA was then recombined into the pCAG 
destination vectors using Gateway® LR-reaction(Invitrogen/Life Technologies). 
6.2.2.2 Cloning of pSUPER-shRNA constructs 
For knock down of Trnp1 three different shRNAs were created (target sequences were 
designed with the help of BlockIT (Invitrogen) and Oligoengine software). The following 
shRNAs were cloned into pSUPER according to the manufacturer’s protocol 
(Oligoengine):  
shRNA#1: 5’-ACTCTGCATTGCTTCCCATACACTG-3’;  
shRNA#4: 5’-GCAGAAAGGCAAGCCACTTCT-3’ and  
shRNA#5: 5’-GATGGACGGCGTCATCTAC-3’.  
According to the manufacturer’s protocol (Oligoengine) pSUPER was digested with 
BglIII/HindIII and the plasmid fragment was cleaned up by agarose gel extraction. 
Annealed oligos were subsequently ligated into BglIII/HindIII digested pSUPER. 
Note: Each of the shRNAs targets different regions within the 3’-UTR of Trnp1. Note that 
these shRNAs are able to knock down endogenous, full length Trnp1 mRNA but that the 
target sequences are not contained in the retroviral pCAG-Trnp1-GFP/dsRed vectors (see 
above).  
6.2.2.3 Cloning of pLVTHM-shRNA constructs 
The three shRNAs were subcloned from the corresponding pSUPER construct into the 
lentiviral pLVTHM plasmid. For that purpose, ClaI/EcoRI excised fragments (including 
H1-Promoter plus the shRNA) from pSUPER were purified using agarose gel extraction 
and ligated with the ClaI/EcoRI digested backbone fragment of pLVTHM. 
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6.2.2.4 Cloning of pSUPER.GFP/Neo-shRNA constructs 
For in vivo analysis all shRNAs used in this study were subcloned into pSUPER.GFP/Neo. 
The advantage of using this construct is the simultaneous expression of GFP from the same 
construct. ShRNAs were subcloned from the corresponding pSUPER construct into the 
pSUPER.GFP/Neo plasmid through EcoRI/XhoI excision of the shRNA fragments 
(including H1-Promoter plus the shRNA) from pSUPER (fragments were purified using 
agarose gel extraction) and ligation with the EcoRI/XhoI digested backbone fragment of 
pSUPER.GFP/Neo.  
Note: As each of the shRNAs used in this study target different regions within the 3’-UTR 
of Trnp1 which is not contained in the pCAG-Trnp1-GFP/dsRed vector (see above), 
pCAG-Trnp1-dsRed was also usable to rescue the knock down effect of shRNAs. 
 
All constructs were verified by fully sequencing the insert before use in experiments. The 
constructs are all depicted in “9 – Plasmid maps”. For in vivo applications plasmids were 
produced under endotoxin free conditions(Qiagen EndoFree Plasmid Maxi Kit). 
Alternatively DNA purified from CsCl gradients was used. 
  
6.2.3 Biochemical Protein Methods 
6.2.3.1 Cell / Tissue Lysis 
Cells or tissues were generally pelleted by centrifugation and shock frozen in liquid 
nitrogen and stored at - 80 °C until tissue Lysis.  
 
RIPA buffer Lysis: 
Generally cells or tissues were lyzed using RIPA buffer (see 6.1.1.8) with the addition of 
complete protease inhibitor cocktail (Roche). Alternatively higher salt concentrations 
ranging from 300mM to 1M NaCl were used to release proteins bound to DNA. Other 
alterations also included the addition of EtBr (25 µg/µl end concentration) to release DNA 
bound proteins. An adequate amount of RIPA buffer was added to the cells / tissue (e.g. 
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100µl of RIPA to 2 E14 cortices or 150µl per 35mm dish of cultured cells) and 
homogenized by pipetting up and down with a 200 µl tip. The homogenates were sonicated 
in order to open nuclei and sheer DNA (5 sec at 10 % power). Samples were centrifuged at 
14.000rpm, 4°C for 30min to remove cellular debris and DNA. Supernatant was collected 
and protein concentration was measured using the BCA method. 
 
Acidic extraction of DNA associated molecules using HRSB buffers: 
Nuclei were first prepared by re-suspending the cellular pellet in 3 volumes of HRSB – 
0.5 % NP40 (see 6.1.1.8). The mixture was kept for 10 minutes on ice and then 
homogenized by pipetting up and down 10 times with a 200 µl pipette tip. Nuclei 
suspension was pipetted on top of a 1 ml HRSB-Sucrose (see 6.1.1.8) and centrifuged for 
5 min at 2400 g at 4 °C. Sedimented nuclei were reconstituted in 10 pellet volumes 
Extraction – EDTA buffer and kept on ice for 10 minutes followed by a centrifugation step 
at 3000 g at 4 °C. Supernatant was kept and labeled as washing fraction. For acidic 
extraction, the pellet was resuspended in 10 pellet volumes (or more) ice-cold 0.4 M HCl 
and kept on ice for 1 h. Samples were vortexed every 15 min during the 1 h incubation 
time. Samples were centrifuged for 10 min at 13 000 rpm and supernatant (acid 
supernatant containing most of DNA bound molecules) was collected. 8 volumes of 
acetone were added to the pellet, mixed and then stored at -20 
0
C overnight. The next day, 
acetone pellets were centrifuged at 4600 rpm for 10 min at 4 
0
C and pellets were washed 
with 0.5 ml acetone (-20
0
C), spun at 4600 rpm for 5 min. The pellet was dried and 
resuspended in 100 µl SDS loading buffer. Nuclei, washing fraction, acidic supernatant 
and acidic pellet were separated by SDS PAGE and western blotting was performed to 
detect the protein of interest.  
 
Samples were generally resuspended in Laemmli buffer and boiled for 5 min at 95 °C and 
cooled down on ice prior to SDS PAGE. In general 5-30 µg of total protein were loaded 
per lane on an SDS gel. 
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6.2.3.2 Perchloric Acid Extraction 
Perchloric acid extraction is used to extract highly basic proteins such as linker Histone H1 
or high mobility group proteins (HMGs) according to the protocol described by (Lindner et 
al., 1998; Talasz et al., 2002). HEK cells transfected with peGFP Trnp1-GFP-N3 (to 
express Trnp1-GFP fusion protein) were pelleted and the pellet was resuspended in 3 pellet 
volumes of 6.6 % (w/v) HClO4 (e.g. for a pellet of the size of 40 µl, 120 µl of 6.6 % HclO4 
were added) to reach an end concentration of roughly 5 % HClO4. Eppendorf tubes were 
then rotated for 1 – 1.5 h at 4 °C. The insoluble material was then pelleted at 21 000 rcf for 
5 min at 4 °C and the supernatant was subsequently dialyzed against 0.1 M acetic acid 
containing 1 mM DTT for 2 x 1 h at 4°C and 1 x overnight. at 4°C. The samples were 
filled up to a volume of 500 µl with 20 mM Tris, 1 mM DTT, pH 6.8 and then frozen at -
80 °C (for minimum 30 minutes) and material was lyophilized overnight. For 
lyophilization (a.k.a freeze drying) the lids of the eppendorf tubes were covered with holes 
in order to make lyophilization possible. The pellet was then reconstituted in 50 – 100 µl 
(depending on size of the pellet) of 20 mM Tris, 1 mM DTT, pH 6.8. Coomassie Gels or 
western blotting was then performed to test for Trnp1 extraction. 
6.2.3.3 SDS-Polyacrylamide gel electrophoresis (SDS-PAGE) (Tris-Glycine) 
Tris-Glycine gels were prepared according to (Laemmli, 1970). 
Solutions: 30 % (w/v) Acrylamide/Bis Solution (BioRad) 
20 % (w/v) SDS (Sodium dodecylsulfate) 
10 % (w/v) APS (Ammoniumperoxodisulfate) 
TEMED 
Buffers: separation gel buffer: 1.5 M Tris/HCl, pH 8.8 
Stacking gel buffer: 0.5 M Tris/HCl, pH 6.8 
1x running buffer: 25 mM Tris-base, 192 mM Glycine, 0.1 % SDS 
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Separating gel: 
Gel 
Percentage 
Acryl-
amide 
[ml] 
2 M Tris, 
pH 8.8 
[ml] 
20 % 
SDS 
[µl] 
ddH2O 
[ml] 
10 % APS 
[µl] 
TEMED 
[µl] 
Final 
volume 
[ml] 
8 % 4.05 3.75 75 7.05 75 15 15 
10 % 4.95 3.75 75 6.15 75 7.5 15 
12% 6 3.75 75 5.1 75 7.5 15 
14% 7.05 3.75 75 4.05 75 7.5 15 
 
Stacking gel: 
Acrylamide
[ml] 
1 M Tris, pH 6.8 
[ml] 
20 % SDS 
[µl] 
ddH2O 
[ml] 
10 % APS 
[µl] 
TEMED 
[µl] 
Final 
volume 
[ml] 
0.975 1.875 37.5 4.575 37.5 7.5 7.5 
 
SDS PAGE was performed using the vertical Mini-PROTEAN 3 cell System (BIO-RAD 
165-3301). Gels were polymerized with the corresponding gel casting system. After 
pouring the separation gel isopropanol was added on top as a thin layer in order to assure a 
defined boundary layer. As soon as the separating gel was polymerized (approximately 
45min-1 h) isopropanol was removed and the remaining space washed with ddH2O to 
remove remaining isopropanol residues. The stacking gel was poured and a comb pushed 
in the gel. After 30min protein samples could be loaded and electrophoresis was performed 
in 1x running buffer at 80V first (about 15 minutes to allow slow running through the 
stacking gel)  and then at 150-200V when probes reached the separation gel.  
6.2.3.4 Western blot (wet blot) 
Transfer-buffer:  192 mM Glycine,  
25 mM Tris-Base,  
20 % Methanol 
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Following SDS-PAGE, the gel was equilibrated in transfer-buffer for 5 min. Whatman-
sheets and a nitrocellulose or PVDF membrane were cut to the size of the gel and soaked in 
transfer-buffer. The gel and the membrane were sandwiched between soaked pieces of 
sponge pads, Whatman paper, and perforated plastic plates as follows: 
Anode (+) 
Sponge pad 
3 Whatman-sheets 
Nitrocellulose/PVDF 
SDS gel 
3 Whatman-sheets 
Sponge pad 
Cathode (-) 
The transfer was performed in a blotting tank (Biorad) for 1h at 100V. Alternatively Gels 
were run overnight at 4°C 30V constant.  
6.2.3.5 Western blot detection 
Buffers: PBST: 1xPBS, 0.05%Tween20 
10x TBST (Tris buffered saline Tween): 1M Tris/HCl 
1.5 M NaCl 
   TBST: 1xTBS, 0.05 % Tween 20  
Detection Kit: ECL-Kit (GE Healthcare) 
After western blot transfer of the proteins to the nitrocellulose/PVDF membrane, 
nonspecific binding was blocked by incubation of the membrane for 1 h in 5 % (w/v) 
skimmed milk in TBST or PBST. The primary antibody was diluted in 5 % (w/v) skimmed 
milk in TBST or PBST to an appropriate concentration and the blot was incubated for 2-
4 h at room temperature or alternatively overnight at 4 °C. Afterwards the membrane was 
briefly rinsed twice with TBST or PBST, and further incubated two times in TBST or 
PBST for 10 min. The appropriate secondary antibody (directed against the species of the 
primary antibody) conjugated to horseradish-peroxidase (HRP, dilution 1:10.000 in TBST 
or PBST) was incubated for 1 h at room temperature. The membrane was again rinsed 
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(twice with TBST or PBST) and washed two times in TBST or PBST for 10 min. The 
protein of interest was detected by enhanced chemical luminescence (ECL) utilizing the 
reaction of Luminol and H2O2, which is catalyzed by HRP. For this purpose, the membrane 
was incubated with the ECL reagent (GE Healthcare) and the chemiluminescence signal 
was visualized by exposure of Hyperfilm ECL (Amersham) films.  
6.2.3.6 Reprobing of western blot membranes (stripping) 
Stripping-buffer:  62.5 mM Tris/HCl pH 6.7 
100 mM -Mercaptoethanol  
2 % SDS  
For reprobing the membrane with different antibodies, the previously applied antibodies 
had to be removed first. For this purpose, stripping-buffer was preheated to 80 °C. The 
membrane was incubated in 100-200 ml preheated stripping-buffer on a horizontal shaker 
until room temperature was reached (30-45 min). The membrane was further washed 
several times in TBST (3-5 times). The blot was again blocked in TBST/5 % (w/v) 
skimmed milk for 1 h, and a new primary antibody could be applied as described. 
6.2.3.7 Coomassie staining 
Coomassie staining solution:  0.1 % (w/v) Coomassie Brilliant Blue R-250 
     45 % (v/v) Methanol 
     45 % (v/v) dd H2O 
     10 % (v/v) Acetic acid 
Destaining/fixation solution:  30 % (v/v) Methanol 
     60 % (v/v) dd H2O 
     10 % (v/v) Acetic acid 
After SDS-PAGE, the gel was incubated with Coomassie-staining solution on a horizontal 
shaker for 30 min. Afterwards, the gel was washed several times with destaining solution 
on a horizontal shaker, until the nonspecific Coomassie background had been removed. 
The gel was rehydrated in ddH2O for 1-3 h. Two sheets of Whatman-paper were soaked 
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with ddH2O and the gel was put on top of the Whatman-papers and covered with sealing 
film.  
Alternatively Colloidal Blue Staining Kit (Invitrogen/Life Technologies, Cat no. LC6025) 
was used according to the manufacturer’s protocol. 
 
6.2.3.8 Mass Spectrometry 
For Mass Spectrometry protein probes were separated using SDS PAGE. Proteins on gels 
were fixed for 2h by incubation in a solution of 10 % acetic acid, 50 % methanol. Gels 
were then stained using colloidal blue staining kit and protein bands were excised and 
submitted to mass spectrometry. To avoid contamination of the samples with human 
proteins, the whole procedure was carried out with pharmaceutical water and with full 
coverage of all body parts (such as wearing a coat, gloves, a mask, glasses). Band excision 
was carried out under a laminar flow. Mass spectrometry was carried out by the 
“Zentrallabor für Proteinanalytik” (ZfP) at the LMU München. 
 
6.2.4 Trnp1 Antibody generation 
Antibody recognition sites were selected as described in 4.1.1. Two different epitopes of 
Trnp1 were used to order antibodies generated by “Peptide Specialty Labs GmbH 
Heidelberg”. Epitope1 consisting of 19 amino acids: AETPVEGQELQRWRQGASG and 
Epitope2 consisting of 20 amino acids: PEPDSPFRRSPPRGPASPQR. Antibodies were 
raised in guinea pig. For each immunization serum of the animal was collected after 3 and 
after 4 immunizations (immunizations were carried out every other week). Specificity and 
affinity for Trnp1 protein were subsequently tested. 
 
6.2.5 Cell- and Tissue-Culture Methods 
6.2.5.1 Preparation of Coverslips coated with PDL 
Cover glasses were first washed in acetone and further boiled for 30 minutes in ethanol 
containing 0.7% HCl. Cover slips were washed twice in 100% ethanol thereafter and dried 
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at room temperature. Subsequently cover glasses were sterilized through autoclaving for 2h 
at 180°C. One sterilized cover slip was added to each well of a 24 well plate and moistened 
with PBS. PBS was replace by 1% poly-D-lysine (PDL) in PBS and glasses were 
incubated for at least 2h at 37°C. Afterwards cover slips were washed three to four times 
with autoclaved Millipore water. Plates were dried for 2h under a laminar flow and then 
stored at 4°C until use (usually within several days). 
6.2.5.2 Cultivation of HEK cells 
Culture medium:  DMEM (Dulbecco’s Modified Eagles Medium)  
10 % FCS 
1 % Penicillin/Streptomycin  
The cells were cultivated at 37 °C and 5 % CO2 in T-75 flasks. Cells were passaged with 
Trypsin-EDTA at 80% confluency. For passaging, cells were washed with sterile 1x PBS 
once, and trypsinized with 1.5 ml of Trypsin-EDTA for 3-5 min at 37 °C. The detached 
cells were re-suspended in 4.5 ml fresh growth medium until a single cell suspension was 
present. Aliquots (1/20-1/3) of the resuspended cells were plated on flasks containing 10-
15ml ml fresh medium and equally distributed by gentle shaking. 
6.2.5.3 Freezing of cells for long term storage 
Freezing medium: 10 % (v/v) DMSO in growth medium  
20 % FCS and w/o antibiotics 
Cells at 70-80 % confluency were used for freezing. HEK cells from a T-75 flask were 
trypsinized as described and transferred into 15 ml tubes with 10 ml of fresh medium. The 
cells were pelleted at 300g for 5 min and resuspended in 3-4.5 ml freezing medium. 1.5 ml 
aliquots were transferred into cryovials (Nunc). The vials were directly incubated in a 
cryobox (Nunc) containing Isopropanol at -80 °C overnight, and afterwards transferred into 
a liquid nitrogen tank. 
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6.2.5.4 Thawing cells 
Cells frozen in liquid nitrogen were quickly thawed at 37 °C in a water bath. Cells were 
then transferred into a T-75 flask with 15 ml of fresh medium and equally distributed by 
gentle shaking. The medium was replaced the next day to remove residual DMSO.  
6.2.5.5 Dissociated cell cultures of the embryonic cerebral cortex 
Timed pregnant mice (E12 or E14) were anesthetized with CO2 and sacrificed by cervical 
dislocation. Embryos were isolated by caesarian sections and immediately placed into ice 
cold Hanks balanced salt medium (HBSS) supplemented with 10 mM HEPES. Cortices 
were dissected from embryos (telencephalic hemispheres were separated and the 
ganglionic eminence, the hippocampal anlage, the olfactory bulbs and the meninges were 
removed) and pooled in ice cold HBSS containing 10 mM HEPES and spun down at 
1200 rpm for 5 minutes. After addition of Dulbecco’s modified Eagle medium (DMEM) 
containing 10% fetal calf serum (FCS) tissue was dissociated with a fire polished, filtered 
Pasteur pipette. Cells were again centrifuged at 1200 rpm for 5 minutes and resuspended in 
fresh medium (DMEM, 10% FCS). Cells were counted using a “Neubauer” microscope 
counting chamber and primary cortical cultures were plated on PDL coated coverslips at a 
density of 2,5 x 10
5
 cells/well (in 100 µl volume per coverslip). 2 h later 400 µl medium 
was added and- if needed – cells were infected with a low titer (<25 particles) of virus. 
Medium changes and fixation after 7 days in vitro were performed as described previously 
(Heins, 2001; Costa et al., 2007; Asami et al., 2011). A clear separation of clones – each 
derived from a single cell could be achieved as described previously (Williams et al., 1991; 
Haubst et al., 2004; Costa et al., 2007) by using a low number of viral particles (<25 clones 
per well).  
6.2.5.6 Transient transfection of cells with Lipofectamine 
Cells were plated on 6 well dishes at 30-40 % confluency the day before transfection in 
4 ml total volume. Prior transfection, growth medium was collected and replaced with 
OptiMEM. Cells were transfected with Lipofectamine2000 (Invitrogen) according to the 
manufacturer’s protocol. 0.5 µg of plasmid DNA was used per well in a 12 well dish. 
Alternatively, 1,5-2 µg of plasmid DNA was used per well of a 6 well dish.  
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2-4 hours later, OptiMEM was replaced by conditioned medium (collected prior to 
transfection). Reporter expression was generally visible 12-16 h later. 
6.2.5.7 Retroviral production 
For Virus production all viral construct were purified using a caesium chloride density 
gradient centrifugation. Using this method ensures separation of supercoiled DNA from 
linear and open circular DNA. Viral production was performed with technical support by 
Simone Bauer, Ines Mühlhahn, Dr. Alexandra Lepier or Detlef Franzen.. Replication 
incompetent MLV based, VSV-G pseudo typed retroviruses of the different pCAG 
constructs (see above) were produced in GPG-293 packaging cells (Ory et al., 1996) as 
described previously (Tashiro et al., 2006; Heinrich et al., 2011). Packaging cells were 
transfected with the viral plasmids (pCAG constructs) and incubated in packaging medium 
for production. Viral particles in supernatant were collected after 48 h (first harvest) and 
72 h (second harvest). Viral particles were filtered and estimation of the titer was 
performed as previously described (Hack et al., 2005) resulting in a typical titer of 5x10
7
/ 
ml. 
6.2.5.8 Time-lapse video microscopy 
Live imaging of dissociated cultures from the embryonic cerebral cortex at E14 was 
performed (Costa et al., 2008; Eilken et al., 2009) with a cell observer (Zeiss) at a constant 
temperature of 37
o
C and 8 % CO2. Phase contrast images were acquired every 5 minutes 
for 6-8 days using a 20x phase contrast objective (Zeiss) and an AxioCamHRm camera 
with a self-written VBA module remote controlling Zeiss AxioVision 4.7 software (Rieger 
and Schroeder, 2009). Single-cell tracking was performed using a self-written computer 
program (TTT) (Rieger and Schroeder, 2009). Movies were assembled using Image J 
1.42q (National Institute of Health, USA) software with 3 frames per second. 
6.2.5.9 Dual Luciferase reporter Assay 
Transcriptional activity of Trnp1 on selected promoters was tested by luciferase reporter 
assay. The assays were performed in multipotent P19 teratocarcinoma cells that can easily 
be differentiated into neurons (by exposure to retinoic acid) thereby representing a cell line 
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with neurogenic potential. Cells were cultured in DMEMGlutaMAX, 10%FCS, Pen/Strep 
media and 20 h prior to transfection P19 cells were plated at a density of 8 x 10
5
 cells per 
well (24 well plate) in media without antibiotics. Co-transfections of 1 µg expression 
plasmid, 1 µg of the promoter construct (driving firefly (Photinus pyralis) luciferase) and 
0.1 µg of Renilla-TK luciferase plasmid (Promega) (for control of transfection efficiency) 
was performed in medium w/o serum using Lipofectamine2000 (Invitrogen) according to 
the manufacturer’s protocol. 4 hours after transfection, medium was changed and 48 hours 
later cell extracts were prepared for luciferase activity measurement with a luminometer 
(Berthold Centro LB 960) according to the manufacturer’s instruction protocol (Promega). 
Relative light units were normalized to Renilla luciferase activity and then to control 
transduced cells.  
As promoter constructs, the pGL3-based promoter plasmids containing the Tbr2 promoter 
or the Pax6 consensus sites P6CON (PD-binding site) were used. As expression plasmids, 
the retroviral vector constructs, expressing Trnp1 and Pax6 under the CAG promoter were 
used.  
6.2.5.10 Fluorescence recovery after photo bleaching (FRAP) 
In order to determine the strength of DNA-Protein interaction fluorescence recovery after 
photo bleaching (FRAP) is a commonly used technique. In this context FRAP is used to 
measure the speed of diffusion of one protein which correlates with the mobility of the 
same. The protein of interest is fused to a fluorescing protein such as GFP. The fusion 
protein is expressed in vitro and the fluorescent signal is bleached using a short laser pulse. 
The time of recovery is then recorded and a correlation between the speed of signal 
recovery and immobility/mobility of the protein can be visualized. Proteins tightly bound 
to cell compartments are immobile and thus will be slow in diffusion and recovery of the 
signal in the area that was bleached. The signal will recover slowly as compared to such 
that are freely available or loosely attached and mobile (Schermelleh et al., 2005). All 
FRAP experiments in this study were carried out in the laboratory of Professor Dr. 
Heinrich Leonhardt with the help of Katrin Schneider. 
To express Trnp1 fused to GFP, C2C12 or HeLa cells and alternatively also murine 
primary cortical culture of embryonic day 14 were transfected with peGFP-Trnp1 with 
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Lipofectamine2000 as described (6.2.5.6). FRAP Experiments were then performed 48h 
later. Time lapse analysis was performed under 5% CO2 atmosphere at 37°C with a 
spinning disc microscope (PerkinElmer, Ultra View Vox). The upper or left part of the 
nuclei were bleached with 100% laserintensity of the 488nm laser. Recovery was recorded 
with 20% laser intensity. Nuclei were imaged for 5 seconds before and 60 seconds after 
bleaching. 
 
6.2.6 In vivo Methods 
6.2.6.1 Animals 
C57BL/6J wild-type mice were bred in the animal facility of the Helmholtz-Zentrum 
München and the day of the vaginal plug was considered embryonic day (E) 0. The day of 
birth is considered postnatal (P) day 0. Animals were kept in a 12h day-night cycle. All 
experimental procedures were performed in accordance with guidelines of the European 
Union and the government of upper Bavaria.  
6.2.6.2 Anesthesia 
For perfusion animals were anesthetized by intraperitoneal injection of Ketamine 
(Ketamine hydrochloride 100 µg per gram of bodyweight) and Rompun 
(Xylazinhydrochloride, 20 µg per g of bodyweight). For in in utero operations mice were 
anaesthetized by intra-peritoneal (i.p.) injection of a solution containing Fentanyl 
(0.05 mg/kg), Midazolam (5 mg/kg) and Medetomidine (0.5 mg/kg) (Btm license number: 
4518395). Anesthesia was terminated by subcutaneous injection of a solution containing 
Buprenorphine (0.1 mg/kg), Atipamezol (2.5 mg/kg), Flumazenil (0.5 mg/kg). 
6.2.6.3 In utero Electroporations 
Animals were operated as approved by the Government of Upper Bavaria under licence 
number 55.2-1-54-2531-144/07 and number 55.2-1-54-2532-79/11. E13.5 timed pregnant 
mice were anaesthetized as described above. In utero electroporations were done as 
described before (Saito, 2006). Briefly, the abdomen of the animal was depilated using 
common depilation cream. Uterine horns were exposed through caesarian section. Sterile, 
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pre-warmed saline (Ringer solution) was repeatedly applied during the operation to keep 
intestines moist. Animals were kept on a heating blanket during the whole process of 
operation. Plasmids (endotoxin free (!) DNA) were mixed with Fast Green (2.5 mg/μl, 
Sigma) and 1 µl (at a concentration of 1µg/µl) was injected into the lateral ventricle by use 
of a glass capillary (self made with a micropipette puller) under illumination of the uterine 
horns by a halogen cold light. DNA was electroporated into the telencephalon with four 
pulses of 38 mV and 100 ms. After electroporation, the uterine horns were carefully 
repositioned into the abdominal cavity, which was then filled with pre-warmed saline. The 
abdominal wall was then sewn closed by surgical sutures with medical sewing equipment. 
Anesthesia was terminated as described above and animals were monitored.  
One to three days later, animals were injected with BrdU intraperitoneally (if needed – 
depending on the experiment) and sacrificed one hour later. Animals were anesthetized 
with CO2 and sacrificed by cervical dislocation. Embryos were dissected and brains were 
either fixed as described below (6.2.6.5) or used for FACS sorting. 
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Figure  43 Schematic drawing of in utero electroporation 
Adopted from Shimogori and Grove (2001) 
 
6.2.6.4 BrdU administration 
In order to label proliferating cells in S-phase 5-bromo-2’-deoxyuridine (BrdU, dissolved 
in saline) was injected intraperitoneally (5 mg per 100 g bodyweight). As a thymidine 
analogue BrdU is incorporated into newly synthetized DNA during S-phase thereby 
labeling proliferating cells. BrdU was administered one hour prior to sacrifice – thereby 
labeling acutely proliferating cells in S-phase at this time. 
6.2.6.5 Fixation and Sectioning of Mouse Brains  
Embryonic brains were fixed for 1,5-6 h (E10/E12: 1,5 h; E14: 2 h; E16/E16,5: 4 h; E18: 
6 h) in 4 % Paraformaldehyde (PFA) (in PBS) with gentle rotation at 4 °C. Adult animals 
were perfused and brains were post fixed overnight in 4 %PFA (in PBS). Brains were then 
cryoprotected in 30 % sucrose (in PBS) overnight, embedded in tissue-tek and frozen on 
dry ice. Brains were stored at  -20 °C until they were cryosectioned (12-30µm). 
 
6.2.7 Immuno labeling 
Cell cultures were fixed in 4 % PFA for 15 minutes and washed with PBS. For immuno 
labeling, sections of fixed brains (see above) or fixed cell cultures on coverslips were 
E13.5 
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blocked with 2 %BSA, 0.5 % Triton-X100 (in PBS) for 1 h prior to staining. Primary 
antibodies were applied in blocking solution overnight at 4 °C (cryosections) or for 2 h at 
room temperature (for coverslips). Sections or coverslips were washed at least three times 
in PBS, 0,1 % Triton-X100. Fluorescent secondary antibodies were applied according to 
the manufacturer’s protocols (Jackson or Molecular Probes) for 2 h at RT. Following 
secondary antibody incubation the sections or coverslips were again washed at least three 
times with PBS, 0,1 % Triton-X100. To visualize nuclei, sections or cover glasses were 
incubated for 10 minutes in 0.1 μg/ml DAPI (4′,6-Diamidin-2-phenylindol, Sigma). 
Sections were mounted in Aqua Polymount (Polyscience). Stainings were analyzed using 
Zeiss (LSM710) or Leica (SP5) confocal laser-scanning microscopes or, alternatively Zeiss 
AxioImager.M2 for fluorescence images.  
Several Primary antibodies required one of the following specific pre-treatments to retrieve 
the antigen: 
HCL pre-treatment: sections were pretreated with 2 N HCl for 30 min and subsequently 
neutralized with sodium-tetraborate (0.1 M Na2B4O7, pH: 8,5) for 2 x 15 minutes prior to 
primary antibody incubation. This pre-treatment was especially necessary for Trnp1 and 
BrdU antibodies. 
Citrate-buffer pre-treatment: Coverslips were boiled for 30 sec and sections for 8 min in 
0.01 M sodium citrate (pH6) at 700 V in a microwave. This pre-treatment was necessary 
for Pax6 antibody (mIgG1 – Developmental Hybridoma Bank).  
After pre-treatment, sections were washed extensively with PBS prior to incubation with 
the primary antibody. If co-labelling with two different primary antibodies required no pre-
treatment for one antibody but pre-treatment for the other antibody, staining without pre-
treatment was performed first. Antibody-antigen complexes were then post-fixed with 4 % 
PFA (in PBS) for 30 min at RT followed by several washing steps before pre-treatment 
was applied for the second primary antibody.  
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6.2.8 Fluorescence Activated Cell Sorting 
To identify genes responding to overexpression or knock down of Trnp1, cortices from 
E14 embryos electroporated one day earlier (at E13 with either Trnp1 overexpressing 
plasmid, shRNA plasmid or control plasmid) were dissected removing the ganglionic 
eminence, olfactory bulb and the hippocampal anlage as well as the meninges. Cortical 
cells were enzymatically dissociated using 0.05 % Trypsin/EDTA for 15 min at 37 °C with 
subsequent resuspension of cells in DMEM containing 10 % fetal calf serum (FCS) to stop 
the enzymatic reaction and a fire polished Pasteur pipette (pre-incubated in DMEM/FCS to 
coat the glass) was used to mechanically dissociate the cells. The cells were finally 
resuspended in PBS and GFP positive cells were isolated using the FACSAriaIII (BD 
Bioscience) system at purity mode and a flow rate lower than 1200 cells per second for 
high purity. Forward- and sideward scatter were adjusted to exclude cell debris and include 
only GFP positive cells (endogenous GFP expression without staining using the 488nm 
laser) of interest. Gating for GFP fluorescent cells was set using WT cortical cells from 
non-electroporated embryos. To enhance efficiency of RNA extraction and RNA quality 
cells were directly sorted into RLT (QIAGEN®) buffer.  
6.2.9 Microarray Analysis 
RNA was isolated from FACS sorted GFP positive cells (from embryonic day 14 embryos 
– 4 different litters per condition, cells from different embryos were pooled per litter) (see 
6.2.8) using the Rneasy Micro kit (Qiagen) or Rneasy Mini kit (Qiagen) according to the 
manufacturer’s instructions including digestion of remaining genomic DNA. For 
microarray analysis RNA concentration and quality was measured using the Agilent 2100 
Bioanalyzer. The Agilent software assigns a specific quality number to the RNA sample 
based on its electrophoretic profile. This RNA Integrity Number (RIN) ranges from 1 
(reflecting totally degraded RNA) to 10 (reflecting completely intact RNA). For 
microarray analysis only high quality RNA (RIN > 7) is used. RIN values of the used 
samples ranged from 8.0 to 10.  
For each microarray 0.5 – 2 ng of RNA per experiment was first amplified using the 
„Ovation Pico WTA System V2“ kit in combination with the Encore Biotin Module 
(Nugen). Then, 2.1 µg of amplified cDNA was hybridized to Affymetrix Gene ST 1.0 
Material and Methods 
 
 128 
arrays (containing about 28.000 probe sets) according to the manufacturer’s instructions. 
Expression console software (Affymetrix) was used for quality control and to obtain 
annotated normalized RMA gene-level data (standard settings including sketch-quantile 
normalization). The statistical analysis of the microarray data was performed by utilizing 
the statistical programming environment R (Team, 2005) implemented in CARMAweb 
(Rainer et al., 2006). Genewise testing for differential expression was done employing the 
limma t-test and Benjamini-Hochberg multiple testing correction (FDR < 10%). Datasets 
were filtered for average expression > 50 in at least one group (overexpression, knock 
down or WT) and for linear ratios > 1.5 x (o.e. / WT or kd / WT). Heatmaps were 
generated with CARMAweb. GO term and pathway enrichment analyses were done with 
GePS software (Genomatix, Germany) or Ingenuity Pathway software and significant 
terms (p<0.05) were determined. 
 
6.2.10 Data Analysis 
Quantifications of cellular distributions after in utero electroporation were carried out on 
single optical sections (confocal microscopy). For each electroporated brain, sections of 
different rostral to caudal regions were used representing the full electroporated region. 
Each brain slice was analyzed in a 200 µm radial stripe for GFP+ cell distribution, BrdU, 
Pax6 and Tbr2 percentage or numbers. For oRG quantifications, Pax6+ cells outside of the 
Tbr2+ dense cellular band (typically more than 200 µm away from apical surface) were 
quantified. Quantifications are given as the mean +/- SEM. For the overexpression analysis 
(pCAG-GFP vs. pCAG-Trnp1-GFP) more than 4000 cells were quantified from 5 different 
embryos (from 3-4 different litters) for each control and overexpression. For the knock 
down analysis (pSUPER.GFP/Neo vs. pSUPER.GFP/Neo-shRNA) more than 3500 cells 
were quantified from 5 different embryos (from 2-4 different litters) for each control, 
knock down and rescue experiments. 
For the in-vitro clonal analysis, clone size and clone composition of each clone was 
determined and the mean was calculated per experiment (5 coverslips per experiment, with 
less than 25 clones each) from 4 independent experiments.  
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Statistical significance was tested using nonparametric Mann-Whitney U-Test (also called 
Wilcoxon rank-sum test or Mann–Whitney–Wilcoxon (MWW) test) in the case of in vivo 
studies (in utero electroporations) and Students t-test in the case of in vitro studies. P-
values less than 0.05 were considered significant. 
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7 Appendix 
7.1 Mass Spectrometry Data 
Mass spectrometry analysis showing top 100 proteins found with Trnp1-GFP pull down. Note that only proteins marked in yellow 
were reproducibly found in three independent replicates. All the other proteins were found in only one or two out of three replicates. 
Accessio
n 
MW 
[kDa
] 
Description 
GFP 
Averag
e 
GFP-
Trnp1 
Averag
e 
Trnp1/ 
GFP 
Log2 
(Trnp1/GFP
) 
Q6NT89 23,5 TMF-regulated nuclear protein 1 OS=Homo sapiens GN=TRNP1 1,000E0 3,263E8 3,263E8 28,28 
Q80ZI1 23,1 TMF-regulated nuclear protein 1 OS=Mus musculus GN=Trnp1 1,000E0 2,672E8 2,672E8 27,99 
gi225007648 114,6 ribonucleases P/MRP protein subunit POP1 [Homo sapiens] 1,000E0 7,441E7 7,441E7 26,15 
Q76LN2 67,9 NADH-ubiquinone oxidoreductase chain 5 OS=Rousettus amplexicaudatus GN=MT-ND5 1,000E0 3,221E7 3,221E7 24,94 
P34812 19,7 Allophycocyanin subunit B18 OS=Aglaothamnion neglectum GN=apcF 1,000E0 8,372E6 8,372E6 23,00 
P31689 44,8 DnaJ homolog subfamily A member 1 OS=Homo sapiens GN=DNAJA1 1,000E0 8,065E6 8,065E6 22,94 
P61026 22,5 Ras-related protein Rab-10 OS=Homo sapiens GN=RAB10 1,000E0 7,707E6 7,707E6 22,88 
Q9Y3F4 38,4 Serine-threonine kinase receptor-associated protein OS=Homo sapiens GN=STRAP 1,000E0 7,206E6 7,206E6 22,78 
P20674 16,8 Cytochrome c oxidase subunit 5A, mitochondrial OS=Homo sapiens GN=COX5A 1,000E0 7,165E6 7,165E6 22,77 
Q96HS1 32,0 Serine/threonine-protein phosphatase PGAM5, mitochondrial OS=Homo sapiens 1,000E0 6,653E6 6,653E6 22,67 
gi4506457 36,9 reticulocalbin-2 precursor [Homo sapiens] 1,000E0 6,027E6 6,027E6 22,52 
P32007 32,9 ADP/ATP translocase 3 OS=Bos taurus GN=SLC25A6 1,000E0 5,475E6 5,475E6 22,38 
gi30424655 23,4 ras-related protein Rab-6B [Mus musculus] 1,000E0 5,331E6 5,331E6 22,35 
Q9Y230 51,1 RuvB-like 2 OS=Homo sapiens GN=RUVBL2 1,000E0 4,904E6 4,904E6 22,23 
P48047 23,3 ATP synthase subunit O, mitochondrial OS=Homo sapiens GN=ATP5O 1,000E0 4,672E6 4,672E6 22,16 
P31948 62,6 Stress-induced-phosphoprotein 1 OS=Homo sapiens GN=STIP1 1,000E0 4,532E6 4,532E6 22,11 
O60884 45,7 DnaJ homolog subfamily A member 2 OS=Homo sapiens GN=DNAJA2 1,000E0 4,520E6 4,520E6 22,11 
gi18390323 23,9 ras-related protein Rab-14 [Mus musculus] 1,000E0 4,506E6 4,506E6 22,10 
gi83305924 39,6 Mitochondrial import inner membrane translocase subunit TIM50 1,000E0 3,808E6 3,808E6 21,86 
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O95721 29,0 Synaptosomal-associated protein 29 OS=Homo sapiens GN=SNAP29 1,000E0 3,569E6 3,569E6 21,77 
A6H767 45,3 Nucleosome assembly protein 1-like 1 OS=Bos taurus GN=NAP1L1 1,000E0 3,479E6 3,479E6 21,73 
Q86YZ3 282,2 Hornerin OS=Homo sapiens GN=HRNR 1,000E0 3,380E6 3,380E6 21,69 
Q96EY1 52,5 DnaJ homolog subfamily A member 3, mitochondrial OS=Homo sapiens GN=DNAJA3 1,000E0 3,291E6 3,291E6 21,65 
Q9BVK6 27,3 Transmembrane emp24 domain-containing protein 9 OS=Homo sapiens GN=TMED9 1,000E0 3,252E6 3,252E6 21,63 
Q53GQ0 34,3 Estradiol 17-beta-dehydrogenase 12 OS=Homo sapiens GN=HSD17B12 1,000E0 3,233E6 3,233E6 21,62 
P36542 33,0 ATP synthase subunit gamma, mitochondrial OS=Homo sapiens GN=ATP5C1 1,000E0 3,163E6 3,163E6 21,59 
Q9Y265 50,2 RuvB-like 1 OS=Homo sapiens GN=RUVBL1 1,000E0 3,067E6 3,067E6 21,55 
O75534 88,8 Cold shock domain-containing protein E1 OS=Homo sapiens GN=CSDE1 1,000E0 2,273E6 2,273E6 21,12 
O00161 23,3 Synaptosomal-associated protein 23 OS=Homo sapiens GN=SNAP23 1,000E0 2,253E6 2,253E6 21,10 
O75190 36,1 DnaJ homolog subfamily B member 6 OS=Homo sapiens GN=DNAJB6 1,000E0 2,233E6 2,233E6 21,09 
P62854 13,0 40S ribosomal protein S26 OS=Homo sapiens GN=RPS26 1,000E0 2,225E6 2,225E6 21,09 
gi6755448 24,7 vesicle-trafficking protein SEC22b [Mus musculus] 1,000E0 2,109E6 2,109E6 21,01 
P50402 29,0 Emerin OS=Homo sapiens GN=EMD 1,000E0 2,053E6 2,053E6 20,97 
O43169 16,3 Cytochrome b5 type B OS=Homo sapiens GN=CYB5B 1,000E0 1,831E6 1,831E6 20,80 
gi169164514 9,7 PREDICTED: barrier-to-autointegration factor-like [Homo sapiens] 1,000E0 1,814E6 1,814E6 20,79 
Q862I1 17,8 60S ribosomal protein L24 OS=Bos taurus GN=RPL24 1,000E0 1,812E6 1,812E6 20,79 
P27708 242,8 CAD protein OS=Homo sapiens GN=CAD 1,000E0 1,732E6 1,732E6 20,72 
P32322 33,3 Pyrroline-5-carboxylate reductase 1, mitochondrial OS=Homo sapiens GN=PYCR1 1,000E0 1,708E6 1,708E6 20,70 
Q3MJ13 123,3 WD repeat-containing protein 72 OS=Homo sapiens GN=WDR72 1,000E0 1,667E6 1,667E6 20,67 
O95816 23,8 BAG family molecular chaperone regulator 2 OS=Homo sapiens GN=BAG2 1,000E0 1,655E6 1,655E6 20,66 
gi4759300 11,3 vesicle-associated membrane protein 3 [Homo sapiens] 1,000E0 1,569E6 1,569E6 20,58 
Q9HCN8 23,6 Stromal cell-derived factor 2-like protein 1 OS=Homo sapiens GN=SDF2L1 1,000E0 1,563E6 1,563E6 20,58 
P61019 23,5 Ras-related protein Rab-2A OS=Homo sapiens GN=RAB2A 1,000E0 1,553E6 1,553E6 20,57 
P51149 23,5 Ras-related protein Rab-7a OS=Homo sapiens GN=RAB7A 1,000E0 1,513E6 1,513E6 20,53 
O95831 66,9 Apoptosis-inducing factor 1, mitochondrial OS=Homo sapiens GN=AIFM1 1,000E0 1,469E6 1,469E6 20,49 
gi288558822 34,1 Cyclin-dependent kinase 1; Short=CDK1 1,000E0 1,433E6 1,433E6 20,45 
Q9Y3D0 17,7 UPF0195 protein FAM96B OS=Homo sapiens GN=FAM96B 1,000E0 1,339E6 1,339E6 20,35 
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O14654 133,7 Insulin receptor substrate 4 OS=Homo sapiens GN=IRS4 1,000E0 1,316E6 1,316E6 20,33 
P62873 37,4 Guanine nucleotide-binding protein subunit beta-1 OS=Homo sapiens GN=GNB1 1,000E0 1,269E6 1,269E6 20,28 
O95292 27,2 
Vesicle-associated membrane protein-associated protein B/C OS=Homo sapiens 
GN=VAPB 
1,000E0 1,258E6 1,258E6 20,26 
O15173 23,8 
Membrane-associated progesterone receptor component 2 OS=Homo sapiens 
GN=PGRMC2 
1,000E0 1,232E6 1,232E6 20,23 
P51148 23,5 Ras-related protein Rab-5C OS=Homo sapiens GN=RAB5C 1,000E0 1,225E6 1,225E6 20,22 
gi5453559 18,5 ATP synthase subunit d, mitochondrial isoform a [Homo sapiens] 1,000E0 1,149E6 1,149E6 20,13 
P51970 20,1 NADH dehydrogenase 1 alpha subcomplex subunit 8 OS=Homo sapiens GN=NDUFA8 1,000E0 1,128E6 1,128E6 20,11 
Q56JX8 17,2 40S ribosomal protein S13 OS=Bos taurus GN=RPS13 1,000E0 1,060E6 1,060E6 20,02 
O14579 34,5 Coatomer subunit epsilon OS=Homo sapiens GN=COPE 1,000E0 1,042E6 1,042E6 19,99 
P53597 36,2 Succinyl-CoA ligase subunit alpha, mitochondrial OS=Homo sapiens GN=SUCLG1 1,000E0 9,798E5 9,798E5 19,90 
P09211 23,3 Glutathione S-transferase P OS=Homo sapiens GN=GSTP1 1,000E0 9,477E5 9,477E5 19,85 
gi32454741 46,4 serpin H1 precursor [Homo sapiens] 1,000E0 9,242E5 9,242E5 19,82 
Q0MQG6 30,1 NADH dehydrogenase iron-sulfur protein 3, mitochondrial OS=Pongo abelii GN=NDUFS3 1,000E0 9,128E5 9,128E5 19,80 
O24111 17,1 40S ribosomal protein S5 (Fragment) OS=Nicotiana plumbaginifolia GN=RPS5 1,000E0 8,865E5 8,865E5 19,76 
Q9BSD7 20,7 Nucleoside-triphosphatase C1orf57 OS=Homo sapiens GN=C1orf57 1,000E0 8,499E5 8,499E5 19,70 
P17844 69,1 Probable ATP-dependent RNA helicase DDX5 OS=Homo sapiens GN=DDX5 1,000E0 8,105E5 8,105E5 19,63 
P54920 33,2 Alpha-soluble NSF attachment protein OS=Homo sapiens GN=NAPA 1,000E0 8,037E5 8,037E5 19,62 
A6H769 22,1 40S ribosomal protein S7 OS=Bos taurus GN=RPS7 1,000E0 7,819E5 7,819E5 19,58 
P62701 29,6 40S ribosomal protein S4, X isoform OS=Homo sapiens GN=RPS4X 1,000E0 7,707E5 7,707E5 19,56 
P00387 34,2 NADH-cytochrome b5 reductase 3 OS=Homo sapiens GN=CYB5R3 1,000E0 7,612E5 7,612E5 19,54 
O14625 10,4 C-X-C motif chemokine 11 OS=Homo sapiens GN=CXCL11 1,000E0 7,267E5 7,267E5 19,47 
Q9NTJ3 147,1 Structural maintenance of chromosomes protein 4 OS=Homo sapiens GN=SMC4 1,000E0 7,175E5 7,175E5 19,45 
P49721 22,8 Proteasome subunit beta type-2 OS=Homo sapiens GN=PSMB2 1,000E0 6,902E5 6,902E5 19,40 
Q13257 23,5 Mitotic spindle assembly checkpoint protein MAD2A OS=Homo sapiens GN=MAD2L1 1,000E0 6,886E5 6,886E5 19,39 
Q15293 38,9 Reticulocalbin-1 OS=Homo sapiens GN=RCN1 1,000E0 6,775E5 6,775E5 19,37 
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Q53H96 28,6 Pyrroline-5-carboxylate reductase 3 OS=Homo sapiens GN=PYCRL 1,000E0 6,754E5 6,754E5 19,37 
Q8WUK0 22,8 Protein-tyrosine phosphatase mitochondrial 1 OS=Homo sapiens GN=PTPMT1 1,000E0 6,034E5 6,034E5 19,20 
P40616 20,4 ADP-ribosylation factor-like protein 1 OS=Homo sapiens GN=ARL1 1,000E0 5,972E5 5,972E5 19,19 
Q16099 107,2 Glutamate receptor, ionotropic kainate 4 OS=Homo sapiens GN=GRIK4 1,000E0 5,825E5 5,825E5 19,15 
Q16637 31,8 Survival motor neuron protein OS=Homo sapiens GN=SMN1 1,000E0 5,575E5 5,575E5 19,09 
P57088 28,0 Transmembrane protein 33 OS=Homo sapiens GN=TMEM33 1,000E0 5,542E5 5,542E5 19,08 
O00483 9,4 NADH dehydrogenase 1 alpha subcomplex subunit 4 OS=Homo sapiens GN=NDUFA4 1,000E0 5,529E5 5,529E5 19,08 
P29692 31,1 Elongation factor 1-delta OS=Homo sapiens GN=EEF1D 1,000E0 5,389E5 5,389E5 19,04 
P21670 29,5 Proteasome subunit alpha type-4 OS=Rattus norvegicus GN=Psma4 1,000E0 5,154E5 5,154E5 18,98 
P15880 31,3 40S ribosomal protein S2 OS=Homo sapiens GN=RPS2 1,000E0 5,127E5 5,127E5 18,97 
O14980 123,3 Exportin-1 OS=Homo sapiens GN=XPO1 1,000E0 5,063E5 5,063E5 18,95 
Q13409 71,4 Cytoplasmic dynein 1 intermediate chain 2 OS=Homo sapiens GN=DYNC1I2 1,000E0 4,948E5 4,948E5 18,92 
O43819 29,8 Protein SCO2 homolog, mitochondrial OS=Homo sapiens GN=SCO2 1,000E0 4,847E5 4,847E5 18,89 
gi51038269 31,1 complement inhibitory receptor [Homo sapiens] 1,000E0 4,825E5 4,825E5 18,88 
gi8655683 36,1 hypothetical protein [Homo sapiens] 1,000E0 4,812E5 4,812E5 18,88 
gi119590124 9,0 cornichon homolog 4 (Drosophila), isoform CRA_b [Homo sapiens] 1,000E0 4,770E5 4,770E5 18,86 
Q15363 22,7 Transmembrane emp24 domain-containing protein 2 OS=Homo sapiens GN=TMED2 1,000E0 4,758E5 4,758E5 18,86 
A6NIZ1 20,9 Ras-related protein Rap-1b-like protein OS=Homo sapiens 1,000E0 4,715E5 4,715E5 18,85 
Q96C36 33,6 Pyrroline-5-carboxylate reductase 2 OS=Homo sapiens GN=PYCR2 1,000E0 4,714E5 4,714E5 18,85 
Q9QZP1 30,4 Survival of motor neuron protein-interacting protein 1 OS=Rattus norvegicus GN=Sip1 1,000E0 4,687E5 4,687E5 18,84 
O43592 109,9 Exportin-T OS=Homo sapiens GN=XPOT 1,000E0 4,497E5 4,497E5 18,78 
Q12904 34,3 Aminoacyl tRNA synthetase complex-interacting multifunctional protein 1  GN=AIMP1 1,000E0 4,001E5 4,001E5 18,61 
Q8N5K1 15,3 CDGSH iron sulfur domain-containing protein 2 OS=Homo sapiens GN=CISD2 1,000E0 3,946E5 3,946E5 18,59 
P09543 47,5 2',3'-cyclic-nucleotide 3'-phosphodiesterase OS=Homo sapiens GN=CNP 1,000E0 3,937E5 3,937E5 18,59 
O00165 31,6 HCLS1-associated protein X-1 OS=Homo sapiens GN=HAX1 1,000E0 3,933E5 3,933E5 18,59 
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Q04898 11,6 
Putative uncharacterized protein YMR321C OS=Saccharomyces cerevisiae 
GN=YMR321C 
1,000E0 3,792E5 3,792E5 18,53 
P52434 17,1 
DNA-directed RNA polymerases I, II, and III subunit RPABC3 OS=Homo sapiens 
GN=POLR2H 
1,000E0 3,759E5 3,759E5 18,52 
Q5RFC2 64,9 Melanoma-associated antigen D2 OS=Pongo abelii GN=MAGED2 1,000E0 3,704E5 3,704E5 18,50 
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7.2 Transcriptome Analysis 
7.2.1 Trnp1 knock down versus control GFP electroporation (152 genes) 
Transcriptome analysis of Trnp1 knock-down (shRNA#5) electroporated cells versus 
control (GFP) electroporated embryonic cortical cells 24 hours post electroporation. 152 
genes fulfilled the criteria of p < 0.01, a fold change ration of > 1.5 and average expression 
> 50. Expression levels upon Trnp1 overexpression are shown for comparison.  
Probeset Gene symbol or ID 
Ratios 
(p < 0.01, 
ratio > 1.5x 
Av > 50) 
KD OE Ctrl 
KD 
vs 
Ctrl 
OE 
vs 
Ctrl 
KD 
vs 
OE 
Up regulated genes 
10584580 Snord14e 4,62 817 387 177 4,62 2,19 2,11 
10398326 Meg3 4,54 982 349 217 4,54 1,61 2,81 
10444589 Hspa1b 4,11 310 102 75 4,11 1,35 3,05 
10366951 Ndufa4l2 3,85 90 22 23 3,85 0,93 4,15 
10450369 Hspa1a 3,69 248 80 67 3,69 1,19 3,11 
10582376 Fam38a 3,28 50 18 15 3,28 1,17 2,81 
10450367 Hspa1b 2,72 285 111 105 2,72 1,06 2,57 
10427095 Tenc1 2,71 51 20 19 2,71 1,05 2,60 
10450365 ENSMUST00000082728 2,69 1071 630 397 2,69 1,58 1,70 
10372324 Syt1 2,37 52 25 22 2,37 1,14 2,07 
10407126 Plk2 2,37 388 159 164 2,37 0,97 2,43 
10384885 Spnb2 2,29 388 180 169 2,29 1,07 2,15 
10458843 Sema6a 2,24 171 138 76 2,24 1,80 1,25 
10382360 D11Wsu47e 2,24 66 44 29 2,24 1,50 1,50 
10487595 ENSMUST00000083123 2,12 58 33 27 2,12 1,20 1,77 
10506781 2010305A19Rik 1,94 56 37 29 1,94 1,29 1,51 
10524882 Wsb2 1,93 307 228 159 1,93 1,43 1,35 
10491621 4932438A13Rik 1,93 63 27 32 1,93 0,84 2,29 
10455967 2610318N02Rik 1,92 224 174 117 1,92 1,48 1,29 
10443120 Ggnbp1 1,90 226 171 119 1,90 1,44 1,32 
10422892 2410089E03Rik 1,89 117 83 62 1,89 1,34 1,41 
10427862 Cdh6 1,86 155 149 84 1,86 1,78 1,05 
10394805 2410018L13Rik 1,85 75 57 40 1,85 1,42 1,31 
10581013 Cdh11 1,80 111 77 62 1,80 1,24 1,45 
10399671 Hpcal1 1,78 72 52 41 1,78 1,27 1,40 
10596281 Dnajc13 1,74 115 73 66 1,74 1,11 1,57 
10433633 Mkl2 1,73 59 40 34 1,73 1,19 1,45 
10365302 A230046K03Rik 1,72 201 123 117 1,72 1,05 1,64 
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10503184 Chd7 1,72 280 214 163 1,72 1,31 1,31 
10548940 Lmo3 1,71 175 120 102 1,71 1,17 1,46 
10345704 ENSMUST00000083695 1,69 128 74 76 1,69 0,98 1,72 
10508228 Zmym6 1,68 76 52 46 1,68 1,15 1,46 
10355534 Tns1 1,68 108 67 65 1,68 1,04 1,61 
10569494 Tnfrsf22 1,66 56 39 34 1,66 1,16 1,43 
10394833 ENSMUST00000085626 1,66 52 43 31 1,66 1,36 1,22 
10425623 Csdc2 1,64 78 77 47 1,64 1,63 1,01 
10425799 Rnu12 1,63 89 88 55 1,63 1,60 1,02 
10515688 Szt2 1,60 221 158 138 1,60 1,14 1,40 
10448563 E4f1 1,58 94 74 60 1,58 1,24 1,28 
10437852 4921513D23Rik 1,56 328 237 210 1,56 1,13 1,38 
10422781 Rictor 1,56 85 62 54 1,56 1,13 1,37 
10366409 Zfc3h1 1,54 135 94 88 1,54 1,07 1,44 
10478854 Slc9a8 1,54 156 117 101 1,54 1,15 1,33 
10493189 Mef2d 1,53 63 53 41 1,53 1,28 1,19 
Down regulated genes 
10478401 Ttpal 0,66 37 45 56 0,66 0,80 0,83 
10560983 Dedd2 0,66 37 45 56 0,66 0,80 0,83 
10390618 Neurod2 0,66 387 541 584 0,66 0,93 0,72 
10556658 9030624J02Rik 0,66 140 195 211 0,66 0,92 0,72 
10376444 Hist3h2bb-ps 0,66 775 1041 1173 0,66 0,89 0,74 
10448030 GENSCAN00000033295 0,66 70 107 106 0,66 1,01 0,65 
10571567 Sorbs2 0,66 317 437 479 0,66 0,91 0,72 
10433691 Ntan1 0,66 101 134 153 0,66 0,88 0,75 
10447120 Tmem178 0,66 284 426 433 0,66 0,98 0,67 
10384555 Aftph 0,66 162 227 247 0,66 0,92 0,72 
10478962 2010011I20Rik 0,66 289 455 440 0,66 1,03 0,63 
10542317 Cdkn1b 0,65 686 1069 1051 0,65 1,02 0,64 
10376455 Hist3h2a 0,65 654 943 1004 0,65 0,94 0,69 
10369779 Ado 0,65 54 69 83 0,65 0,84 0,78 
10536429 Tmem106b 0,65 113 120 174 0,65 0,69 0,94 
10582474 Chmp1a 0,65 52 83 80 0,65 1,04 0,62 
10352548 Slc30a10 0,65 298 420 460 0,65 0,91 0,71 
10510176 Smarca5 0,65 86 134 133 0,65 1,01 0,64 
10553501 Slc17a6 0,64 198 314 307 0,64 1,03 0,63 
10490950 Bhlhe22 0,64 50 72 78 0,64 0,93 0,69 
10369989 Ddt 0,64 265 348 415 0,64 0,84 0,76 
10478374 Gdap1l1 0,64 132 221 207 0,64 1,07 0,60 
10545697 Dguok 0,63 44 60 69 0,63 0,87 0,73 
10476401 Plcb1 0,63 114 160 180 0,63 0,89 0,71 
10419073 Tspan14 0,63 169 173 268 0,63 0,65 0,98 
10573048 Anapc10 0,63 43 58 69 0,63 0,85 0,74 
10352092 Zfp238 0,62 606 822 970 0,62 0,85 0,74 
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10430748 Rangap1 0,62 134 264 215 0,62 1,23 0,51 
10399465 Fam84a 0,62 62 95 99 0,62 0,95 0,65 
10474867 ENSMUST00000121613 0,62 103 154 165 0,62 0,93 0,67 
10398195 Ccnk 0,62 268 378 432 0,62 0,87 0,71 
10370914 Fam108a 0,62 77 114 124 0,62 0,92 0,67 
10376459 ENSMUST00000116301 0,62 106 166 171 0,62 0,97 0,64 
10460517 Brms1 0,62 35 53 57 0,62 0,93 0,66 
10383012 Pgs1 0,62 47 76 76 0,62 1,00 0,62 
10543802 Plxna4 0,62 256 377 414 0,62 0,91 0,68 
10376603 Drg2 0,62 171 265 277 0,62 0,96 0,65 
10591472 Cdc37 0,62 215 339 350 0,62 0,97 0,64 
10388042 6330403K07Rik 0,62 625 1068 1016 0,62 1,05 0,59 
10578763 Sap30 0,61 246 390 401 0,61 0,97 0,63 
10597833 Sec22c 0,61 32 57 52 0,61 1,09 0,56 
10439695 Tagln3 0,61 435 772 712 0,61 1,08 0,56 
10544936 Neurod6 0,61 1373 1974 2255 0,61 0,88 0,70 
10604053 Nkrf 0,61 78 128 129 0,61 1,00 0,61 
10497673 Zmat3 0,60 71 85 118 0,60 0,71 0,85 
10604100 Ndufa1 0,60 318 592 527 0,60 1,12 0,54 
10538394 Plekha8 0,60 44 59 74 0,60 0,80 0,76 
10483737 Atf2 0,60 219 345 364 0,60 0,95 0,63 
10434758 St6gal1 0,60 110 181 183 0,60 0,99 0,61 
10408081 Hist1h1b 0,60 1774 2944 2967 0,60 0,99 0,60 
10576335 Def8 0,60 39 46 66 0,60 0,69 0,87 
10524310 Ttc28 0,59 511 771 862 0,59 0,89 0,66 
10391454 Vat1 0,59 202 289 342 0,59 0,85 0,70 
10486166 Ccdc32 0,59 130 225 219 0,59 1,03 0,58 
10469514 Bmi1 0,59 161 210 273 0,59 0,77 0,77 
10388520 Glod4 0,59 79 108 135 0,59 0,80 0,73 
10464586 Gstp2 0,59 244 341 417 0,59 0,82 0,72 
10494288 Golph3l 0,59 126 211 215 0,59 0,98 0,60 
10529305 Tmem129 0,59 62 99 106 0,59 0,93 0,63 
10437205 Pcp4 0,58 378 507 647 0,58 0,78 0,75 
10360202 Nhlh1 0,58 421 601 722 0,58 0,83 0,70 
10572757 Rab8a 0,58 221 382 380 0,58 1,00 0,58 
10465209 Mtvr2 0,58 361 591 621 0,58 0,95 0,61 
10503259 Trp53inp1 0,58 245 359 422 0,58 0,85 0,68 
10410370 Zfp71-rs1 0,58 46 75 79 0,58 0,94 0,61 
10547173 Zfp422 0,58 69 103 120 0,58 0,86 0,67 
10535184 Psmg3 0,57 71 136 125 0,57 1,09 0,52 
10411508 Ptcd2 0,57 67 141 117 0,57 1,20 0,48 
10591517 Cdkn2d 0,57 116 178 203 0,57 0,87 0,65 
10548857 Hist4h4 0,57 219 399 387 0,57 1,03 0,55 
10382300 Map2k6 0,56 125 204 221 0,56 0,92 0,61 
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10591726 Ecsit 0,56 58 78 103 0,56 0,76 0,74 
10550597 Fbxo46 0,56 106 129 189 0,56 0,68 0,82 
10529708 Zfp518b 0,56 123 203 220 0,56 0,92 0,61 
10410341 Zfp87 0,55 83 139 151 0,55 0,92 0,60 
10459604 4933403F05Rik 0,55 50 77 91 0,55 0,84 0,65 
10579341 Mpv17l2 0,55 294 437 540 0,55 0,81 0,67 
10469046 Phyh 0,55 85 83 156 0,55 0,53 1,03 
10577999 Unc5d 0,54 70 99 132 0,54 0,76 0,71 
10511498 Plekhf2 0,54 127 224 238 0,54 0,94 0,57 
10408200 Hist1h4f 0,53 467 764 877 0,53 0,87 0,61 
10558029 Sec23ip 0,53 118 178 224 0,53 0,80 0,66 
10427991 Trio 0,53 50 107 94 0,53 1,13 0,46 
10488589 Fam110a 0,52 216 375 420 0,52 0,89 0,58 
10531610 Rasgef1b 0,51 228 406 443 0,51 0,92 0,56 
10496621 Gtf2b 0,51 161 287 316 0,51 0,91 0,56 
10430593 Josd1 0,51 127 245 250 0,51 0,98 0,52 
10608656 NM_024475.3 0,50 53 101 106 0,50 0,96 0,53 
10397882 Chga 0,49 112 180 229 0,49 0,79 0,62 
10440344 Robo2 0,49 187 320 384 0,49 0,83 0,58 
10568553 Chst15 0,48 81 145 171 0,48 0,85 0,56 
10601878 Tceal1 0,46 71 134 154 0,46 0,87 0,53 
10378024 Mis12 0,45 71 180 156 0,45 1,16 0,39 
10574096 Ap3s1 0,44 384 865 867 0,44 1,00 0,44 
10604230 Ap3s1 0,44 398 863 901 0,44 0,96 0,46 
10455542 Ap3s1 0,44 374 861 856 0,44 1,01 0,43 
10361055 Vash2 0,43 49 87 114 0,43 0,76 0,57 
10381416 Rnd2 0,43 139 244 321 0,43 0,76 0,57 
10499643 Chrnb2 0,43 44 95 103 0,43 0,93 0,46 
10567999 Ccdc101 0,43 29 64 69 0,43 0,93 0,46 
10473349 Ypel4 0,42 102 118 245 0,42 0,48 0,86 
10408225 Hist1h4c 0,39 359 907 925 0,39 0,98 0,40 
10576639 Nrp1 0,38 110 235 290 0,38 0,81 0,47 
10484276 Neurod1 0,37 167 429 448 0,37 0,96 0,39 
10389238 Dusp14 0,36 137 322 377 0,36 0,86 0,43 
10422052 Commd6 0,32 81 168 256 0,32 0,66 0,48 
10371379 Nuak1 0,31 110 315 351 0,31 0,90 0,35 
10453555 2610044O15Rik 0,30 22 45 73 0,30 0,62 0,49 
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7.2.2 Trnp1 overexpression vs. control GFP electroporation (31 genes) 
Transcriptome analysis of embryonic cortical cells electroporated for overexpression of 
Trnp1 compared to cells electroporated with GFP control. 31 genes fulfilled the criteria of 
p < 0.01, average expression levels of > 50 and fold change ratios of > 1.5. Expression 
levels upon Trnp1 knock down are shown for comparison. 
Probeset Gene symbol or ID 
Ratios 
(p < 0.01, 
ratio > 1.5, 
Av > 50) 
KD OE Ctrl 
KD vs 
Ctrl 
OE 
vs 
Ctrl 
KD 
vs 
OE 
Up-regulated genes 
10543058 Dlx5 8,61 182 221 26 7,11 8,61 0,83 
10472809 Dlx1 5,42 156 143 26 5,94 5,42 1,10 
10483626 Dlx2 4,94 148 169 34 4,31 4,94 0,87 
10601612 Atrn 3,09 27 60 19 1,38 3,09 0,45 
10556611 ENSMUST00000083940 2,88 44 60 21 2,10 2,88 0,73 
10396466 1700086L19Rik 2,65 43 58 22 1,98 2,65 0,75 
10584580 Snord14e 2,19 817 387 177 4,62 2,19 2,11 
10360832 1700056E22Rik 2,18 81 101 46 1,75 2,18 0,80 
10357948 Ppp1r12b 2,17 101 126 58 1,74 2,17 0,80 
10384504 Meis1 1,71 52 62 36 1,44 1,71 0,84 
10381462 Rdm1 1,70 54 79 46 1,16 1,70 0,68 
10539220 AW146020 1,69 48 59 35 1,40 1,69 0,83 
10451860 Pot1b 1,69 76 107 63 1,20 1,69 0,71 
10565570 4632434I11Rik 1,64 47 70 43 1,11 1,64 0,68 
10425623 Csdc2 1,63 78 77 47 1,64 1,63 1,01 
10543118 Glcci1 1,62 226 262 161 1,40 1,62 0,86 
10398326 Meg3 1,61 982 349 217 4,54 1,61 2,81 
10586416 Pif1 1,60 50 69 43 1,16 1,60 0,72 
10382508 Ict1 1,60 193 327 205 0,94 1,60 0,59 
10458767 Trim36 1,59 64 75 47 1,37 1,59 0,86 
10443459 Srsf3 1,58 245 385 243 1,01 1,58 0,64 
10599719 Slc9a6 1,57 55 51 32 1,71 1,57 1,09 
10490653 Gmeb2 1,55 78 107 69 1,13 1,55 0,73 
Down-regulated genes 
10460085 Cndp2 0,66 102 77 116 0,88 0,66 1,33 
10452030 Plin3 0,66 40 38 58 0,70 0,66 1,06 
10419073 Tspan14 0,65 169 173 268 0,63 0,65 0,98 
10521907 1810013D10Rik 0,56 63 60 107 0,59 0,56 1,04 
10469046 Phyh 0,53 85 83 156 0,55 0,53 1,03 
10445338 Enpp5 0,51 107 50 97 1,09 0,51 2,13 
10473349 Ypel4 0,48 102 118 245 0,42 0,48 0,86 
10444068 Tapbp 0,43 71 49 115 0,62 0,43 1,44 
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7.3 Abbreviations
Amino acids 
A Ala Alanine 
R Arg Arginine 
N Asn Asparagine 
D Asp Aspartate 
C Cys Cysteine 
Q Gln Glutamine 
E Glu Glutamate 
G Gly Glycine 
H His Histidine 
I Ile Isoleucine 
L Leu Leucine 
K Lys Lysine 
M Met Methionine 
F Phe Phenylalanine 
P Pro Proline 
S Ser Serine 
T Thr Threonine 
W Trp Tryptophan 
Y Tyr Tyrosine 
V Val Valine 
 
 
 
 
 
 
 
Nucleobases 
A Adenine 
C Thymine 
G Guanine 
T Cytosine 
U Uracil 
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General Abbreviations 
% Percent 
°C Degrees Celsius 
3’-UTR 3’-UnTranslated Region 
5’-UTR 5’-UnTranslated Region 
aa amino acid 
APS Amonium PerSulfate 
bHLH Basic Helix Loop Helix 
bp base pair 
BP Basal Progenitors 
BrdU 5-Bromo-2’-deoxyUridine 
bRG 
basal Radial Glia (also 
called oRG) 
BSA Bovine Serum Albumine 
cDNA 
complementary 
DeoxyriboNucleic Acid 
CNS Central Nervous System 
CP Cortical Plate 
Ctx Cortex 
DAPI 
4′,6-DiAmidin-2-
PhenylIndol 
Dcx Doublecortin 
dd double distilled (ultrapure) 
DG Dentate Gyrus 
Dlx Distal less homeobox 
DMEM 
Dulbecco’s Modified Eagle 
Medium 
DNA DeoxyriboNucleic Acid 
dNTP 
deoxyriboNucleoside 
TriPhoshate 
ds 
double stranded 
(DNA/RNA) 
E.coli Escherichia coli 
FACS 
Fluorescence Activated Cell 
Sorting 
FCS Fetal Calf Serum 
FRAP 
Fluorescence Recovery after 
Photobleaching 
g grams 
GABA 
Gamma-Amino Butyric 
Acid 
GCL Granule Cell Layer 
GE Ganglionic Eminence 
GFAP 
Glial Fibrillary Acidic 
Protein 
GFP Green Fluorescent Protein 
GL  Glomerular Layer 
h hours 
HBSS 
Hank’s Balanced Salt 
Solution 
HCl Hydrochloric acid 
HEPES 
4-(2-Hydroxyethyl)-1-
piperazineethanesulfonic 
acid 
HRP HorseRadish Peroxidase 
IgG/IgM Immunoglobuline G/M 
INM 
Interkinetic Nuclear 
Migration 
IRES 
Internal Ribosomal Entry 
Site 
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ISH In Situ Hybridization 
IZ Intermediate Zone 
kb kilobase 
kDa kiloDalton 
kg kilograms 
LB Luria-Bertani medium 
LGE 
Lateral Ganglionic 
Eminence 
Mash1 
Mammalian achaete scute 
homologue 1 
MGE 
Medial Ganglionic 
Eminence 
min minute 
ng nanograms 
Ngn2 Neurogenine 2 
NP-40 Nonidet P-40 
o.N. Over Night 
OB Olfactory Bulb 
oRG 
outer Radial Glia (also 
called bRG) 
PAGE 
PolyAcrylamide Gel 
Electrophoresis 
Pax6 Paired box gene 6 
PBS Phosphate Buffered Saline 
PCR Polymerase Chain Reaction 
PDGFR 
Platelet Derived Growth 
Factor Receptor  
PDL Poly-D-lysine 
PFA ParaFormAldehyde 
PH3 Phospho-Histone 3 
RC2 Radial glial Cell marker 2 
RG Radial Glia 
RMS Rostral Migratory Stream 
RNA RiboNucleic Acid 
rpm revolutions per minute 
RT Room Temperature 
s seconds 
SDM 
Standard Deviation 142ft he 
Mean 
SDS Sodium DodecylSulfate 
SEM Standard Error of the Mean 
SEZ SubEpendymal Zone 
SGZ SubGranular Zone 
shRNA Short hairpin RNA 
ss 
single stranded 
(DNA/RNA) 
SVZ Subventricular Zone 
TAE Tris Acetate EDTA buffer 
TAP 
Transit Amplifying 
Precursor 
TBR1/2 
T-Box tRanscription factor 
1/2 
TBS Tris Buffered Saline 
TBST 
Tris Buffered Saline with 
Tween 20 
TE Tris-EDTA buffer 
TEMED 
N, N, N’, N’-TetraMethyl-
EthylenDiamine 
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Tris 
Tris-(Hydroxymethyl)-
aminomethane 
Trnp1 
TMF regulated nuclear 
protein 1 
Tween 20 
polyoxyethylensorbitan-
monolaurate 
U enzyme units 
UV UltraViolet light 
V Volts 
v/v volume per volume 
VZ Ventricular Zone 
w/o without 
w/v weight per volume 
wt wild type 
µg Microgram(s) 
µl  Microlitre(s) 
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8 Plasmid maps 
8.1 pCMV-Sport6-Trnp1 
 
8.2 pENTR1A-Trnp1 
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8.3 pCAG-Trnp1-GFP 
 
8.4 pCAG-Trnp1-dsRed 
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8.5 pSUPER-shRNA 
 
8.6 pLVTHM 
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8.7 pLVTHM-shRNA 
 
8.8 pSUPER.GFP/Neo-shRNA 
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8.9 peGFP-Trnp1-N3 
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